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The expression of extracellular proteolytic activities is highly regulated in both
prokaryotic and eukaryotic systems. This regulation can occur at multiple levels
including expression of the protease genes, secretion, processing of an inactive secreted
precursor to its active form and/or the posttranslational glycosylation of the proteins.
These regulatory mechanisms are vital to ensure that expression is tightly controlled.
Porphyromonas gingivalis has been associated with adult periodontitis and in the
development of many systematic diseases. The major virulence factors of P. gingivalis,
the gingipains, are responsible for pathogenesis including degradation of complement
and immunoglobulin, inactivation of cytokines and their receptors, aggregation of
platelets, attenuation of neutrophil antibacterial activities, and increase in vascular
permeability and blood clotting prevention. How these gingipains are regulated is poorly
understood. We focused on identifying possible regulators and/or mechanisms P.
gingivalis possesses for the regulation/activation of the gingipains, in addition to other
virulence factors. We have identified and characterized three novel genes, vimA, vimE
and vimF, which are involved in the maturation/activation of the virulence factors of P.
gingivalis. The identification of the production of inactive gingipains and altered
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carbohydrate modification of these gingipains from these isogenic mutants suggests
gingipain maturation may be dependent upon proper carbohydrate biogenesis. We have
also provided evidence for the importance of carbohydrate biogenesis in anchorage of the
gingipains to the cell surface. Protein interaction studies demonstrated the interaction of
the gingipains with VimA and VimE, further suggesting the involvement of VimA and
VimE in a pathway for gingipain maturation. We have also identified other regulatory
proteins in P. gingivalis that interacts with the VimA and VimE proteins. We have also
demonstrated that the periplasmic serine protease, HtrA, and the newly identified RegT,
may play a role in regulating the gingipains and/or growth of P. gingivalis under stressful
environmental conditions. Immunoblot analysis of P. gingivalis challenged mice and/or
periodontitis patients have identified the VimA and/or VimE proteins as excellent
candidates for a therapeutic approach against this periodontal pathogen. Taken together,
we have provided evidence that VimA, VimE and VimE, in addition to proper
carbohydrate biogenesis, play a role in gingipain regulation.
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CHAPTER ONE
INTRODUCTION

It is well documented that Porphyromonas gingivalis is an important etiological
agent of periodontal disease (81). In addition, there is accumulating evidence that
suggests that this organism is associated with several systematic diseases, including
cardiovascular disease (88). While several virulence factors have been identified, there is
still a gap in our understanding of their regulation. It is imperative to understand the
regulatory mechanisms this organism utilizes to regulate their virulence factors and to
ensure its infection, colonization and survival in the host. Knowledge on these
mechanisms will help us design therapeutic strategies to prevent P. gingivalis associated
diseases. This introduction will discuss the role of P. gingivalis in periodontal disease and
other systemic diseases and the known regulatory factors/mechanisms in P. gingivalis
and in other organisms. The maturation, regulation and/or activation of the gingipains and
other cysteine proteases are discussed.

The Anatomy of the Oral Cavity and Periodontal Disease.
Periodontal diseases, which are common among adults, are a group of diseases
that affect the tissues that support and anchor the teeth. Left untreated, periodontal
disease results in the destruction of the gums, alveolar bone (the part of the jaws where
the teeth arise), and the outer layer of the tooth root (16,85,169). Periodontal disease can
range from gingivitis to the advance stages of periodontitis (see figure 1.1). Stages of
periodontal diseases include gingivitis, mild periodontitis, moderate to advanced
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periodontitis. In gingivitis, plaque deposits cause inflammation of the gums, which results
in possible bleeding when brushing. Gingivitis affects about 50% of the population.
Periodontitis is characterized by the hardening of plaque, forming a callus which will
result in the receeding of the gums (132). Periodontal disease occurs in about 80% of the
population. Excessive tissue loss of the gingival tissue and alveolar bone is observed in
advanced periodontitis (132,167). Pockets will form ranging between 3.5-5.5 mm.
Pockets greater than 5.5mm are observed in patients with advanced periodontitis (32),
which leads to destruction of connective ligaments and eventually tooth loss. Periodontal
disease is usually seen as a chronic inflammatory disease. Toxins and virulence factors
from periodontal pathogens cause gum irritation, which stimulates a chronic
inflammatory response leading to the destruction of bone and connective tissue that
support the teeth.
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A

B

C

Figure 1.1. Stages of periodontal disease. A= normal, B= gingivitis, C= Advanced periodontits
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Risk Factors for Periodontitis
Smoking
There are many risk factors for periodontitis. One of the major risk factors
includes smoking. It has been well documented that smoking can cause a reduction or
alteration in saliva production (23,85,122,150,150). Saliva has many antibacterial
components which will protect against periodontal disease and the over-growth of
harmful bacteria in the oral cavity. In addition, smoking can reduce the immune system
function and antibody production in the saliva (17,27,79,114,122). This reduction in
antibodies may result in periodontal disease (17).

Genetics
While microbial and other environmental factors are shown to play a major role in
periodontal disease, there is strong evidence linking certain genetic polymorphisms to
aggressive periodontitis (86,95,109,110). Studies have shown that 30% of individuals are
predisposed to periodontitis. In spite of proper hygiene, these individuals developed
periodontitis (109,110). Some hereditary conditions cause alterations in neutrophil
function and numbers which can result in periodontal disease (3,15,18,19,67).
Polymorphisms in the IL-1 gene, TNFa gene, and the Fc-gamma receptor gene have been
shown to be associated with periodontitis (86,95).

Stress
Stress has been known to modulate the immune response of healthy individuals
(70,74,79). This modulation can weaken the immune defenses against harmful pathogens.
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Houri-Haddad et al has shown that stressed mice challenged with P. gingivalis altered the
response to P. gingivalis (74). A low ratio of IgGl/IgG2 was also observed in stressed
mice (74). It was also demonstrated that stress alters the response of macrophages to
inflammatory signals (74). Collectively, these observations have suggested an upregulation of inflammatory mediators in stressed mice can accelerate periodontal
destruction.

Pregnancy and the Menstrual Cycle.
During pregnancy, many tissues of the body, including the gums, are very
sensitive to the fluctuations to hormones (13,30). A study by Yuan et al. and others
showed that healthy women can have changes in the gums during different stages in the
menstrual cycle (105,155). Most women in the study exhibited oral irritation just before
their menstrual period. Further, during the first months of pregnancy, plaque build-up
causes an inflammation of the gingival tissue which can result in periodontal disease
during the end months of the pregnancy. It has been documented that there is a
correlation between periodontal disease and preterm labor or even still birth of babies
(123,139).

Diabetes
Diabetes is a disease in which blood glucose levels are above normal. Individuals
will diabetes have problems utilizing carbohydrates. Cells use insulin to enable them to
convert glucose into energy. A diabetic’s pancreas does not make enough insulin or cells
in these individuals cannot use insulin properly. As a result, the level of blood glucose
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increases as cells are starved for energy. Over the years, high blood glucose, known as
hyperglycemia, can lead to several complications including damaged nerves and blood
vessels, heart disease and stroke, kidney disease, blindness, nerve problems, gum
infections and amputations. Diabetes, similar to periodontitis can result in the release of
proinflammatory cytokines (88). Periodontal disease can predispose an individual to
diabetes type 2, or in a similar manner, diabetes can predispose an individual to
periodontitis (41,88,120). It is important for a diabetic or pre-diabetic individual to
practice good oral care.

Complications of Periodontitis
In the 1890s, a physician by the name of W.D. Miller said “...various diseases,
both local and general, which have been found to result from the action of micro
organisms which have collected in the mouth, and to the various channels through which
these micro-organisms or their waste products may obtain entrance parts of the body
adjacent to or remote from the mouth...” For a long time, suggestions have been made
about links between periodontal disease and local and systemic diseases. Presently, there
is emerging evidence supporting an association between periodontal disease and local
and systemic diseases (41).

Respiratory Diseases
There have been implications of periodontal disease with respiratory diseases and
disorders. It has been suggested that saliva of infected individuals will carry bacteria,
bacterial antigens, lipopolysaccharides, enzymes and more (159). Aspiration of saliva
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from infected individuals will promote an inflammatory response in the respiratory tract
and may lead to infections in the airways. It is also a possibility that the increased
inflammatory mediators found in the saliva of infected individuals, when aspirated, may
also cause airway infections (159).

Cardiovascular Disease
It has become clear that chronic inflammatory conditions increase the risk of
atherosclerosis (41,88,159). There may be a great risk of cardiovascular disease and
periodontal disease because of the high inflammatory nature of periodontitis (87). It has
been proposed that spread of the infection leading to transient bacteremia will cause
microbial toxins to be released in the blood. These bacterial toxins will then stimulate an
inflammatory response. This inflammatory response can cause platelet aggregation and
thromboembolic effects (14,42). In addition, P. gingivalis is able to invade endothelial
cells and multiply within the cells. The development of atherosclerosis can also be
influenced by the lipopolysaccharides of these periodontal pathogens. Free
lipopolysaccharides will cause activation of the leukocytes, platelets and the endothelium.
Binding of LPS to CD 14 receptors on the phagocytic cells, (monocytes, macrophages),
and the surface of the endothelial occurs. The increase in adhesion molecules would
facilitate leukocyte attachment and migration into the arterial region, leading to an
increase in foam cell formation resulting in atherosclerosis (93,94).
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Stroke
Clinical studies by Grau et al and others showed that individuals with severe
periodontitis has a 4.3 times high risk of a cerebral ischemia than a person with mild
periodontitis or a normal individual (60). The risk was also greater in infected men and
women over 60 years (41,47,60). It was concluded that the increased risk was a result of
atherosclerosis of the large artery and also cardioembolism.

Preterm Labor
Preterm labor has been shown to be caused by bacterial infections and accounts
for 30-50% of preterm births (123). Bacterial infections often lead to infection of the
chorioamnion, extraplacental membranes. This may result in rupturing of the membranes.
The physiology of bacterial-induced preterm labor involves the production of cytokines
and the production of prostaglandins. Abnormal production of these mediators triggers
preterm labor (71,123). In a normal pregnancy, these mediators rises until a threshold is
reached, which will stimulate labor. Studies have shown that there are some correlations
between periodontal disease and preterm delivery (139). In one study, there was a
significant correlation and association with oral pathogens and pregnancy complications.
Fusobacterium nucleatum was detected in 12% of infected amniotic fluid (66). These
periodontal pathogens in the mother may influence the outcome of the pregnancy either
by stimulating an inflammatory response or a direct involvement of the pathogen on the
amnion (71,133,134). A life threatening complication of periodontal disease during
pregnancy is a condition called TTP (50,80). This is a rare disease caused by
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microvascular lesions with platelet aggregation. This condition is associated with
pregnancy among other conditions, including periodontal disease or decaying teeth.

Bacterial Endocarditis
It has been reported that oral pathogens can enter the blood and cause localized
infections in the heart known as infective endocarditis (4,102,151). Oral pathogens that
has been identified from infected hearts includes Streptococcus, Porphyromonas,
Fusobacterium and Actinobacillus (4,11,102,136,143).

Oral Pathogens and Their Involvement in Periodontal Disease.

Identification of Oral Pathogens
Individual organisms are important in periodontal disease. However, it has been
suggested that bacterial interaction with other bacteria and host tissues are important in
the development of periodontal disease (88). These oral pathogens can be identified using
conventional methods, such as culturing, and/or more modern methods, which include
DNA probes for the highly specific 16S rRNA, or PCR (89,90,152). Pathogens which
have been identified in dental caries and periodontal disease includes, Streptococcus.
gordonii, Streptococcus mutans, Actinobacillus actinomycetemcomitans, Bacteroides
fragilis, Treponema denticola, Fusobacterium nucleatum, Porphyromonas. gingivalis
and recently identified E. corrodens and C. rectus. Of these pathogens, A.
actinomycetemcomitans and P. gingivalis have been shown to be the two most important
periodontal pathogens.
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Biofilm and Dental Plaque Formation by Oral Bacteria
Dental plaque is a type of bacterial biofilm formed by oral microbes. Plaque is
defined as a community of microorganism found on the tooth surface in an extracellular
matrix composed of polymers of both microbial and host origins (135). Polymers of the
extracellular matrix are made up of both soluble and insoluble sugars, such as fructans
and glucans (5,135,137). Dental plaque development occurs in five different stages: 1)
Adsorption of host and bacterial molecules to the tooth surface; 2) Passive transport of
oral bacteria to the tooth surface; 3) Co-adhesion of later colonizers to already attached
early colonizers; 4) Multiplication of attached microorganisms and 5) Active detachment.

The Role of Porphyromonas gingivalis in Periodontitis.
Periodontal disease is assumed to be an imbalance of the normal flora in the oral
cavity. There are over 700 different microbial species present in the oral cavity; however,
only a few have been reported to contribute to periodontal disease, as previously
mentioned. Of these organisms, P. gingivalis has been shown to be present in high
numbers in infected individuals. P. gingivalis is a Gram-negative, black pigmented,
asaccharolytic bacteria. P. gingivalis is a secondary colonizer, which is attached when
primary colonizers, which may reduce the oxygen tension in the oral cavity, making the
environment conducive for P. gingivalis (140,141). The host will defend itself against P.
gingivalis leading to an inflammatory response.
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The Inflammatory Response to P. gingivalis
Humans are equipped with mechanisms to recreate homeostasis within the body.
When the imbalance of bacterial pathogens occurs, (ie. P. gingivalis), host cells release
pro-inflammatory cytokine. Pro-inflammatory cytokines include interleukins 1, 6 and 8 in
addition to TNFa (55,157). It also have been documented that the virulence factor of P.
gingivalis, the gingipains can degrade tumore necrosis factor-alpha (TNFa) (28).
Neutrophils are recruited to infected areas by interleukin signals. These neutrophils
produce proteolytic enzymes and reactive oxygen species (ROS) from the oxidative
bursts (33,140). Superoxide is released in the phagosome and then into the surroundings.
The release of superoxide into the environment not only damages the bacteria, but also
causes tissue destruction of the host. Neutrophils will attract other neutrophils which will
amplify the inflammatory response.

Survival Strategies of Porphyromonas gingivalis in an Inflammatory, Oxidative
Stressful Environment, the Periodontal Pocket.

Oxidative Stress Resistance
The periodontal pocket can be a very hostile environment for P. gingivalis, an
anaerobic pathogen. The periodontal pocket undergoes many environmental changes that
can affect bacteria that reside in the oral cavity. Infection with P. gingivalis often leads to
an inflammatory response by the host, a condition that will lead to the increase in ROS or
the depletion of antioxidant molecules and/or enzymes constitute oxidative stress (34). It
is imperative that the organism P. gingivalis posses a mechanism to survive in such a
harsh environment of oxygen and oxygen radicals. In addition, the occasional exposure of
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P. gingivalis to air can give rise to the metabolic conversion of atmospheric oxygen to
ROS (9). P. gingivalis possesses a coordinately regulated system that protects against
oxidative stress. These mechanisms includes the antioxidant enzymes (i.e superoxide
dismutase, peroxidase, and oxidase) (9). It has been shown that the ahpC, rbr and dps
genes play a role by providing protection against oxidative stress (78,158,162). P.
gingivalis also has the ability to accumulate hemin on the surface of the cell. This hemin
layer contributes to the black-pigmented phenotype observed when plated on brucella
blood agar plates. It has also been suggested that this hemin layer can be used by the
organism to protect against oxidative stress (44). The p-oxo dimers help degrade reactive
oxygen species and H2O2 (44).

Chaperones: Microbial Stress Response
Elevated temperatures are also observed in the highly inflammatory oral cavity. In
addition, other bacteria present in the cavity may produce compounds that may alter the
pH of the cavity, which is normally pH 6.9. Exposure to these altered environmental
conditions causes P. gingivalis to up-regulate the expression of heat-shock proteins
(HSPs)(59). These HSPs acts a chaperone that aids in the assembly and folding of
proteins. They can also act as proteases to degrade damaged proteins to help maintain
homeostasis in the organism (59). HSPs help to protect the organism against the harmful
effects of altered environmental conditions. It is imperative that P. gingivalis have these
very important proteins including GroES, GroEL, DnaK, HtpG [Reviewed in
(12,59,104,106,170)] and HtrA (see chapter 7). It has also been suggested that microbial
HSPs may be virulence factors (59). Several groups have reported that soluble HSPs can
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bind toll like receptors leading to an immune response, which will lead to the production
of pro-inflammatory cytokines. Antibodies to HSPs have been shown to be a risk factor
for carotid atherosclerosis (125).

Evaluating the Virulence of P. gingivalis

Animal Models Used to Study P. gingivalis Pathogenesis and Periodontal Disease.
Several animal models have been used to study the pathogenesis of P. gingivalis
and its role in periodontal disease [Reviewed in (58,72)]. Models that have been used
previously include primates, dogs, rodents and sheep (72). Primates, canine and rodent
models have been used for testing the ability of P. gingivalis to invade periodontal tissues
(72). Primate models have been used to examine the disease process and host response to
P. gingivalis and also vaccine testing (72). The effects of P. gingivalis on pregnancy have
been studied in hampsters (72).

Rats have also been used for several studies. Rat periodontal anatomy is very
similar to the humans [Reviewed in (58,72)] . In a rat model, mediators that stimulate
bone resorption were studied. In addition, the affects of diabetes on periodontal diseases
have been studies using a rat model [Reviewed in (58,72)]. To study the pathogenesis of
P. gingivalis, mouse models have been utilized. Baker et al have developed a murine
model to examine oral infections with P. gingivalis (16). A murine abscess model been
used by many investigators to examine the virulence factors on pathogenesis (82,83).
Subcutaneous infections would result in primary lesions at the site of infection and
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secondary lesions away from the infection site. This model has also been used to examine
P. gingivalis on virulence (53).

The Virulence Potential of P. gingivalis.
Subcutaneous injections of mice with P. gingivalis cells results in massive lesions
resulting in the destruction of the soft tissue. The size of the lesions varies among the
different strains of P. gingivalis [Reviewed in (58,72)] . Secondary lesions also form with
the most virulent strains of P. gingivalis (i.e. strain ATCC 53977) [Reviewed in (58,72)].
It has been documented that non-pigment strains of P. gingivalis are avirulent in a murine
model. Fletcher et al. were the first to demonstrate the role of the gingipains in the
pathogenesis of P. gingivalis (53). Kesavalu et al also demonstrated that the gingipains of
P. gingivalis were the major virulence factor that contributes to the lesion formation and
death of the animal (83).

Major Virulence Factors in P. gingivalis.
Many organisms have the ability to adapt to the harsh environment of the host.
The role of P. gingivalis in periodontitis has been the focus of much attention. Several
virulence factors, which can contribute to the pathogenicity of P. gingivalis, have been
suggested. These include fimbriae (adhesins), capsule (anti-phagocytosis),
lipopolysaccharide (bone resorption), proteases (specific and generalized tissue
destruction) and a variety of toxic by-products (e.g., ammonia). Much progress has been
made in defining the specific roles of several of the virulence factors in P. gingivalis
pathogenesis (72). Fimbriae, hemagglutinins and proteases are three of the virulence
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factors which have received much attention (38). In spite of these developments however,
there is a gap in our understanding of the regulation/modulation of these virulence
factors.

Proteases
While several virulence factors are implicated in the pathogenicity of P.
gingivalis, the high-level proteolytic abilities of this organism have been considered to
play the most significant role in its virulence (75,161). The classification of these
proteases has been evaluated by their catalytic functions. The classification includes the
serine, aspartate, thiol and metalloproteinase (72,121). Of these, the collagenases,
aminopeptidases and the trypsin-like proteinases have been shown to be the major key
players in the pathogenesis of P. gingivalis. The trypsin-like proteases recently have
been the focus of study. The major trypsin-like proteases, designated the gingipains {P.
gingivalis +clostripain), are both extracellular and cell-associated (39,129). They consist
of arginine-specific protease [Arg-gingipain, (Rgp)] and lysine-specific protease [Lysgingipain, (Kgp)] (see figure 1.2 and 1.3). The Rgp is encoded by two genes rgpA and
rgpB and Kgp is encoded by a single gene kgp (118). Each gene product is
posttranslationally modified as depicted in figure 1.4.

Several reports have documented

the multiple effects of proteases, which in addition to being essential for growth, play a
role in complement and immunoglobulins degradation, inactivation of cytokines and their
receptors, platelet aggregation, attenuation of neutrophil antibacterial activities, and
increasing vascular permeability as well as prevention of blood clotting (128).
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Proteases may also affect the expression of the other virulence factors. Nakayama
et al. created a rgpA-rgpB double mutant and demonstrated that this arginine-specific
cysteine protease null mutant had few fimbriae on the cell surface when compared to the
wild-type strain (119). Tokuda et al. showed that attachment to human oral epithelial
cells and interaction with other gram-positive bacteria was significantly reduced in a
protease deficient mutant (92,160). The reduced fimbrial expression resulted from an
alteration in transcription of the fimA gene due to the protease defect. Recently, the
proteases have been shown to be involved in hemoglobin binding and adsorption and
heme accumulation further confirming their multiple effects on cellular functions
(7,91,101).
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Fimbriae
Fimbriae appear to be a major adherence-mediating determinant in P. gingivalis
that is also important for invasion of epithelial cells (6,8,42,98,166). Genco et al cloned
and determined the nucleotide sequence for the flmA gene and showed that its
inactivation results in loss of fimbriae production and a phenotype significantly less able
to cause periodontal bone loss in a genotobiotic rat model (107,153). Immunization with
the purified fimbriae resulted in protection against periodontal destruction (49). An
immunodominant epitope from the fimbrial subunit protein was shown by Ogawa et al. to
induce humoral and cellular responses in guinea-pigs and mice (124). This epitope also
produced protective immunity in guinea-pigs infected with P. gingivalis. Lament et al
has shown that purified fimbriae blocked invasion of this organism into normal human
gingival epithelial cells in a dose dependent manner (166). In addition, a fimbriaedeficient mutant was impaired in its invasion capability (166). Other evidence shows
that monoclonal antibodies raised against P. gingivalis fimbriae can be used to prevent
the adherence of P. gingivalis with human epithelial cells (49). This protein or its
subunit peptides may be attractive candidates for vaccine development.

Hemagglutinins.
Hemagglutinins are also proposed to have adhesive properties for P. gingivalis,
allowing it to colonize oral tissue (24,115). Progulske-Fox et al studied the role of
hemagglutinins in the pathogenicity of P. gingivalis. Five genes encoding
hemagglutinins have been identified by this group (99). Disruption of several of those
genes has confirmed their involvement in the hemagglutination phenotype of P.
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gingivalis (99). In addition to in vivo expression of the hemagglutinin genes in a mouse
model, growth phase and hemin levels can modulate their expression (100).
Hemagglutinins are also structurally associated with the gingipains (127,130,142). This
was confirmed as conserved DNA sequences found in these genes were present in the
rgpA and kgp genes (65). In addition, monoclonal antibody against this conserved region
can inhibit hemagglutination, thus implicating this sequence as an important potential
target for vaccine development.

Lipopolysaccharide (LPS)
Lipopolysaccharide of bacteria contributes to their antigenicity and is also
responsible for the inflammatory immune response of the host towards the organism. LPS
consists of two components-lipid A (which is anchored to the cell wall) and the
polysaccharide which is attached to the lipid A through a ketosidic bond. The LPS of P.
gingivalis has been shown to be involved in bone readsorption and alveolar bone loss
(73,154). It has also been reported that the LPS can cause a foam cell formation which
may be correlated with atherosclerosis (131). Collectively these data suggests that the P.
gingivalis lipopolysaccharides play an important role in the pathogenicity of P.
gingivalis.

Capsule
Most strains of P. gingivalis have a capsule layer. Non-capsulated strains also
exist. It has been documented that the capsule of P. gingivalis is correlated with the
virulence of P. gingivalis (26,164). Six encapsulated strains of P. gingivalis was shown to
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cause ulceration and necrosis of skin tissue and caused significant weight loss (96). Non
capsulated strains of P. gingivalis was shown to cause local lesions (96). The capsule of
P. gingivalis were also shown to be involved in the resistance to phagocytosis (26,164).

Membrane Vesicles
Membrane vesicles contain components of the cell membrane, including outer
membrane proteins and lipopolysaccharides (171). Formation of these vesicles is
regulated by cell wall turnover and mechanical motion that may shear the blebs, thus
facilitating their release into the culture medium (171). Membrane vesicles can act as
molecular vehicles carrying virulence factors to the host. It has been reported that the
membrane vesicles of P. gingivalis can degrade the ApoB-100 protein of low density
lipoprotein (LDL) (113). It was also shown to play a role in foam cell formation (131).
Grenier et al demonstrated the ability of membrane vesicles to promote bacterial
resistance against bacterial activity in human serum (61,62).

Regulation of Virulence in P. gingivalis
Environmental Regulation of Virulence
Pathogenic bacteria have the ability to modulate the expression of genes that
encode virulence factors in response to different environmental signals during the course
of infection. These virulence genes are integrated into sophisticated regulatory networks
to facilitate differential expression when needed (54). Several factors, including iron
concentration, pH, osmolarity, temperature and anaerobiosis have been shown to
coordinately regulate the expression of bacterial virulence genes (54,116).
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Temperature
P. gingivalis responds to elevated temperatures by decreasing the expression of
their virulence factors. Prolonged growth at temperatures above 37°C resulted in a
significant decrease in gingipain activity (54,117,126). The decrease in proteolytic
activity could be correlated with a down-regulation of the gingipain gene transcript which
were observed in P. gingivalis cells grown at elevated temperatures (54,126). Distribution
of the gingipains also appeared to be more cell associated when incubated at elevated
temperatures (117). A reduction in hemagglutanin activities was also observed from cells
grown at increased temperatures (126).

Iron and Hemin
Iron and hemin are essential for P. gingivalis virulence, including growth,
gingipain activity and survival (43,84). Decreased virulence potential was observed when
iron-deprived P. gingivalis cells were used to challenge mice (84). In addition, P.
gingivalis cells, which were grown on blood agar plates, were more virulent that P.
gingivalis grown in broth with hemin as the only source (84).

Regulatory Genes Involved in Virulence Regulation
Eukaryotic host cell contact can trigger the transcription of bacterial virulence
genes. The adaptive response, which is often mediated by two-component regulatory
system can also be modulated by histone-like proteins. The mechanism(s) of how
bacterial virulence factors are regulated are not well understood. Our knowledge of their
interaction or coordinate regulation is unknown or implied, at best. If the expression of
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groups of virulence factors required at the same stage of the infection is modulated in a
coordinated fashion via common regulatory pathways, the characterization of the
regulatory genes are of critical importance in understanding the mechanisms of
pathogenesis for P. gingivalis. Only recently, it has been shown that multiple nongingipain genes including the recA, vimA,porR and gppX genes can modulate proteolytic
activity in P. gingivalis (1,2,68,149).

The Role of recA in P. gingivalis
The recA gene product is involved in DNA repair in many organisms. A
Porphyromonas gingivalis FLL32, a recA mutant, was non-pigmented, lacked betahemolytic activity on blood agar and produced significantly less proteolytic activity (2).
Expression of the gingipain genes was unaltered in FLL32 when compared to FLL33 and
the wild-type strain (2). P. gingivalis FLL33 phenotype was very similar to the phenotype
of the parent strain (52). FLL32 exhibited reduced virulence in a murine model and
partially protected the animals immunized with that strain against a subsequent lethal
challenge by the wild-type strain (2). These results indicate that the reduced level of
proteolytic activity in FLL32 may be due to a defect in the processing of the proteases. In
addition, immunization with a non-virulent recA defective mutant of P. gingivalis can
partially protect against a lethal wild-type challenge (2).

Since several known environmental factors can influence virulence gene
expression in P. gingivalis, the influence of these signals on the expression of recA in P.
gingivalis may also be affected. P. gingivalis FLL118, containing a transcriptional fusion

44

of the recA promoter region and the promoterless tetracycline-resistant gene [tetA(Q)2]
and xylosidase/arabinosidase (xa) gene cassette, was constructed and used to evaluate the
influence of these environmental factors on recA (103). Alteration in recA expression was
shown in response to hemin limitation and also in the presence of calcium (increase in
recA promoter activity) (103). Temperature also affected the expression. The highest
level of xylosidase activity was observed in cultures at 32°C with a decline of
approximately 46% as growth temperature increased to 41° C (103). These results
suggest that expression of the recA gene in P. gingivalis W83 is responsive to several
environmental signals.

The Role of vimA in P. gingivalis
Downstream of recA, a 0.9-kb open reading frame was isolated, cloned and
insertionally inactivated using the ermF-ermAM antibiotic resistance cassette. Through
allelic exchange, the

-defective mutant was constructed (1). It has been shown that

recA and vimA are part of the same transcriptional unit (see figure 1.5) (1). When plated
on Brucella blood agar, the mutant strain, designated P. gingivalis FLL92, was non-black
pigmented and showed to be non-hemolytic in comparison to the parent strain, P.
gingivalis W83 (1). Arginine- and lysine-specific cysteine protease activities, which were
mostly soluble, were approximately 90% lower than that of the parent strain(l).
Expression of the gingipain genes was unaltered in P. gingivalis FLL92. In contrast to the
parent strain, P. gingivalis FLL92 showed increased autoaggregration in addition to a
significant reduction in hemagglutinating and hemolysin activities.
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Figure 1.5. The recA locus with the two downstream genes. The recA locus in
composed of the bcp, recA and vimA genes. The hypothetical genes, Pg0791 and
Pg0792 are downstream of this locus.
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In in vivo experiments using a mouse model, P. gingivalis FLL92 was dramatically less
virulent than the parent strain (1). Taken together, these results suggest that the recA
downstream gene, designated vimA (virulence-modulating gene), plays an important role
in virulence modulation in P. gingivalis W83, possibly representing a novel
posttranscriptional or translational regulation of virulence factors in P. gingivalis.

The Role ofporR in P. gingivalis
Shoji et al. have identified a gene that possesses a possible regulatory role in
regulating the virulence factors of P. gingivalis. Gene targeted mutagenesis of the porR
gene resulted in non-pigmented, reduced proteolytic mutants of P. gingivalis (149).
Delayed maturation in fimbrillin as well as gingipain activity was observed. Mutation in
the porR gene also resulted in altered distribution of the gingipains and altered cell
surface polysaccharide profiles in comparison to the wild-type (149). Also, monoclonal
antibody, mAblBS, raised against the fully modified Rgp, did not display any
immunoreactivity in the porR mutant in contrast to the wild-type (40,149). The PorR
shows similarities in proteins involved in LPS biogenesis and sugar containing antibiotics
for other bacteria (149). The homologue to this gene product is in the degT family, which
is thought to be a sensor kinase in a two-component regulatory system of Bacillus
stear othermophilus (149) . Taken together, these results shown that porR plays a role in
the biogenesis of cell surface polysaccharides that may function in the anchorage of the
virulence factors to the cell surface of P. gingivalis.
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The Role of gppX in P. gingivalis
Hasegawa et al demonstrated the first two-component regulatory system that is
involved in the regulation of many of the virulence factors of P. gingivalis (68). A gppXdefective mutant was non-pigmented when plated on blood agar plates. In addition, there
was an alteration in the distribution of the gingipains (68). In stationary phase the
gingipain activity was about 50% of the parent strain (68). Fimbrillin maturation was not
affected by the mutation. Transcriptional analysis of these mutants in comparison to the
wild-type showed no alteration in the transcriptional levels of the gingipain genes of the
vimA or porR transcripts(68). Taken together, these results demonstrate the importance of
this two-component regulatory sensor kinase in the maturation and localization of the
gmgipams.

Involvement of Other Genes
Collectively, these studies suggest that defects in post-translational modification
of the gingipains can affect their activation and distribution. Further, it has been shown
that LPS modifications at the C-terminus of the gingipains are needed for the anchorage
to the surface of the cell (57). Also, additional studies of non-pigmented mutants showed
that mutations that occurred in Kgp or glycosyl transferase genes played a role in the iron
accumulation and pigmentation, fimbrillation, and reduced proteolytic, hemolytic and
hemagglutanin properties of the organism (36).
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Regulation of Gingipains by Antimicrobial Agents
Antibiotics are used for treatment of many different bacterial infections. Antibiotics
work in different ways. They can target the cell wall synthesis

(ie. penicillins), inhibit

the cell membrane (ie. polymyxin), disrupt protein synthesis (ie. tetracyclines and
macrolides), target nucleic acids (ie. quilonones), and there are also competitive
inhibitors (ie. sulfonamides). Tetracyclines, in addition to antimicrobial properties, have
been shown to have directly inhibit Rgp activity (63,76). It was suggested that
tetracyclines may not directly decrease the presence of P. gingivalis numbers in the
periodontal pocket, but may inhibit the gingipain activity (64).

Grenier et al. demonstrated that doxycycline and other tetracycline derivatives have
the potential to inhibit the periodontal pathogens’ proteases (63,64). This inhibitory effect
can help modulate tissue destruction caused by P. gingivalis gingipains. Imamura et al.
also demonstrated the direct inhibitory effect of doxycyline and its analogue on RgpB
activity. 10pm concentrations of doxyclycline were show to prevent the RgpB-mediated
production of vascular permeability-enhancing activity from human plasma (76).

Involvement of P. gingivalis Gingipains in Tissue Invasion and Degradation

Role of the Gingipains in Matrix Destruction
Kgp and Rgps can activate the matrix to cleave the gingival collagen type 1 fibers
[reviewed in (77,128)]. Rgps are also able to degrade fibronectin and a5(31 integrin
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receptors on human fibroblasts [reviewed in (128)]. Since a5pi integrin receptors are
important in the regulation of the collagenase, stromelysin and gelatinase expression in
fibroblasts, it may be assumed that the Rgps may play a major role in connective tissue
damage, possibly resulting in the tissue destruction observed in individuals with
periodontal disease [reviewed in (77,128)].

Invasion of Epithelial Cells by P. gingivalis via the Gingipains
Invasion of epithelial cells is an important strategy used by pathogenic bacteria
for survival and for evading the immune defenses of the host. P. gingivalis has been
observed in these actions (42). This suggests that P. gingivalis possesses strategies that
enables them to bypass the gingival tissues and adhesion components of the cell matrix.
Andrian et al. demonstrated that incubation of P. gingivalis cells with engineered human
oral mucosa (EHOM) tissue, resulted in the localization of P. gingivalis cells at the
basement membrane and connective tissue (10). In contrast to the wild-type, gingipaindeficient strain KDP128, showed no localization of the gingipain-deficient strain in the
basement membrane, but localized only in the gingival epithelial tissue (10). These
results indicate an important role of the gingipains in the invasion of P. gingivalis.
Lamont et al, demonstrated a 78% reduction in the ability of P. gingivalis to invade when
the gingipains are blocked with a cocktail of protease inhibitors, including gingipain
inhibitors (97). The gingipains are shown to be able to degrade extracellular matrix
proteins, including laminin, fibronectin, and type IV collagen. Using specific gingipain
inhibitors, the Arg-gingipains and the Lys-gingipain were shown to promote degradation
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of these extracellular components (10). Arg-gingipains were shown to be the major
proteases involved in cleavage of matrix proteins (see figure 1.6).

The Role of the Gingipains on the Degradation of Cell Membrane Proteins
Kgp can modulate the immune system components by cleavage of particular cell
membrane proteins. Kgp was able to induce cleavage of the C5a receptor [reviewed in
(77,128)]. Cleavage of this receptor would result in suppression of the neutrophil
chemotaxis, phagocytosis and bacteriocidal activities stimulated by the C5a. Gingipains
can also degrade the monocyte CD 14 receptor, which will alter the response of
leukocytes to LPS [reviewed in (77,128)]. Gingipains are also known to cleave CD4
(more) and CD8 on T cells. This usually results in a decrease ratio of CD4:CD8, which
typically observed in patients with periodontitis [reviewed in (77,128)]. Dysregulation of
T cells leads to impairment of T-cell function.
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Figure 1.6. The pathogenesis of the gingipains. The gingipains posesses the ability to
degrade the host tissues and also evade and compromise the hosts’ immune defenses (128).
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Gingipain Secretory Pathway of P. gingivalis

There are several type of secretory pathways found in bacteria. The type I
pathway utilizes proteins that forms channels through the periplasm and the proteins to be
exported are secreted directly from the cytoplasm to the outer membrane without the
assistant of a periplasmic protein [Reviewed in (25,129)]. Type II secretion, similar to
type I, has accessory proteins that are associated with the cell envelope and substrates
cross the inner membrane by the SEC pathway, with subsequent cleavage and folding
occurring in the periplasmic space with the help of a periplasmic intermediate (ie.
chaperones) [Reviewed in (25,129)]. The type III pathway does not require Sec, but
requires a complex of several proteins, which will span the inner and outer membrane.
The type IV pathway utilizes proteins which are found in the periplasm and cytoplasm
and can also be associated with the inner and outer membranes [Reviewed in (25,129)].
The Type V transport system is known as the autotransport system. The pathway which
P. gingivalis utilizes has not been confirmed [Reviewed in (25,129)]. Analysis of the
genome of P. gingivalis shows that P. gingivalis lacks the machinery for the type II, III or
IV secretory pathways [Reviewed in (25,129)]. This suggests that they may use the type 1
or Type V autotransport system. There are speculations that the gingipains may use the
autotransporter pathway [Reviewed in (25,129)]. The gingipains have a cleavable Nterminus, indicating the usage of Sec. Also, the structure of the proenzymes of the
gingipains also suggest the type II pathway. However, the signature sequence for the
autotransport pathway is shown to be observed near the C-terminus of the gingipains
RgpA and Kgp [Reviewed in (25,129)]. In a hypothetical model for gingipain secretion
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the gingipain proenzyme enters in the periplasmic space where the C-terminus attaches
to the outer membrane and the remaing part of the protein translocates to the surface
where it becomes fully processed [Reviewed in (25,129)].

It is unclear how the

extensive posttranslational modifications of the gingipains occur in an alternate model
autotransport secretion mechanism. The gingipains pass through the inner membrane by a
Sec apparatus and translocation through the outermembrane is by a novel unidentified
transport system. It has been speculated that the gingipains may use a different secretory
pathway that the other proteins of P. gingivalis [Reviewed in (25,129)].

The Role of Carbohydrates in Gingipain Maturation and Anchorage

Principles of Glycosylation
Glycosylation is important in the regulation of protein maturation and other cellular
processes. There is new emerging evidence that glycosylation may be important in
gingipain biogenesis in P. gingivalis (40,57,149). In this process, different glycosyl
transferases catalyze the transfer of different carbohydrate moieties from active donors to
specific acceptors (including lipids, proteins and nucleic acids) (29). Glycosyl
transferases have been classified on the basis of the reaction that is catalyzed, substrate
specificity and the homology they have to other glycosyl transferases (29). In
eukaryotes, it has been established that glycosylation occurs in the endoplasmic reticulum
or golgi apparatus (57,69). However, the localization or the mechanism of glycosylation
in prokaryotes has yet to be established. It has been shown in eukaryotes that
glycosylation of proteins play a role in protein folding, protein stablilization, and protein
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conformation by sugar-sugar interaction or sugar-protein interactions (22,57,69). In
addition, it plays a regulatory role in the activation of protein precursors or zymogens,
resulting in active proteins. Only recently, the role of glycosylation and glycosyl
transferases in prokaryotes have been shown to be involved in the attachment of
membrane proteins to bacterial membrane, fimbriae maturation, host-cell adhesion and
also maturation of bacterial proteins (57,163).

The Role of Carbohydrate Modification in Protein Folding and Function
In eukaryotic proteins
Some eukaryotic proteins require proper glycosylation for their activation. Other
proteins, require proper glycosylation in regulating substrate targeting or protein
recruitment and stabilization. Wu et al. demonstrated the importance of glycosylation in
the activation of the proMMP activation (168). Matrix metalloprotinases (MMPs) have
activities against extracellular matrix proteins. The membrane typel MMP (MT1-MMP)
has been shown to be glycosylated. The absence of glycosylation of MT1-MMP did not
affect its folding or activation, but it affected the activation of the MT1-MMP substrate,
pro-MMP-2 (168). The absence of carbohydrate moieties on MT1-MMP also affected the
stable MTl-MMP:TIMP-2:ProMMP-2 trimeric complex and the interactions between
TIMP-2 and MT1-MMP (168).

In bacterial proteins
There are several reports on glycosylation and its effect on protein function in bacteria. In
Helicobactor pylori, Fischer et al. demonstrated that the RecA protein requires proper
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glycosylation for its full activity (51). Two genes downstream of recA, which are
involved in glycosylation and lipopolysaccharide biosynthesis, are required for
posttranslational modification of the RecA protein (51).

In viral proteins
Glycosylation is also vital for the assembly of both non-enveloped and enveloped
viruses. One example of viral protein glycosylation is the rotavirus. The rotavirus is a
major virus involved in gastrointestinal problems. The rotavirus has an outer capsid
protein called VP7 (112). The effect of glycosylation on the folding of the VP7 proteins
is shown to be very cruitial. Mirazimi et al demonstrated the major function of
carbohydrates on VP7 is to promote correct disulfide bonds and folding of the VP7
protein (112).

Carbohydrate Analysis of the Gingipains
Determining the structure of the gingipains, along with their structural chemistry,
can help us understand the pathway or pathways is/are necessary for gingipain maturation
and activation. The Arg-X gingipains are known to be glycoproteins (39,40,57).
Monosaccharide composition of the glycans present on RgpA and RgpB includes Ara,
Rha, Fuc, Man, Gal, Glc, GalNac, GlcNAc and Neu5(Ac). HRgpA is sightly different in
monosaccharide composition, which includes Rha, Man, Gal, Glc, GalNAc and GlcNAc
(40). The percentage weight of carbohydrates of the total RgpA and RgpB is
approximately 15% and less that 1% for HRgpA (40). These specific carbohydrate
modifications may be necessary in the gingipain maturation. As previously mentioned,
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the gingipains are glycoproteins that must undergo extensive carbohydrate modifications.
The membrane-type RgpB is between 70-90 kDa. The C-terminus of RgpB is heavily
modified for its association to the membrane (25,39,57). This heavy modification of the
C-terminus has been suggested to protect periplasmic proteins and possible membrane
proteins (129). The proteolytic activity of the matured RgpB could be deleterious to the
organism. Also, analysis of the C-terminus of RgpA and Kgp shows that these proteins
have a C-terminal motif implicated for LPS attachment to the surface of the organism
(see figure 1.7) (25).
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Figure 1.7. Multipe alignments of P. gingivalis proteins. Multiple alignments of
several proteins in P. gingivalis demonstrates that these proteins posseses a Cterminal motif that is implicated in LPS attachment to the surface of the cell (25).
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Cell Surface Polysaccharides: The Molecular Glue Involved in Gingipain Attachment
The LPS carbohydrate compositions of several P. gingivalis strains are shown in
table 1.1. Unique lipopolysaccharides from other periodontal pathogens, Actinobacillus
and Bacteroides, a close relative to Porphyromonas, have been reported to be involved in
oral bacterial interactions. In Streptococcus, the sugar units P-GalNAc(l-3)-Gal, (3-Gal(l-3)GalNAc and a-Rha-(l-2)-Rha are needed for receptor type of several adherence
proteins. P. gingivalis W83, W50 and ATCC 33277 LPS are composed of neutral and
amino sugars including Rha, Man, Gal, Glc, glucosamine and galactosamine. Paramonov
et al and Matsuo et al structurally characterized the O-antigen polysaccharides from the
LPS of Porphyromonas gingivalis W50 and Porphyromonas circumdentaria 12469,
respectively, using NMR. Since it appears that W83 and W50 may have similar Oantigens, the total PS from the LPS should be similar between strains. HNMR analysis
from W83 showed proton peaks at 1.3, 1.5, 2.1, 3.8, 4.8 and several peaks between 3.24.3 and 4.9-5.2 ppm using TSS as a reference (data not shown). Paramonov et al.
analyzed the structure of the oligosaccharide of P. gingivalis W50. The O-polysaccharide
structure as compsed of the following: tetrasaccharide repeating sequence: -»6)-a.-DGlc/>-(l-*4)-a-L-Rhap-(l-*3)-P-D-GalNAc-(l-G)-a.-D-Gal/>-l^) and carries a
monophosphoethanolamine residue at position C-2 of the a-rhamnose residue in a
nonstoichiometric. As mentioned previously, it has been shown that LPS modifications at
the C-terminus of the gingipains are needed for the anchorage to the surface of the cell.
As demonstrated previously, there have been correlations of cell surface polysaccharide
biogenesis and the attachment of gingipains to the surface of the cell (see figure 1.8).
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Activation of Cysteine Proteases
Maturation/Activation of the Gingipains
The formation of zymogens is an important strategy that organisms use to regulate
the activation of several enzymes. Thus, the gingipain zymogen may be crucial in the
timely activation of the gingipains. Analysis of the N-terminus of the different gingipains
reveals that the N-terminus profragment goes through a series of cleavage [reviewed in
(129)]. Salvesen et al has described an autoprocessing maturation of the gingipain RgpB
proenzyme (111,129). The RgpB proenzyme has only 20% proteolytic activity in
comparison to the fully activated RgpB. It has been suggested that autoprocessing occurs
when the proenzyme is folded correctly (111). The processing occurs in a sequential
manner where the N-terminus goes through two cleavage steps and then the C-terminus is
removed, yielding the fully matured enzyme (see figure 1.9) (111). Processing of RgpA
and Kgp proenzymes may be more complicated and has not been determined. However,
it has been shown that the C-terminus of RgpA and Kgp adhesions are processed by
carboxypeptidase CPG70 (165). It is noteworthy to mention that P. gingivalis W50
mutant defective in CPG70 was shown to be avirulent in a mouse model (37).
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Table 1.1. LPS composition of P. gingivalis strains

Porphyromonas
gingivalis Strains
A7A1-28

53978
W50
33277
W83

Polysaccharide
Composition
Rha, Man, Gal, Glc,
glucosamine, galactosamine
Rha, Glc, Gal, GIcNAc
Rha, Glc, Gal, Man,
glucosamine, galactosamine
Rha, Glc, Gal, Man,
glucosamine, galactosamine
Rha, Glc, Gal, Man,
glucosamine, galactosamine

60

VfDAPST/K

RgpA

Rjy>A45

WEAPSA/K

EETITA/K
RepA44

♦

— Rj!4«A 15" RgpA11 ■{

Rm> \2?

TPNOIM/K
WEAPSA/K
Kup48

H

EETITA/K
KjyjJSi

WNAPAS/K
▼

— Kgpl5 ~ Kg|)l4 |

KgpC

TPNGIN/K

Figure 1.8. The polyproteins RgpA and Kgp. The gingipains RgpA and Kgp
are polyproteins that has specific cleavage points.
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1

Figure 1.9. Auto-processing activation model for pro-RgpB. The pro-RgpB begins to
undergo folding, where the N-terminus of the protein is cleaved by a series of cleavage
followed by the sequential cleavage of the C-terminus resulting in the matured RgpB (111).
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Cysteine Proteases From Other Pathogens
SpeB ofStreptococcus pyogenes
Group A streptococci are very important human pathogens. Streptococcus
pyogenes falls under the group A class of streptococci. S. pyogenes posseses several
virulence factors, including the cysteine proteases streptococcal pyrogenic exotoxin B or
SpeB (35). SpeB is also known as a streptopain. The zymogen form of SpeB runs at 42
kDa, where as the matured proteases is 28kDa (35). Streptopain belongs to the cysteine
protease CIO. It posses a different prodomain that other classes of cysteine proteases
(35). The maturation process of SpeB is similar to many cysteine proteases. Pro-SpeB
undergoes autoprocessesing resulting in eight intermediates until it reaches the mature
28kDa protease (46). Similar to the autoprocessing of RgpB described by Salvesen et al
(111), it was also demonstrated that the rate of activation was faster at high
concentrations of the Pro-SpeB when incubated (46).

SspB of Staphyloccocus aureus
Staphylococcus aureus is the leading cause of nosocomial infections. This
pathogen is equipped with virulence factors including the cysteine protease SspB
(108,144). SspB cleaves arginine residues that are preceeded by a hydrophobic amino
acid, unlike the SpeB, which cleaves arginine, lysine, asparagines, alanine, glutamic acid,
glycine and histidine (108). Most cysteine proteases are assumed to follow three general
stages of maturation. This include folding of the protease, auto-processing of the bonds
between the propeptide and the protease domain followed by the degradation of the
propeptide which will render the protease stable (147,148). This classic maturation
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process is not followed for the maturation of SspB (108). SspB is a staphopain. sspB is in
an operon with the serine protease sspA and sspC as its downstream gene. It has been
shown that SspA is needed for the activation of SspB. SspC acts as an inhibitor of the
SspB propetide and can be inactivated by SspA (108). SspA eliminates the role for autoprocessing.

Similarities Between the Arg-gingipain and the Caspases
Comparison of the structure of the gingipains yielded no homology to other
known proteins. The gingipains are a group of unique proteases that are classified as
cysteine proteases belonging to the clan C25 (48). Although there was a lack of
homology to other known proteins, RgpB was shown to have a similar topology to
caspases from family 14, mainly caspase 1 and caspase 3 (48). There are shared origins
between the caspases and the gingipains. The gingipains (C25), in addition to the
legumains (Cl3), the clostripains (Cl 1) and caspases (Cl4), share a similar motif
consisting of His-Gly-spacer-Ala-Cys (48). The RgpB calatytic domain is subdivided into
two subunits A and B. Each of these subunits contains a caspase folding motif, especially
the B subunit (48,129). Superimposition of the B-subunit of RgpB with the caspase 1
heterodimer shows that the Cys and His catalytic residues share identical sites and
displays similar conformations (see figure 1.10) (48). Showing such similarities between
RgpB and the caspases, the catalytic mechanism of RgpB may be similar to the caspases.
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Figure 1.10. The RgpB fold. The fold of RgpB is very similar to
the fold of caspase three (48).
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Models of Caspase Activation
Caspases are produced in their inactive zymogen form, which can be activated by
proteolytic cleavage (45). These caspase zymogens have an N-terminus pro-domain and a
linker peptide in the protease domain. Internal cleavage sites are present which is capable
of auto-activation or activations as a result of a cascade mechanism (45). Activation of
the caspases are divided into two different mechanisms 1) homo-inactivation, which
requires the recruitment of adaptor proteins and the inactive zymogens, 2)
heteroactivation, which the zymogen becomes activated upon the action of another
protease (156). Presently, the molecular mechanisms for activation of some of the
caspases (initiators) have only been proposed. These models for caspase activation
described below.

The induced proximity model
In this model, the initiator caspases are capable of autoprocessing when they are
in close proximity with each other (20,138,145). Prolonged incubation times with the
zymogens results in activation of the caspase zymogens. Also concentration of the
zymogen appears to be cruitial in their activation. Each capase zymogen has a
zymogenicity ratio of activity in comparison to the fully activated caspase as seen in table
1.2 (138). Caspase 8 is shown to be processed rapidly, suggesting the zymogen must have
basal levels of proteolytic activity (138). This basal activity will allow for auto
processing to occur (see figure 1.11) (21).
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Proximity-induced Dimerization model (Interdimer processing model)
This model is a more recent model describing dimerization of the initiator
caspases (21,146). According to this model, the apoptosome is promotes the
homodimerization of caspase 9, Also in this model, procaspase 8 is activated by an
interdimer processesing mechanism (31). It has been concluded that the procaspase 8 is
activated by cross-cleavage of dimerized zymogens (31). Two cleavage events that may
occur have been described by two additional models: the sequential accessibility model
and the sequential activity model (56). The sequential accessibility model suggests that
the first cleavage site in the zymogen may not be accessible to the pro-caspase until there
is separation of the large and small subunits (and the pro-domain) (56). The sequential
activity model states the first cleavage site may generate an intermediate the can
recognize the second cleavage site (56). It has been demonstrated that the active pro
caspase 8 was able to process other zymogen precursors at the region of the large and
small subunits and the area linking the pro-domain and the large unit (see figure 1.11)
(21).
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Dimerization
►

at a multiprotein
activating complex

Cleavage
-►

of the interdomain linker

Figure 1.11. Activation of the caspases. A= initiator caspase activation model, B= executioner
caspase activation model.
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Table 1.2. Zymogenicities of some caspases compared with two serine proteases.

Zymogenicities of some caspases compared with two serine proteases
Zymogenicity

Protease
Caspase-3

>10,000

Caspase-8

100

Caspase-9

10
>10,000

Trypsin

2-10

Tpa
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Hypothesis

The ability of P. gingivalis to regulate its virulence factors is a strategy that ensures
the timely invasion and destruction in the host. Mechanism of gingipain maturation,
activation and/or regulation have only been suggested or implicated at best. Our overall
objectives are to identify and evaluate the genes and their products that are involved in
virulence regulation in Porphvromonas gingivalis W83 and to elucidate the molecular
mechanismfs) for these genes in virulence regulation. We have postulated a central
hypothesis: carbohydrate biogenesis along with the specific bacterial host factors.
such as vimA, is needed for proper gingipain maturation/activation. Below we have
developed several tentative hypotheses, which may be part of the mechanism for P.
gingivalis gingipain and protein maturation.

1) The vimA, downstream genes may be part of the bcp-recA-vimA transcriptional
unit.
2) VimA and the downstream genes, Pg0791 and Pg0792, play a role in and is/are
needed for the maturation of the gingipains and other proteins. In the absence of
VimA and/or the downstream gene products, the factors (i.e. glycosyl
transferases) needed for posttranslational modification are affected and in return,
affect the maturation of the proteases and other virulence factors of P. gingivalis.
3) Carbohydrate biogenesis is important for the maturation of the gingipains.
Therefore, inactivation of a possible glycosyl transferase gene will affect the
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maturation and activation of the gingipains, therefore, inactivation of a putative
glycosyl transferase, Pg0792, will result in the presence of inactive gingipains.
4) If vimA and Pg0792 are in a pathway needed for protease maturation/activation,
these gene products should interact with the gingipains directly or indirectly and
also interact with other regulatory proteins.
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A. ABSTRACT

Regulation/activation of the Porphyromonas gingivalis gingipains is poorly
understood. A unique 1.3 kb open reading frame downstream of the bcp-recA-vimA
transcriptional unit was cloned, insertionally inactivated using the ermF-ermAM
antibiotic resistance cassette and used to create a defective mutant by allelic exchange. In
contrast to the wild- type W83 strain, the growth rate of the mutant strain (designated
FLL93) was reduced and when plated on Brucella blood agar was non-pigmented and
non-hemolytic. Arginine- and lysine-specific gingipain activities were reduced by
approximately 90% and 85%, respectively, relative to that of the parent strain. These
activities were unaffected by the culture’s growth phase, in contrast to the

-defective

mutant P. gingivalis FLL92, which has increased proteolytic activity in stationary phase.
Expression of the rgpA, rgpB and kgp gingipain genes was unaltered in P. gingivalis
FLL93 when compared to the wild-type strain. Further, in extracellular protein fractions,
a 64 kDa band was identified that was immunoreactive with the RgpB-specific
proenzyme antibodies. Using active-site labeling with DNS-EGR-CK or immunoblot
analysis, there was no detectable protein band representing the gingipain catalytic
domain. In vitro protease activity could be slightly induced by a urea denaturationrenaturation cycle in an extracellular protein fraction, in contrast to the

-defective

mutant P. gingivalis FLL92. Expression of flanking genes, including recA, vimA and
Pg0792 was unaltered by the mutation. Taken together, these results suggest that the
vimA downstream gene, designated vimE (virulence modulating gene E), is involved in
the regulation of protease activity in P. gingivalis.
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B. INTRODUCTION

As a common theme, the expression of extracellular proteolytic activities is highly
regulated in both prokaryotic and eukaryotic systems [reviewed in (6, 40)]. This
regulation usually occurs at the level of expression of the protease genes, secretion and/or
processing of an inactive secreted precursor to its active form. The multiple layers of
regulation are vital to ensure that expression is tightly controlled in the appropriate
temporal and spatial patterns. Porphyromonas gingivalis, a black-pigmented, Gram
negative anaerobe has been implicated as an important etiological agent in adult
periodontitis [reviewed in (19, 23, 38)]. While several virulence factors including
hydrolytic enzymes, fimbriae, hemagglutinin, capsule, and lipopolysaccharide have been
implicated in the pathogenicity of P. gingivalis, the high proteolytic abilities of this
organism is the focus of much attention as it is considered to play the most significant
role in virulence (25). The major proteases, called gingipains, are both extracellular and
cell-associated. They consist of arginine-specific protease [Arg-gingipain, (Rgp)] and
lysine-specific protease [Lys-gingipain, (Kgp)] (25). Although glycosylation appears to
be important for their activation [reviewed in (10, 31)], there remains a gap in our
knowledge on the regulation/activation of the P. gingivalis gingipains.

Previously, we have reported that the recA locus can affect the phenotypic
expression and distribution of the gingipains in P. gingivalis (1,2, 27). Using the cloned
vimA gene, which is downstream of the recA gene and part of the bcp-recA-vimA
transcriptional unit, a defective mutant was constructed by allelic exchange (1). The
mutant strain, designated FLL92, was non-black-pigmented and showed increased
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autoaggregration, in addition, to a significant reduction in proteolytic, hemolytic and
hemagglutinating activities (1). In vivo experiments using a mouse model, P. gingivalis
FLL92 had dramatically reduced virulence when compared to the wild-type W83 strain
(1). While a reduction in Arg-X- and Lys-X-specific proteolytic activities was observed
in P. gingivalis FLL92, transcription of the gingipain genes was unaltered in this mutant
when compared to the wild-type strain (1). Furthermore, the partially processed RgpB
proenzyme was secreted in P. gingivalis FLL92 (27). Collectively, these observations
suggest the vimA gene in P. gingivalis may be involved in virulence modulation via an
ability to affect protease activation/maturation. In addition, appearance of the gingipain
proenzyme forms and the growth phase-dependent activation of proteolytic (27) activity
have raised the possibility of multiple mechanisms for gingipain activation/maturation
involving multiple bacteria-specific factors.

We have further investigated a unique 1.3 kb gene downstream of the vimA gene to
determine its relationship to the bcp-recA-vimA transcriptional unit and to evaluate its
role, if any, in protease activation. In this report, we have created and characterized a P.
gingivalis isogenic mutant (FLL93) defective in this gene now designated vimE. While
this gene was expressed independent of the vimA, its inactivation resulted in reduced
Arg-X- and Lys-X-specific proteolytic activities that were not affected by the phase of
growth. In addition, in vitro protease activity was slightly activated by a urea
denaturation-renaturation cycle. These results suggest an important role for the vimE
gene in protease activation/maturation in P. gingivalis and further confirm the
requirement of multiple specific host factors in this process.
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C. MATERIAL AND METHODS
C.l. Bacterial strains and growth conditions

Strains and plasmids used in this study are listed in Table 1. P. gingivalis strains
were grown in brain heart infusion (BHI) broth supplemented with 0.5% yeast extract
(both from Difco Laboratories, Detroit, ML), hemin(5 pg/ml), vitamin K (0.5 |ag/ml),
and cysteine (0.1%) (all from Sigma-Aldrich, St. Louis, MO). Escherichia coli strains
were grown in Luria-Bertani broth. Unless otherwise stated, all cultures were incubated at
37°C. P. gingivalis strains were maintained in an anaerobic chamber (Coy
Manufacturing, Ann Arbor, MI.) in 10% LL, 10% CO2, 80% N2. Growth rates for
P. gingivalis and E. coli strains were determined spectrophotometrically (optical density
at 600 nm [OD6oo])- Antibiotics were used at the following concentrations: clindamycin,
0.5 pg/ml; erythromycin, 300 pg/ml; and carbenicillin, 100 pg/ml.

C. 2. DNA isolation and analysis

P. gingivalis chromosomal DNA was prepared by the method of Marmur (22). For
plasmid DNA analysis, DNA extraction was performed by the alkaline lysis procedure of
Bimboim and Doly (4). For large-scale preparation, plasmids were purified using the
Qiagen (Santa Clarita, CA.) plasmid maxi kit. DNA was digested with restriction
enzymes as specified by the manufacturer (Roche, Indianapolis, IN.). For DNA
subcloning, the desired fragments were isolated from 0.8% agarose gels run in Tris-
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acetate-EDTA (TAE) buffer then purified using a Gene Clean kit as recommended by the
manufacturer (QBiogene, Inc., La Jolla, CA.).

C.3. Generation of Pg0791 (vimE) mutant P. gingivalis strain

A 2.5-kb fragment carrying the intact vimE and Pg0792 downstream genes was
amplified by PCR using the PI and P5 oligonucleotide primer (Table 2). This fragment
was cloned into the pCR 2.1-TOPO plasmid vector (Invitrogen, Carlsbad, CA) and
designated pFLLSO. The ermF-ermAM cassette which confers erythromycin/clindamycin
resistance in E. coli and P. gingivalis (9) was PCR amplified from pVA2198 using Pfu
turbo (Stratagene, La Jolla, CA) and ligated into the Hindi restriction site of the vimE
gene. The resultant recombinant plasmid, pFLL81, was used as a donor in electroporation
of P. gingivalis W83.

C.4. Electroporation

Electroporation of cells was performed as previously reported (9). Briefly, 1 ml of an
actively growing culture of P. gingivalis was used to inoculate 10 ml of BHI broth
supplemented with yeast extract, hemin and vitamin K, which was then incubated
overnight at 37°C. Ninety milliliters of the same prewarmed (37°C) medium was then
inoculated with 3 ml of the overnight culture and incubated for an additional 4 h until
(OD 6oo) of 0.7 was obtained. The cells were then harvested by centrifugation at 3000 x g
for 15 min at 4°C and washed twice in 50 ml of electroporation buffer (10% glycerol,
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1 mM MgCli; filter sterilized; stored at 4°C). The final cell pellet was resuspended in
0.5 ml of electroporation buffer. A 100-pl sample of resuspened cells and 5 pg of DNA
was placed in a sterile electrode cuvette (0.2-cm gap). The cells were then pulsed with a
Bio-Rad (Hercules, CA) gene pulser at 2,500 V for 9.5 ms and then incubated on ice for
5 min. The cell suspension was then added to 0.5 ml of BHI broth supplemented with
yeast extract, hemin and vitamin K and incubated for approximately 16 h. A 100-pl
sample was plated on solid medium containing Erythromycin and incubated anaerobically
at 37°C for 5 to 10 days

C.5. Growth curve analysis

Actively growing P. gingivalis W83, FLL92 and FLL93 cultures were inoculated at
an initial [(OD 500) of 0.2] in BHI broth supplemented 0.5% yeast extract (both from
Difco Laboratories, Detroit, ML), hemin (5 pg/ml), vitamin K (0.5 pg/ml), and cysteine
(0.1%), (all from Sigma-Aldrich, St. Louis, MO). Aliquots, (500 pi) were taken every 4
hours and growth rate was determined by spectrometer.

C.6. Hemolytic activity assay

Hemolytic activity was determined as previously reported (11). Briefly, bacterial
cells from overnight cultures were harvested by centrifugation (10,000 x g for 30 min)
using a Sorvall RC5C centrifuge, washed three times with PBS and then resuspended to a
final (OD6oo) of 1.5. Sheep erythrocytes (Hemostat Laboratories, Dixon, CA) were
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harvested by centrifugation (4,400 x g for 25 min) and washed with IX (Phosphate
Buffered Saline) PBS until the supernatant was visually free of hemoglobin pigment. The
washed erythrocytes were suspended to a final concentration of 1% in IX PBS.
Hemolytic activity was determined by mixing an equal volume of bacterial cells with 1%
erythrocytes in PBS. This mixture was then incubated at 37°C. Samples (500 pi) were
withdrawn every 2 h and then centrifuged (1,300 x g for 5 min) in an Eppendorf
5403 centrifuge. The optical density was determined by spectrophotometry at 405 nm. As
a negative control, erythrocytes were used alone.

C.7. Hemagglutination studies

Hemagglutinin activity was determined as previously reported (11). Twenty-four
hour cultures of P. gingivalis W83, FLL92 and FLL93 cells were harvested by
centrifugation (10,000 x g, 15 minutes). Cells were washed twice in IX PBS and
resuspended to a final optical density (OD600) of 1.5. Sheep erythrocytes were washed
twice with IX PBS and resuspended to a final concentration of 1% in IX PBS. An
aliquot (100 pi) of the bacterial suspension was serially diluted two-fold with IX PBS in
round-bottom 96-well microtiter plates. An equal volume (100 pi) of 1% sheep
erythrocytes was mixed with each dilution and incubated at 4°C for 3 hours.
Hemagglutination was visually assessed and the hemagglutination titer was determined as
the last dilution that showed complete hemagglutination.
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C.8. Cell fraction preparation
One-liter cultures of P. gingivalis strains FLL92 and W83 were grown from actively
growing cells. Preparations of whole-cell culture, cell-free medium, cell suspension,
vesicles, and vesicle-free medium were made as previously reported (27). The whole-cell
culture (WC) fraction is a sample of the culture after the bacterium has been grown to a
specific growth phase. This sample has the bacterial cells suspended in the growth
medium, and the enzyme activity includes the gingipains that are attached to the bacterial
cell surface plus those that are secreted in the culture medium. After centrifugation, the
cell pellet was resuspended, and the enzyme activity in this sample (the cell suspension
fraction, CS) represents the gingipains that are attached to the bacterial cell surface;
While the enzyme activity in the supernatant (the cell-free medium fraction, CF) includes
the gingipains that are secreted in the culture medium. Secreted gingipains can be either
be associated with vesicles or soluble in the culture medium; thus, ultracentrifugation of
the cell-free fractions will yield a vesicle pellet (V) and a supernatant of soluble
gingipains (VF).

C.9. Preparation of P. gingivalis extracellular fractions
One liter cultures of P. gingivalis strains FLL92, FLL93 and W83 were grown from
actively growing cells. Cells were harvested by centrifugation 10,000 x g for 30 minutes.
The cell-free culture fluid was precipitated with 37.5% or 60% acetone (-20°C), and the
protein pellet was resuspended in 7 ml of 100 mM Tris-HCl buffer (pH 7.4), dialyzed for
24 h against the same buffer, and then stored on ice or at 0°C. The presence of Arg-X-
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and Lys-X-specific cysteine protease activities was determined by microplate reader
(BioRad Laboratories, Hercules, CA).

C.10. Production of rabbit polyclonal antibodies against the RgpB proenzyme
Extracellular proteins were prepared from the culture supernatant of P. gingivalis
FLL92 (vwl4-defective) grown to exponential phase (OD 500) of 0.8. The cells were
harvested by centrifugation (10,000 x g, 30 min), and the supernatant was further clarified
by filtration through a 0.45-pm-pore-size membrane (Millipore Corporation, Billerica,
MA.). The cell-free culture fluid was precipitated with 37.5 % acetone (-20°C), and the
protein pellet was resuspended in 7 ml of 100 mM Tris-HCl buffer (pH 7.4), dialyzed for
24 h against the same buffer, and then stored on ice or at 0°C. The protein concentration
was determined as described below. The extracellular proteins (25 pg/lane) were
separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
using NuPAGE 4-12% Bis-Tris gels. A 64 kDa band representing the partially processed
RgpB proenzyme (27) was excised using a gel cutter. A total of approximately 12 mg of
the RgpB proenzyme protein was excised from gels, placed in IX PBS and stored at 80°C. The frozen gel slices were sent to Zymed Laboratories Inc. (South San Francisco,
CA) for the production of polyclonal rabbit RgpB proenzyme antibodies using the
manufacture's standard protocol. Dilutions and efficiency of the antibodies were tested in
laboratory using the purified RgpB proenzyme.
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C.ll. Protein concentration determination
Protein concentration was calculated spectrophotometrically using the Warburg formula
within the protein function of the Eppendorf Biophotometer (Brinkman. Westbury, NY).

C.12. SDS-PAGE and immunoblot analysis

SDS-PAGE was performed with a 4 to 12% bis-Tris separating gel in MOPS
(morpholinepropanesulfonic acid)-SDS running buffer (NuPAGENovex gels; Invitrogen,
Carlsbad, CA) according to the manufacturer's instructions. Samples were prepared (65%
sample, 25% 4x NuPAGE EDS sample buffer, 10% NuPAGE reducing agent), heated at
72°C for 10 min, and then electrophoresed at 200 V for 65 min with the XCell SureLock
Mini-Cell (Invitrogen). The separated proteins were then transferred to BioTrace
nitrocellulose membranes (Pall Corporation, Ann Arbor, MI) and processed at 15 V for
25 min with a Semi-Dry Trans-blot apparatus (Bio-Rad Hercules, CA). The blots were
probed with antibodies against specific protease domains and species specific secondary
antibodies conjugated to HRP (Zymed Laboratories, South San Francisco, CA).
Immunoreactive proteins were detected by the procedure described in the Western
Lightning Chemiluminescence Reagent Plus kit (Perkin-Elmer Life Sciences, Boston,
MA.). The secondary antibody was immunoglobulin G (heavy plus light chains)horseradishperoxidase conjugate (Zymed Laboratories, Inc., South San Francisco, Calif).
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C.13. Protease assays

The presence of Arg-X- and Lys-X-specific cysteine protease activities was determined
using a microplate reader (Bio-Rad, Hercules, CA)by the method of Potempa et al. (30)

C.14. Analysis of P. gingivalis Pg0791 mutant genes by RT-PCR

Total RNA was extracted from P. gingivalis strains grown to early stationary phase
(ODeoo ) of 1.2 to 1.3 using RiboPure kit (Ambion, Austin, TX). The primers used for
reverse transcription-PCR (RT-PCR) analysis (Table 2) were specific for the recA, rgpA,
rgpB, kgp, Pg0791, or Pg0792 genes. The RT-PCR reaction (50 pi) contained 1 pg of
template RNA in the Superscript One-step RT-PCR reaction mix (Invitrogen, Carlsbad
CA). Negative controls were reactions in the absence of reverse transcriptase.

C.15. Denaturation-renaturation procedure for in vitro protease activation
Extracellular protein fractions from P. gingivalis were mixed with 8 M urea and
incubated at 4°C for 1 h as described previously (26). The urea was slowly removed from
the mixture by centrifugation (10,000 Xg) in a Millipore filtration unit (Biomax 10K
NMWL membrane, 0.5 ml volume) with the addition of increasing volumes of 100 mM
Tris-HCl buffer (pH 7.4.)
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C.16. Flourescence labeling of protease by using DNS-EGR-CK
Fluorescence labeling of proteases in the extracellular protein fraction from P.
gingivalis was done as previously reported (3). Briefly, solutions of extracellular protein
fractions from P. gingivalis were treated at 4°C for 10 min with equal volumes of 0.2 M
Tris-HCl (pH 8.4) containing 20 mM CaC^ and 20 mM 2-mercaptoethanol. Dansylglutamyl-glycyl-arginyl chloromethyl ketone (DNS-EGR-CK) (0.25 mg; Calbiochem,
San Diego, CA) was dissolved in 600 pi of 95% (vol/vol) aqueous ethanol just before use.
Fifty microliters was added to the reduced protease solution, and the reaction was allowed
to proceed at 4°C until the enzyme activity (monitored by BApNA hydrolysis) was
abolished. Samples of the protein solution were then dried in a SpeedVac concentrator
(Thermo Savant, Holbrook, NY). To identify the protease band unambiguously after
SDS-PAGE, labeling was also performed in the presence of 50 pM leupeptin. The dried
fluorescence-labeled proteases were then treated with NuPAGE SDS-PAGE sample
buffer (Invitrogen, Carlsbad, CA) and subjected to electrophoresis.
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Table 2.1. Plasmids and strains used in this study

Plasmids
pCR-2.1 TOPO
pFLLSO
pFLL81
pVA2198

Phenotype/Description
Apr, Kmr
pCR 2.1-TOPO Pg0791:Pg0792
pCR 2.1- TOPO Pg0791:Pg0792:: ermF-ermAM
Spr, ermF-ermAM

Source
Invitrogen
This study
This study
(9)

Bacterial strains
Porphyromonas gingivalis
W83
FLL92
FLL93

Wild-type
wmA-defective
wmE-defective

(1)
This study

Escherichia coli
DH5a

F" <t)80d/acZA M15 A(/acZYA-argF) U169 recA1 endAI
hsdRI 7(rk-, mk+) phoA supE44 A.' fh/-1 gy/A96 re/AI

Invitrnnpn

Topic
F'mcrA A (mrr-hsdRMS-mcrBC) (j)80/acZA Ml5 A/acX74
Invitrogen
recAl are 139 A (ara-/eu)7697 ga/U ga/K rpsL (StrR) endA'l
nupG

111

D.RESULTS
D.l. Inactivation of the vimE gene in P. gingivalis W83 by allelic exchange
mutagenesis
Isogenic mutants of P. gingivalis W83 defective in the PG0791
(www.oralgen.lanl.gov) or [TIGR ORF PG0883 (www.tigr.org)] gene (designated vimE)
were constructed by allelic exchange mutagenesis. The circular recombinant plasmid
pFLL81, which carries the ermF-ermAM cassette in the unique Hindi restriction site (bp
909 of the open reading frame) of the vimE gene, was used as a donor in electroporation
of P. gingivalis W83 (Fig. 2. 2A). Because the plasmid was unable to replicate in
P. gingivalis, we predicted that two double-crossover events between the regions flanking
the erythromycin marker and the wild-type gene on the chromosome would result in
replacement of a segment of the wild-type gene with a fragment conferring erythromycin
resistance. Following electroporation and plating on selective medium (BHI containing
lOpg/ml erythromycin), we detected approximately 61 erythromycin-resistant colonies
after a 5-day incubation period. To compare their phenotypic properties with those of
wild-type strain W83, all mutants were plated on Brucella blood agar plates (Anaerobic
Systems Inc., San Jose, CA.). In contrast to the wild-type strain, all mutants displayed a
non-black-pigmented, non-beta-hemolytic phenotype.
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Table 2.2. Primers used in this study

PI Pg0791 iyimE) forward
P2 Pg0791 (yimE) reverse
P3 Pg0791 (vimE) reverse (intragenic)
P4 Pg0792 foward (intragenic)
P5 Pg0792 reverse (intragenic)
P6 Pg0792 reverse
P7 vimA forward
P8 vimA reverse
P9 recA forward
P10 recA reverse
Pll pro-kgp forward
P12 pro-kgp reverse
P13 pro-rgpA forward
P14 pro-rgpA reverse
P15 pro-rgpB forward

5’ATGAATACTGAAGTAATCCAC 3'
5’ TTGGTCGATGGCCGTTTCGTA 3’
5’ T C AGC ACTTCCTT GCAC AAC 3’
5’ CAGTCGCACGGCGATGTGTTT 3’
5’ GC AGGAT GGAGC GGGAGTATT C 3’
5’ TTCACGCGAAAAAGTGGAGAT 3’
5’ ATGCCCATCCCTCTATACCTG 3’
5’ TACCTGTTTTTGCTGACCGG 3’
5’ ATGGCAGAAGAAAAGATACCC 3’
5’ TGAATGTTTGTTGCGAATGG 3’
5’ AT GAGGAAATTATTATT GCT GAT CG 3’
5’ TT GAAGAGCT GTTTATAAGCT GTTT 3’
5’ AT GAA AAACTT GA AC AAGTTT GTTT C 3’
5’ CCGGTGTGTAACGCCCTG 3’
5’ CGACCGATGAAGACTTCG 3’
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D.2. Confirmation of inactivation of vimE by PCR analysis
Chromosomal DNA from 5 randomly chosen clindamycin/erythromycin resistant
colonies and the wild-type W83 strain were analyzed by PCR to confirm the inactivation
in the vimE gene. If the vimE gene was interrupted by the ermF-ermAM cassette, a 3.4 kb
fragment was expected to be amplified using primers PI and P2 (table 2.2). The
expected 3.4 kb and 1.3 kb fragments were observed in the 5 clindamycin resistant strains
and the wild-type W83 respectively (Fig. 2.2B). The orientation of the ermF-ermAM
cassette was also confirmed by restriction digest (data not shown). Taken together these
results indicated the insertional inactivation of the chromosomal vimE gene with the 2.1
kb ermF-ermAM antibiotic cassette was successful. One mutant designated P. gingivalis
FLL93 was randomly chosen for further study. A generation time of 3 h was determined
for P. gingivalis W83 and P. gingivalis FLL92 in contrast to 4.75 h for P. gingivalis
FLL93.
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P7

P9

P1

P4

......... 1

bcp

recA

= vimA

P10

vimE

P8

Pg0792

P3 P2

Figure 2.1. Diagram of the
locus and the two downstream genes.
Diagram shows ORF taken form www.oralgen.lanl.gov. of the recA locus and
the two downstream genes are shown with given primer locations.
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P. gingivalis FLL93
(representative vzmL-defective mutant)
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Figure 2.2. Construction of a v/rntF-defective mutant by allelic exchange
mutagenesis and confirmation by PCR analysis. pFLLSl contains the vimE gene
interrupted by an ermF-ermAM cassette [the vimE gene with flanking sequences was
amplified by PCR; the ermF-ermAM cassette was purified from pVA2298]. The
circular recombinant plasmid pFLLSl was integrally introduced into P. gingivalis W83
by electroporation. A reciprocal recombination event between areas of homology on
the chromosome and regions flanking the ermAM-ermF cassette on pFLLSl replaced
the intact vimE with an inactivated copy. Oligonucleotide primers specific for the vimE
gene (PI and P2; Table 2) were then used to amplify that gene from total cellular DNA
from P. gingivalis. Lane 1, P. gingivalis FLL93.1 (vimE::ermF-ermAM); lane 2, P.
gingivalis FLL93.2 (vimE::ermF-ermAM); lane 3, P. gingivalis FLL93.3 {vimEwermFermAM); lane 4, P. gingivalis FLL93.4 (vimEv.ermF-ermAM); lane 5, P. gingivalis
FLL93.5 (vimE::ermF-ermAM); and lane 6, P. gingivalis W83 (wild-type).

116

D.3. Hemolytic activity is reduced in P. gingivalis FLL93
Cell- and vesicle-associated hemolysins which will liberate hemoglobin from
erythrocytes are produced in P. gingivalis apparently by two distinct genes (15). Further
other hemolysin-like genes have been identified from the P. gingivalis genome project
[(www.oralgen.lanl.gov), (26)]. P. gingivalis FLL93, FLL92 and W83 were evaluated
for hemolysin activity by their ability to lyse erythrocytes. As shown in figure 2.3A,
there was reduced hemolytic activity in P. gingivalis FLL93 when compared to the wildtype P. gingivalis W83 strain. Further, this level of hemolytic activity was similar to the
v/myt-defective isogenic mutant P. gingivalis FLL92 or the negative control.

D.4. Hemagglutinin activity in P. gingivalis FLL93
We assessed the hemagglutination potential of P. gingivalis FLL93 in comparison to
P. gingivalis W83 and P. gingivalis FLL92 the non-proteolytic v/m/1-defective mutant.
In contrast to the wild-type strain, there was a reduction in hemagglutinin activity in P.
gingivalis FLL93 (Fig. 2.3B). This level of activity was similar to P. gingivalis FLL92
and the negative control
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Figure 2.3. Hemolytic and hemagglutinin activities of P. gingivalis FLL93 is
reduced. Bacterial cells from overnight cultures were harvested by centrifugation,
washed three times with IX PBS and then resuspended to a final (OD600) of 1-5. Sheep
erythrocytes were harvested by centrifugation and washed with IX PBS until the
supernatant was visually free of hemoglobin pigment. The washed erythrocytes were
suspended to 1% in IX PBS. (Panel A) Hemolytic activity was determined by mixing
equal volumes of bacterial cells with 1% erythrocytes in PBS. This mixture was then
incubated at 37°C. Samples (500 pi) were withdrawn every 2 h and then centrifuged. The
optical density was determined by spectrophotometry at 405 nm. As a negative control,
erythrocytes were used alone. This experiment was done in triplicate and average values
are plotted. (♦ W83, ■ FLL92, AFLL93, ©negative control). (Panel B)
Hemagglutination activity of P. gingivalis was performed on P. gingivalis W83, FLL92
and FLL93 cells that were serially diluted two-fold in IX PBS. Aliquots (100 pi) of the
dilution were then mixed with an equal volume of 1% sheep erythrocytes and incubated
at 4°C for 3 hours in a round-bottom microtiter plate. The hemagglutination titer was
determined as the last dilution that showed full agglutination. Lane 1 W83; lane 2,
FLL92; Lane 3 FLL93; Lane 4 negative control, was sheep erythrocytes alone (Fig. 3B).
Error bars indicate the standard error of the mean of three independent trials.
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D.5. Inactivation of the vimE gene affect proteolytic activity in P. gingivalis

We previously reported that the proteolytic activity of the non-black pigmented recA
defective mutant (P. gingivalis FLL32), or

-defective mutant (P. gingivalis FLL92)

was reduced by more that 90% when compared with the wild-type strain (1,2). In
addition, a late onset of proteolytic activity was also reported in the vimA mutant when
compared to the wild-type strain (27). Because hemolysis and hemagglutinin activities
can be associated with gingipain activity in this organism (21, 35), P. gingivalis FLL93
was assayed for proteolytic activity using N-a-benzoyl-DL-arginine-p-nitroanilide
(BApNA) and acetyl-lysine-p-nitroanilide (ALNA). In late-exponential-growth-phase
cultures, both Arg-X and Lys-X protease activity in P. gingivalis FLL93 were very
similar to P. gingivalis FLL92, which was reduced by approximately 90% compared to
the wild-type strain (Fig. 2.4). In stationary phase cultures of P. gingivalis FLL93, there
was just a slight increase in Lys-X activity, however, there was no change in Arg-X
activity (Fig 2. 4). This is in contrast to the expected late onset of proteolytic activity that
was observed in P. gingivalis FLL92 (Fig. 2.4). The proteolytic activity of the wild-type
remained constant throughout this growth phase. The proteolytic activity distribution
pattern was the same for both P. gingivalis FLL93 and the wild-type (Fig. 2.5). In
exponential growth phase most of the activity was cell-associated which was reduced in
stationary phase. Taken together, these data suggest that under the same physiological
condition, the proteolytic profile for P. gingivalis FLL93 can be severely altered by
mutations affecting the vimE gene expression in P. gingivalis.
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Figure 2.4. Inactivation of vimE resulted in decreased proteolytic activity of P.
gingivalis. P. gingivalis was grown to late log phase [(ODeoo) of 0.7- 0.8] or
stationary phase [(ODeoo) of 1.4-1.5] in BHI broth supplemented with yeast extract,
hemin and vitamin K. Activities against Rgp (A) and Kgp (B) were tested in whole
cell culture. The results shown are representative of three independent experiments in
triplicate. E = exponential phase; L = stationary phase. Error bars indicate the
standard error of the mean of three independent trials.
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Figure 2.5. Distribution of the proteases in P. gingivalis FLL93. Activities against
BApNA (A and C) and ALNA (B and D) were tested in whole cell culture (WC), cell
free media (CF), cell suspension (CS), vesicle (V) and vesicle free (VF) of P.
gingivalis W83 (A and B), and P. gingivalis FLL93 (C and D) grown to stationary
phase (OD 500) of 1.4-1.5. The activity of WC for each strain was assumed to equal
100 %. WC=CS+CF, CF=V+VF
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D.6. Expression of the gingipain genes in the v/mE-defective mutant

The reduced proteolytic activity in P. gingivalis FLL93 strain could have been the
result of alteration in transcription of the gingipain genes. There is also the possibility
that the vimE gene may be involved in the posttranslational regulation of gingipain
expression. In previous reports of mutations in two genes (recA and vimA) upstream of
the vimE genes, a reduction in gingipain activity was also observed although the
expression of those genes was unaltered (1, 2). Furthermore, the partially processed
RgpB gingipain proenzyme was identified in the vzm^4-defective mutant suggesting a
defect in gingipain biogenesis at the posttranslational level (27). To determine the
presence of mRNA transcripts for the gingipain genes (rgpB, rgpA and kgp), total RNA
was isolated from the wild-type W83 strain and P. gingivalis FLL93 grown to stationary
phase. Specific oligonucleotide primers as described in Table 2 for rgpB, rgpA, and kgp
were used in RT-PCR reactions to amplify a predicted region of the gingipain gene
transcripts. When the reverse transcriptase was present in the reaction, amplified products
of the predicted size (0.8 kb for rgpB and 0.9 kb for rgpA and kgp) were observed for all
three gingipain gene mRNA transcripts in both strains (Fig. 2.6).
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P. gingvalis
FLL93

A

P. gingvalis
W83

rgpA rgpBkgp16s rgpArgpBkgp 16s

+RT

B

rgpA rgpBkgp16s

rgpA rgpBkgp16s

-RT

Figure 2.6. Major gingipains are expressed in viVwis-defective mutant of P.
gingivalis. DNase-treated total RNA extracted from P. gingivalis W83 and FLL93
grown to stationary phase was subjected to RT-PCR analysis.
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D.7. Identification of gingipain proenzyme in P. gingivalis FLL93

The presence of mRNA transcript for the gingipains genes in P. gingivalis FLL93
may suggest a defect in gingipain biogenesis which could be similar to the vimAdefective (P. gingivalis FLL92) isogenic mutant previously reported (1). We have also
shown previously that precipitation of extracellular proteins from P. gingivalis FLL92
with 37.5% acetone can enrich for the partially processed RgpB proenzyme (27).
Extracellular fractions obtained from culture supernatants of P. gingivalis FLL93 grown
to late-exponential phase (OD 6oo) of 0.8, were assessed by Western blot analysis using
antibodies against the RgpB proenzyme. As shown in figure 2.7, the RgpB proenzyme
specific antibodies revealed a 64 kDa immunoreactive band in P. gingivalis FLL93,
which is similar in size to the RgpB proenzyme previously reported in the vwl4-defective
mutant FLL92 (27). It is also noteworthy, that the antibodies do not immunoreact with
any proteins present in the W83 extracellular fractions.
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Figure 2.7. Immunoreactivity of the RgpB proenzyme in P. gingivalis FLL93.
Western blot analysis using specific RgpB proenzyme antibodies as probes was
done on the extracellular fractions from P. gingivalis W83 (Lanel), FLL92 (Lane
2) and FLL93 (Lane 3). All lanes contained 20 pg of acetone (37.5%) precipitated
proteins from the supernatant fractions of cultures in BHI medium at exponential
growth phase.
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D.8. In vitro protease activation using urea

We have previously shown that in vitro protease activity could be induced by a urea
denaturation-renaturation cycle in non-proteolytic extracellular protein fractions from P.
gingivalis FLL92 grown to late exponential phase (27). This was consistent with the
presence of a partially processed protease in those fractions. Proteolytic cleavage is a
common mechanism that can generate an active enzyme from a larger proenzyme (17).
While activation can be achieved by the action of other proteolytic enzymes, we cannot
rule out the possibility that an inhibitor may be present at its catalytic site of the enzyme
or the tertiary structure of the proenzyme may be incompatible for activation. Since most
proteins are denatured in the presence of high concentrations of urea and some will
renature if the high concentration is slowly reduced, extracellular proteins from P.
gingivalis FLL93 grown to late exponential phase or stationary phase were subjected to a
urea denaturation-renaturation cycle. Figure 2.8 shows a slight activation of Rgp and Kgp
in the extracellular protein fraction from P. gingivalis FLL93 grown to late exponential or
stationary phase compared to the wild-type.
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Figure 2.8. Protease activation in the extracellular protein fraction from P.
gingivalis FLL93. P. gingivalis was grown to stationary phase (ODeoo) of 1.3 in 1
liter of BHI broth supplemented with hemin and vitamin K. Acetone (37.5%)precipitated proteins were mixed with 8 M urea and incubated at 4°C for 1 h. The
urea was slowly removed from the mixture by centrifugation (10,000 x g) in a
Millipore filtration unit with the addition of increasing volumes of 100 mM Tris-HCl
buffer (pH 7.4). Activities for Rgp and Kgp were tested. Error bars indicate the
standard error of the mean of three independent trials.
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D.9. The Rgp active site is not labeled by DNS-EGR-CK in P. gingivalis FLL93

DNS-EGR-CK binds irreversibly to the active site of the arginine-specific proteases
of P. gingivalis and can be detected by UV illumination following electrophoresis (3).
To determine if the active site or catalytic domain is exposed or accessible in Arggingipain from P. gingivalis FLL93, extracellular fractions that were labeled with DNSEGR-CK was subjected to SDS-PAGE and analyzed using a UV-transilluminator. As
expected, DNS-EGR-CK treated extracellular proteins from the wild-type strain generate
fluorescent bands characteristic of the arginine-specific proteases catalytic domain (Fig.
2.9). Similarly, DNS-EGR-CK treatment of extracellular proteins from P. gingivalis
FLL92, grown to stationary phase showed a 48 kDa fluorescent band (Fig. 2.9).
However, there was no detectable specifically labeled protein that was similar in size to
the 48 kDa band in the late exponential or stationary phase extracellular protein fraction
from P. gingivalis FLL93 (Fig. 2.9). There was also no detectable specifically labeled
protein that was similar in size to the 64 kDa partially processed RgpB proenzyme in the
late exponential or stationary phase extracellular protein fraction.
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Figure 2.9. The Rgp active site is not labeled by DNS-EGR-CK in P. gingivalis
FLL93 extracellular fractions. Acetone-precipitated extracellular proteins from P.
gingivalis W83, P. gingivalis FLL93 and P. gingivalis FLL92 were labeled with the
fluorescent irreversible inhibitor DNS-EGR-CK and subjected to SDS-PAGE on 4
to 12% NuPAGE gels (Invitrogen, Carlsbad, CA). The gels were viewed under UV
light to visualize labeled proteins. (A) All the lanes were labeled with DNS-EGRCK. (B) All the lanes in panel B were labeled with DNS-EGR-CK in the presence
of 50 pM leupeptin. Each lane contains 20 pg of protein. The arrow indicates the
DNS-EGR-CK-labeled protein band. E=exponential phase; L=stationary phase
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D.10. vimE can be independently expressed

The similar phenotypic properties of the non-proteolytic
gingivalis FLL32, and the

-deficient mutant, P.

-defective mutant, P. gingivalis FLL92 may be explained

by a polar effect (1). To determine if vimE is co-transcribed with vimA, RT-PCR using
W83 RNA was performed using primers for vimA (P7) and vimE (P3). In the absence of
RT, no amplified fragment was observed (Fig. 2.10). However, a 2.0 kb fragment was
amplified consistent with the expected size. To determine if vimE was co-transcribed
with the downstream gene Pg0792, RT-PCR using W83 RNA and primers for vimE (PI)
and Pg0792 (P5) were used. As shown in figure 2.1 OB, a 2.3 kb fragment of the size
expected was amplified. Taken together, these results indicate that vimE appears to be co
transcribed with vimA or Pg0792 and may be a part of the bcp-recA-vimA transcriptional
unit. In the absence of vimE, there is little gingipain activation. Further, the late onset of
gingipain activity in the v/myf-defective mutant may suggest that the vimE gene could be
independently expressed (8). RT-PCR of total RNA showed that the expected fragment
for the vimE gene could be amplified from the vzmyf-defective mutant (Fig. 2.11 A). In a
similar experiment using RNA from the v/mFfdefective mutant, the downstream gene
Pg0792 was amplified (Fig. 2.1 IB).
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vimA-vimE vimA-vimE
(+RT)
(-RT)

A
2.0 kb—►

B

vimE-Pg0792vimE-Pg0792
(+RT)
(-RT)

2.3 kb—►

Figure 2.10. vimE can be co transcribed with vimA or Pg0792. 1 |ig of total
DNAse treated RNA from P. gingivalis W83 from exponential phase (OD 500) of
0.6 using RiboPure Kit (Ambion, Austin, TX) as subjected to RT-PCR. Co
transcription of vimA and vimE (A) Lane 1, P7 and P3, plus reverse transcriptase;
lane 2, P7 and P3, minus reverse transcriptase. Co-transcription of vimE and
Pg0792 (B) Lane 3, PI to P5, plus reverse transcriptase; lane 4, PI to P5, minus
reverse transcriptase.

131

A

recA
-RT

recA
+ RT

kb

vimA
+ RT

vimA
-RT

vimE
+ RT

vimE
-RT

1.3
1.0

B
1.0

kb recA
+ RT

recA
-RT

vimA
+RT

vimA
-RT

vimE
+RT

vimE Pg0792 Pg0792

_RT

►

0.9------►
0.7------ ►

Figure 2.11. The vimE gene can be independently expressed. Total DNase-treated
RNA was extracted from P. gingivalis FLL92 and P. gingivalis FLL93 grown to
stationary phase (OD600) of 1.3 using the RiboPure Kit (Ambion, Austin, TX). Samples
(1 pg) were subjected to RT-PCR. Panel A. Expression of vimA flanking genes in P.
gingivalis FLL92.
Panel B. Expression of vimE flanking genes from P. gingivalis
FLL93.
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E. DISCUSSION

We have used a genetic approach in this study to further assess the role of specific
host factors in protease regulation/activation in P. gingivalis. Several recent studies [(1,
12, 36), reviewed in (25)] have identified non-gingipain genes that are involved in the
modulation of gingipain activity and other virulence factors in P. gingivalis. A
comparison of several of the P. gingivalis mutants from these studies have raised the
possibility of multiple mechanisms for gingipain activation. Mutation in the vimA, porR
or gppX gene has shown growth-phase-dependent activation of proteolytic activity that is
mostly soluble (1, 12, 36). A mechanism of activation by these genes is currently not
understood, furthermore, it is unclear if they are part of a common pathway for gingipain
activation. Although these mutants had a similar proteolytic profile, inactivation of each
gene did not affect the expression of the others.

The vimE gene, which is downstream of vimA, does not appear to show any
significant similarity with any known genes (www.oralgen.lanl.gov). P. gingivalis
FLL93, the isogenic mutant defective in this gene, showed reduced proteolytic activity,
reduced doubling time and was non-black-pigmented in this study. This phenotype of P.
gingivalis FLL93, could be related to the reduced gingipain activity and, in particular,
reduced membrane-associated activity. This would be similar to P. gingivalis FLL32, a
-defective mutant (2) and P. gingivalis FLL92, a v/myf-defective mutant (1). These
results would also be consistent with other reports (8, 21, 28, 37) of the involvement of
gingipains, especially Kgp, with hemoglobin binding, absorption and heme accumulation.
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Hemolysin activity appears to be modulated by the vimE gene in P. gingivalis. In
this study, P. gingivalis FLL93, the vz'mis-defective mutant, showed no hemolytic activity
when grown on blood plates or incubated with sheep erythrocytes. Because the protease
Kgp has been shown to have hemoglobinase activity (21) and plays a role in erythrocyte
degradation (34), our results are not surprising because of the reduced proteolytic activity
in P. gingivalis FLL93. In addition to the effect of proteolytic activity on the hemolysin
potential, several hemolysin-like genes have been identified from the P. gingivalis
genome project [(www.oralgen.lanl.gov), (26)]. Furthermore, there is genetic evidence
for the involvement of two distinct hemolysins in the hemolysin activity of P. gingivalis
(15). Taken together, these observations may suggest regulation of those genes or gene
products by the vimE gene, although we cannot rule out the effect of the gingipains on
their expression. There is evidence that the gingipains are involved in the processing of
other proteins (14, 39).

The vimE gene in this study appears to also affect hemagglutination in P. gingivalis.
Hemagglutination of sheep erythrocytes was reduced in P. gingivalis FLL93, the vimEdefective mutant. Again, these observations are not unexpected due to the reduced
proteolytic activity of P. gingivalis FLL93. The proteases RgpA and Kgp have
hemagglutinating activity (35). Further, a monoclonal antibody (mAb 61BG1.3) that
inhibited the hemagglutination and selectively prevented the re-colonization of P.
gingivalis in periodontal patients was found to recognize a peptide within the adhesin
domain encoded by rgpA, kgp and hagA (5, 16). In addition to the association of the
gingipains with hemagglutination in P. gingivalis, the presence of several genetically
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distinct genes including hemagglutinin genes hagB, and hagC have been reported (20,
32). In this study, the effects of the vimE gene product on hemagglutination in P.
gingivalis may also implicate the regulation of those genes or gene products by this gene.

Consistent with previous reports on two isogenic mutants (P. gingivalis FLL32, a
-defective mutant and P. gingivalis FLL92, a vzm^-defective mutant) with reduced
proteolytic activity, there was no detectable alteration of the gingipain genes in P.
gingivalis FLL93. RgpB was secreted in an inactive form in the

-defective mutant

suggesting a role of the vimA gene in the post-translational regulation of protease activity
in P. gingivalis (27). A comparison of the extracellular proteins using the RgpB
proenzyme-specific antibodies revealed a 64 kDa immunoreactive band in P. gingivalis
FLL93, which was similar in size to the RgpB partially processed proenzyme previously
reported in the vzmyf-defective mutant P. gingivalis FLL92 (27). There were also an
80kDa immunoreactive band which preliminary studies may suggest to be the full length
unprocessed RgpB which was absent in P. gingivalis W83 and P. gingivalis FLL92.
Other bands may be intermediate products of the processing. In the process of
maturation, the active site would become accessible. If there is defect in this process in P.
gingivalis FLL93, very little active site labeling with DNS-EGR-CK of the 48 kDa
catalytic domain of RgpB would be observed in cultures from exponential or stationary
phase. As observed in this study, active site labeling was undetected in P. gingivalis
FLL93. This further confirms that there may be a defect in the activation/maturation of
the gingipains. Collectively, these observations may suggest that the vimE gene product,
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similar to VimA, is involved in the post-translational regulation of protease activity in P.
gingivalis.
An active enzyme can be generated from a larger polypeptide by autoprocessing
or by the action of other proteolytic enzymes (17). Several cysteine proteases are
converted to their active forms by removal of the prosegment by an autocatalytic
mechanism (17). There is accumulating evidence that a multicomponent maturation
pathway(s), perhaps including an autolytic mechanism, may be involved in the production
of Arg-X- and Lys-X-specific proteases in P. gingivalis (3, 24, 33). While it is clear that
proteolytic processing of the gingipain precursors in P. gingivalis is required to produce
the isoforms detected, it has been shown that denaturing and refolding of proteins can
also induce the autoprocessing of RgpB (27). We have shown that there is very little
activation after urea treatment in the

-defective mutant extracellular fraction. The

presence of an 80 kDa proenzyme immunoreacting band, which was absent in the vimA
mutant, may indicate that vimE is needed for the initial processing of RgpB. The
processing of the 64 kDa RgpB proenzyme intermediate in vimA mutant could have been
enhanced by the denaturing-renaturing experiments (27)

The distribution of the proteolytic activity in P. gingivalis FLL93 was similar to the
wild-type strain and in contrast to P. gingivalis FLL92, the v/myt-defective mutant, that
had mostly soluble proteolytic activity with little or no cell-associated activity (1, 27).
While there was a unique late onset of Arg-X- and Lys-X-specific proteolytic activity in
P. gingivalis FLL92 (27), there were little or no observed changes of proteolytic activity
in stationary phase in the P. gingivalis FLL93, the v/mL'-defective mutant. Collectively,
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our observations could support a hypothesis that suggests the regulation of proteolytic
activity in P. gingivalis may occur by multiple mechanisms. During exponential growth
phase proteolytic activity in P. gingivalis may be regulated in a vimA dependent manner.
However, during stationary phase, an alternative pathway for protease activation may be
upregulated to overcome/bypass the vimA mutation or is activated in the absence of
VimA. In addition, in the absence the vimE gene product, as observed in this study,
there is minimal activation of proteolytic activity during exponential or stationary growth
phase. The specific functional role of VimE during protease activation is unclear and is
being further investigated in our laboratory.

The vimE gene appears to be co-transcribed with either vimA or Pg0792 and may
be a part of the bcp-recA-vimA transcriptional unit. Further, its inactivation did not have
any polar effect on the expression of the downstream gene. Because both the vimE and
vimA genes have a similar effect on protease biogenesis in P. gingivalis, it is likely that
they may be a part of the same or different pathway(s) that involved in protein
maturation, including protease activation/maturation. Currently, there is no information
on the regulation of these genes. Since gingipain activation in the v/mE-defective mutant
is not growth-phase related and that gene product is required for activation/maturation
both vimA and vimE genes could be regulated differently. This question is under further
evaluated in our laboratory.

The effect of proteolytic activity on virulence in P. gingivalis is well documented
[reviewed in (7, 13, 18, 29)]. Inactivation of the gingipain genes has been demonstrated
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to reduce the virulence potential of P. gingivalis. Thus, modulation of virulence in P.
gingivalis may be coordinated via an ability to modulate proteolytic activity. Although
not directly tested in this study, the vimE gene may be an important virulence gene.
Because inactivation of the vimE gene resulted in reduction in proteolytic activity and
had a pleiotropic effect on other important virulence factors, P. gingivalis FLL93 would
be expected to have a reduced pathogenic potential in contrast to the wild-type strain.
This would be consistent with the vz'myt-defective mutant that had a similar phenotype as
P. gingivalis FLL93 and was dramatically less virulent than the wild-type strain in the
mouse model (1).

In summary, we have constructed an isogenic mutant of P. gingivalis that is
defective in the vimE gene downstream of the bcp-recA-vimA transcriptional unit. While
this mutant had reduced proteolytic activity, there was no detectable reduction of the
gingipain genes transcription. Further, this mutant in contrast to the wild-type strain,
showed reduced hemolytic and hemagglutinating activities. The vimE gene appears to be
independently expressed and its identification represents a potentially new mechanism for
regulating proteolytic activity and virulence in P. gingivalis. It is unclear however, if
there is any interaction between the vimE and vimA gene products, this is under further
investigation in the laboratory.
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A. ABSTRACT

We have previously shown that gingipain activity in Porphyromonas gingivalis is
modulated by the unique vimA and vimE genes. To determine if these genes had a similar
phenotypic effect on protease maturation/activation, isogenic mutants defective in those
genes were further characterized. Western blot analyses using anti-gingipain antibodies,
showed RgpA-, RgpB- and Kgp- immunoreactive bands in membrane fractions, as well
as, the culture supernatant of both P. gingivalis W83 and FLL93, the Wm£-defective
mutant. In contrast, the membrane of P. gingivalis FLL92, the vz'myf-defective mutant,
demonstrated immunoreactivity only with RgpB antibodies. Using mass spectrometry or
western blot, the full length, RgpA, and RgpB were identified from extracellular
fractions. In similarly extracellular fractions from P. gingivalis FLL92 and FLL93,
purified RgpB activated only arginine-specific activity. In addition, the LPS profiles of
the vimA and vimE mutants were truncated in comparison to W83. While glycosylated
proteins were detected in the membrane and extracellular fractions from the vimA or
vz'wfs-defective mutants, a monoclonal antibody (mAb 1B5) that reacts with specific
sugar moieties of the P. gingivalis cell surface polysaccharide and membrane associated
Rgp gingipain, showed no immunoreactivity with these fractions. Taken together, these
results indicate a possible defect in sugar biogenesis in both the vimA- and vimEdefective mutants. These modulating genes play a role in the secretion, processing and/or
anchorage of the gingipains on the cell surface.
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B. INTRODUCTION

Porphyromonas gingivalis, a black-pigmented, Gram-negative anaerobic bacterium,
is an important etiological agent of chronic periodontitis. Further, accumulating data
suggests that this organism is also associated with systemic diseases and complications
including atherosclerosis, preterm births and low birth weight babies (15). While several
virulence factors are implicated in the pathogenicity of P. gingivalis, the high-level
proteolytic abilities of this organism have been considered to play the most significant
role in its virulence (7, 11, 14, 15, 17). The major proteases called gingipains, consist of
arginine-specific protease (Arg-gingipain [Rgp]) and lysine-specific protease (Lysgingipain [Kgp]). The Rgp is encoded by two genes, rgpA and rgpB, while Kgp is
encoded by a single gene, kgp. These proteases, which are both extracellular and cellassociated, are required for growth of the organism and other housekeeping functions,
which include processing enzymes for various cell surface proteins, including individual
proteases (24). Moreover, the multiple pathogenic effects of the gingipains, such as,
degradation of complement and immunoglobulin, inactivation of cytokines and their
receptors, aggregation of platelets, attenuation of neutrophil antibacterial activities, and
increase in vascular permeability and blood clotting prevention are well documented (14).

We have reported previously that the vimA and vimE genes can modulate the
phenotypic expression of the gingipains in P. gingivalis (1, 23). While the vimA gene is
part of the bcp-recA-vimA transcriptional unit, the downstream vimE can either be co
transcribed with vimA or can be independently expressed (23). The vimA and vimEdefective mutant strains designated P. gingivalis FLL92 and FLL93, respectively, were
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non-black pigmented and showed significant reductions in proteolytic, hemolytic, and
hemagglutinating activities (1, 23). In in vivo experiments using a mouse model, the
virulence of P. gingivalis FLL92 was dramatically reduced in comparison to that of the
wild-type W83 strain (1). While reductions in Arg-X- and Lys-X-specific proteolytic
activities were observed in P. gingivalis FLL92 and FLL93, transcription of the gingipain
genes was unaltered in these mutants compared to that of the wild-type strain (1, 23). A
similar phenotype of the gingipain genes was also seen in P. gingivalis FLL32, a recAdefective isogenic mutant that had reduced Arg-X- and Lys-X-specific proteolytic
activities(2). The 64 kDa RgpB partially processed proenzyme was secreted in both P.
gingivalis, FLL92 and FLL93 (19, 23). The distribution of the proteolytic activity in P.
gingivalis FLL93 was similar to the wild-type strain and in contrast to P. gingivalis
FLL92, the vz'm^-defective mutant, that had mostly soluble proteolytic activity with little
or no cell-associated activity (23). While there was a unique late onset of Arg-X- and
Lys-X-specific proteolytic activity in P. gingivalis FLL92, there were little or no
observed changes of proteolytic activity in stationary phase in the P. gingivalis FLL93,
the v/tfiE-defective mutant (23). Collectively, these observations have raised the question
that the regulation of proteolytic activity in P. gingivalis may occur by multiple
mechanisms. Further, it is unclear if the vimA and vimE gene products are part of a
common pathway for protease maturation/activation.
In this report, we have further characterized the v/m£'-defective P. gingivalis
FLL93 strain in comparison to the

-defective strain FLL92 and the wild-type. Our

findings suggest an important role for these genes in gingipain secretion, processing
and/or anchorage of the gingipains on the cell surface.
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C. MATERIAL AND METHODS
C.l. Bacterial strains, growth conditions and plasmids

P. gingivalis W83, and isogenic strains FLL92 and FLL93 were grown in brain heart
infusion (BHI) broth (Difco Laboratories, Detroit, ML) supplemented with hemin (5
pg/ml), vitamin K (0.5 pg/ml), and cysteine (0.1%) and yeast extract (0.5%). Unless
otherwise stated, all cultures were incubated at 37°C and maintained in an anaerobic
chamber (Coy Manufacturing, Ann Arbor, ML) in 10% FL, 10% CO2, and 80% N2. The
growth rates for the P. gingivalis strains were determined spectrophotometrically (optical
density at 600 nm [OD6oo])-

C.2. Preparation of P. gingivalis extracellular fractions

One-liter cultures of P. gingivalis strains FLL92, FLL93 and W83 were grown from
actively growing cells. Cells were harvested by centrifugation 10,000 x g for 30 minutes.
The cell-free culture fluid was precipitated with cold (-20°C), 37.5% or 60% acetone and
the protein pellet was resuspended in 7 ml of 100 mM Tris-HCl buffer (pH 7.4), dialyzed
for 24 h against the same buffer, and then stored on ice or at 0°C.

C.3. Preparation of membrane fraction

One-liter cultures of P. gingivalis strains FLL92, FLL93 and W83 were grown from
actively growing cells to stationary phase (ODeoo of 1.3-1.4). Cells were harvested by
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centrifugation 10,000 x g for 30 minutes. Membrane fractions were prepared by using the
French Pressure Cell Press (American Instrument Company, Silver Spring, MD). The
lysed cells were then centrifuged at 27,000 x g for 1 h. The supernatant was subjected to
ultracentrifugation at 100,000 x g for 1 h. The pellet, designated the membrane fraction,
was resuspended in 100 mM Tris HC1 pH 7.4 containing lOmM Tos-Lys-CH2Cl (TLCK),
a protease inhibitor. The remaining supernatant was considered the cytosolic fraction.

C.4. Membrane vesicle preparation

P. gingivalis W83, FLL92 and FLL93 were grown for 48 h in BHI supplemented with
hemin and vitamin K. Membrane vesicles were prepared as previously described (19).

C.5. Protease assays

The presence of Arg-X- and Lys-X-speciflc cysteine protease activities was determined
using a microplate reader (Bio-Rad, Hercules, CA) as previously reported (20).

C.6. Gel electrophoresis and immunoblot analysis

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed with a 4 to 12% Bis-Tris separating gel in MOPS (morpholinepropanesulfonic
acid)-SDS running buffer according to the manufacturer's instructions (NuPAGENovex
gels; Invitrogen, Carlsbad, CA). Samples were prepared (65% sample, 25% 4x NuPAGE
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LDS sample buffer, 10% NuPAGE reducing agent), heated at 72°C for 10 min, and then
electrophoresed at 200 V for 65 min in the XCell SureLock Mini-Cell System
(Invitrogen, Carlsbad, CA). The protein bands were visualized by staining with Simply
Blue Safe stain (Invitrogen, Carlsbad, CA). The separated proteins were then transferred
to BioTrace nitrocellulose membranes (Pall Corporation, Ann Arbor, ML) and processed
at 15 V for 25 min with a Semi-Dry Trans-blot apparatus (Bio-Rad, Hercules, CA). The
blots were probed with gingipain specific antibodies. Immunoreactive proteins were
detected by the procedure described in the Western Lightning Chemiluminescence
Reagent Plus kit (Perkin-Elmer Life Sciences. Boston, MA). The secondary antibody was
immunoglobulin G (heavy plus light chains)-horseradish peroxidase conjugate (Zymed
Laboratories, Inc., South San Francisco, CA.).

C.7. Activation of inactive gingipains using purified RgpB

Approximately 2.5 units of purified RgpB (Athens Research & Technology. Athens,
CA) was incubated with approximately 750 pg of extracellular extracts of P. gingivalis
FLL92 grown to exponential phase (OD 6oo of 0.7) or P. gingivalis FLL93 grown to
stationary phase. The reaction was performed in activated assay buffer (0.1 M Tris pH
7.6, 0.2 M NaCl, 5 mM CaCL, 10 mM NaOH, 9 mM L-cysteine). Samples were
incubated at 37°C for 1 hour under anaerobic conditions (10% H2, 10% CO2, 80% N2).
Samples were then assayed for proteolytic activity and analyzed by immunoblot analysis.
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C.8. LPS and polysaccharide isolation and silver staining

Overnight cultures of P. gingivalis W83, FLL92 and FLL93 were grown to
stationary phase. LPS isolation was done according to the manufacturer’s protocol (Intron
Biotechnology, Korea). Polysaccharides (PS) were separated from Lipid A by treating the
LPS preparations with 2% acetic acid for 2 hours at 100°C. The soluble fraction
containing the PS was purified using the Superdex 75 column (Amersham Biosciences,
Piscataway, NJ). LPS were subjected to electrophoresis (SDS-PAGE) on 4-12% Bis-Tris
gel using the MOPS running buffer. PS were subjected to electrophoresis (SDS-PAGE)
on 4-12% Bis Tris gel using the MES running buffer. LPS and PS were visualized using
the SilverQuest Silver Staining Kit according to manufacturer’s instructions (Invitrogen,
Carlsbad CA).

C.9. Mass spectrometry sequence analysis

Extracellular fractions of P. gingivalis FLL93 from stationary phase was subject to
SDS-PAGE. Desired bands were excised from the gel and dried in a speed vac for Ih.
Dried gel bands were then reduced with 20 pi of 20mM TCEP at 56°C and then alkylated
with 20pl of 40mM iodoacetamide for 30 minutes at 23°C. Alkylated samples were then
washed twice with lOOmM ammonium bicarbonate and dried using the speed vac for Ih.
Digestion buffer (15 pi of 0.05 pg/pl trypsin stock diluted in 3% acetic acid) was added
to dried gel slice and incubated for 10 minutes on ice. Excess digestion buffer was
removed and 10 pi of lOOmM ammonium bicarbonate was added to cover the gel slice to
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prevent drying. The gel slices were then incubated for 16 h at 30°C. After 16 h, an
additional 10 pi of lOOmM ammonium bicarbonate was added to gel slices and then
incubated for an additional 30 minutes at 30°C. Proteins were then trapped, washed and
eluted using the ZipTipcis according to manufacturer’s instructions (Millipore, Bellerica,
MA). Eluted peptides were dried in the speed vac for 5-10 minutes and resuspended in
0.05 % trifluoroacetic acid (TEA) in MS grade water. All buffers were prepared in
lOOmM ammonium bicarbonate. Tryptic peptides were separated and analyzed on a
Picoview Model PV-500 Nanospray ESI unit (New Objective, Woodburn, MA) coupled
to an LCQ Deca XP Ion Trap Mass Spectrometer (Thermo Electron, San Jose, CA) using
a four-event program consisting of a full MS scan followed by 3 MS/MS events for the
most intense ions on full MS. A 75p by 10 cm capillary column packed with 5p C-18
coated silica was developed with a 40 minute gradient elution program of 2 to 90%
acetonitrile buffered with 0.5% acetic acid and 0.005% TEA at a flow rate of 300
nl/minute. Data was collected with the Xcalibur software (Thermo Electron) and
screened using Bioworks 3.1 Turbosequest software (Thermo Electron) against a
pgin.fasta database downloaded from the Los Alamos National Laboratory
(www.oralgen.lanl.gov) website. Peptide tandem mass spectra were screened to filter out
low/poor quality spectra. Individual peptide matches were also confirmed using the blast
database at www.oralgen.lanl.gov. Proteins were considered to be identified if at least
two different peptides were identical matches.
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C.10. Glycoprotein staining

Membrane and extracellular fractions from P. gingivalis FLL92, FLL93 and W83 at
stationary phase were subjected to electrophoresis (SDS-PAGE). Glycoprotein staining
was performed according to the manufacturer’s Pro-Q Emerald Glycoprotein Gel and
Blot Stain Kit protocol (Molecular Probes, Eugene, OR). Total protein was stained
according to the manufactures S YPRO Ruby stain protocol (Molecular Probes, Eugene,
OR).
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D.RESULTS
D.l. Extracellular proteins from P. gingivalis FLL93

Although there was a dramatic reduction in proteolytic activity in P. gingivalis
FLL93, there appeared to be expression of the gingipain genes (23). Furthermore, the
RgpB proenzyme specific antibodies revealed a 64 kDa immunoreactive band in P.
gingivalis FLL93, which was similar in size to the partially processed RgpB proenzyme
previously reported in the vwl4-defective mutant FLL92 (19). This may suggest a
posttranscriptional regulation of gingipain maturation/activation. To examine any
changes in extracellular proteins from P. gingivalis FLL93 in comparison to the wildtype W83 and v/m^4-defective mutant FLL92, fractions from exponential and stationary
growth phases of all three strains were analyzed by SDS-PAGE. As shown in figure 1 A,
there were multiple protein bands, in contrast to P. gingivalis FLL92, that were unique to
P. gingivalis FLL93. Also, in contrast to P. gingivalis FLL92, there were many high
molecular weight bands that were unaffected by growth phase (Fig. 3.IB).

To determine the presence of the gingipains in P. gingivalis FLL93, culture
supernatants from cells grown to early stationary phase were evaluated using antibodies
against RgpB, RgpA and Kgp. As shown in figure 3.2, the extracellular proteins from P.
gingivalis FLL93 showed multiple unique immunoreactive bands to RgpB, RgpA and
Kgp in contrast to the wild-type strain or P. gingivalis FLL92, the v/myl-defective mutant.
Although there was no detectable gingipain activity in this fraction, it is noteworthy that a
50 kDa band which is similar to the expected size of the catalytic domain for RgpA (Fig.
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3.2B) and Kgp (Fig. 3.2C) was present. A 48 kDa band representing the catalytic domain
of RgpB was present in the wild-type strain and P. gingivalis FLL92 but was faintly
detected in P. gingivalis FLL93. It is also noteworthy that in the v/m£’-defective mutant
there was no processing of any of the gingipains from exponential phase to stationary
phase unlike the vzmyt-defective mutant FLL92 (Fig. 3.2 D, E and F).

D.2. Identification of the gingipain proenzymes

To confirm the identity of the 64 kDa band that immunoreacted with anti-RgpB
specific antibodies in P. gingivalis FLL93, this protein was isolated by SDS-PAGE and
its sequence determined by LC-MS. This 64 kDa protein was revealed to be the partially
processed RgpB proenzyme with its attached propeptide. This protein was secreted in P.
gingivalis FLL93 in both exponential and stationary growth phases (Fig .3.2A and 3.2D).
A high-molecular weight protein band of 185 kDa that immunoreacted with anti-RgpA
antibody (Fig 3.2D and 3.2E) was also confirmed by mass spectrometry to be the
unprocessed proenzyme for RgpA. Also, immunoblot analysis using RgpB proenzyme
antibodies (data not shown) and RgpB antibodies shows an 80kDa immunoreacting band
(Fig. 3 2A and 3.2D). This band may be the unprocessed, full length form of RgpB.
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Figure 3.1. SDS-PAGE of acetone-precipitated P. gingivalis extracellular
proteins
Acetone precipitated proteins from culture supernatants of P. gingivalis cells grown
to exponential phase (A) or stationary phase (B) were separated by SDS-PAGE and
stained with Simply Blue safestain. All lane contained 20pg of proteins. Lane 1 P.
gingivalis W83; Lane 2 P. gingivalis FLL92; Lane 3 P. gingivalis FLL93.
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Figure 3.2. Extracellular protease profile of P. gingivalis FLL92 and FLL93 from
exponential and stationary growth phases
Western blots analysis of extracellular proteins from P. gingivalis grown to
exponential and stationary growth phases were separated by SDS-PAGE and
immunoreacted with gingipain specific antibodies. Lane 1, P. gingivalis W83; Lane
2, P. gingivalis FLL92; Lane 3, P. gingivalis FLL93. Panel A and D = rabbit antiRgpB, Panel B and E= chicken anti-RgpA, C and F= chicken anti-Kgp.
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D.3. Membrane protein profile of P. gingivalis FLL93

The gingipains can play a role in the processing of outer membrane proteins from P.
gingivalis (23). Thus, reduction in functional or active gingipains may result in
unprocessed proteins on the membrane of P. gingivalis. As shown in figure 3.3A, SDSPAGE analysis of membrane preparations from P. gingivalis strains W83, FLL92 and
FLL93 shows that there are multiple unique protein bands in the membrane preparation
of P. gingivalis FLL93 in comparison to the wild-type and the vz'myf-defective mutant
FLL92. Several of the protein bands in the vzmE-defective mutant FLL93 had molecular
weights higher than 90 kDa.

D.4. Gingipain distribution in P. gingivalis FLL93

Similar to the vz'myf-defective mutant (1), the reduced membrane protease activity in
P. gingivalis FLL93 (23) may indicate the absence and/or lack of activation of the cellassociated gingipains. To determine the presence of the cell-associated gingipains in P.
gingivalis FLL93, membrane preparation of P. gingivalis W83, FLL92 and FLL93 were
immunoreacted with antibodies against RgpA, RgpB and Kgp. As shown in figure 3.3B,
antibodies against RgpB revealed immunoreactive bands in the membrane fractions from
P. gingivalis W83, FLL92 and FLL93. There were no immunoreactive bands in the
membrane preparations from P. gingivalis FLL92 using antibodies against RgpA (Fig.
3.3C) or Kgp (Fig. 3.3D). It is noted that in contrast to the wild-type strain, there were
unique high-molecular-weight bands in P. gingivalis FLL93 that immunoreacted with
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antibodies against RgpA, RgpB and Kgp. Taken together, these data may suggest that
the gingipains RgpA and Kgp are not anchored in the membrane of the vzm^-defective
mutant P. gingivalis FLL92. In contrast, all the gingipains, although inactive, were
present in the membrane fraction on the vzm£-defective mutant P. gingivalis FLL93.

162

A

1 2 3

kD

c

B

1

2 3

D

1

2

3

1

2

3

191 —

64 —

51
39 —
28 —

19 —

Figure 3.3. Analysis of membrane proteins of P. gingivalis.
Membrane
preparations of P. gingivalis grown to stationary phase were analyzed by SDS-PAGE
and stained with Simply Blue safe stain and subjected to immunoblot analysis using
anti-gingipain antibodies. Panel A=stained proteins, Panel B= rabbit anti-RgpB, Panel
C= chicken anti-RgpA, D= chicken anti-Kgp. All lanes contained approximately
20pg of protein. Lane 1 P. gingivalis W83; Lane 2 P. gingivalis FLL92; Lane 3 P.
gingivalis FLL93.
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D.5. Analysis of membrane vesicles

Gingipain activity was assayed in membrane vesicle fractions from P. gingivalis
FLL92, FLL93 and the wild-type strain. As shown in figures. 4, there was gingipain
activity in the membrane vesicle fraction from P. gingivalis FLL92 and the wild-type
strain. However, most of the gingipain activity in P. gingivalis FLL92 (Fig. 3.4 A) could
be dialyzed away from the membrane vesicles in contrast to the wild-type strain (Fig.3.
4B). Western blot analysis revealed the presence of less intense immunoreactive bands to
RgpA (Fig. 3.5A) and Kgp (Fig. 3.5B) in the membrane vesicle fraction from P.
gingivalis FLL92 compared to the wild-type strain. In addition to the high molecular
weight bands that may represent unprocessed gingipain species, immunoreactive bands
similar in size to the catalytic and adhesins domains of the gingipains were observed in P.
gingivalis FLL92. Immunoblot analysis of vesicles showed only unique high-molecularweight bands in P. gingivalis FLL93 in contrast to W83. It is noteworthy that a protein
band with a molecular weight greater than 200 kDa and identified by LC-MS as RagA
(TonB-dependent outer membrane receptor protein) was also present in the vesicles of P.
gingivalis FLL93 (Fig. 3.6).
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Figure 3.4. Most active gingipains are released into the vesicle supernantant of P.
gingivalis FLL92.
Membrane vesicle preparations of P. gingivalis W83 and FLL92 isolated from a twoday old culture were dialyzed and fractions were then analyzed for Rgp (BApNA) or
Kgp (ALNA) activity. Solid bars represent activity of membrane vesicles after
dialysis, and striped bars represent protease activity found in the dialysis
supernatants. Panel A P. gingivalis FLL92, Panel B P. gingivalis W83.
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Figure 3.5. RgpA and Kgp analysis of membrane vesicles.
Membrane vesicles isolated from P. gingivalis W83 and isogenic mutants FLL92 and
FLL93 were separated by SDS-PAGE and then subjected to immunoblot analysis using
anti-RgpA (A) and anti-Kgp (B) antibodies. All lanes contained 20 pg of protein. Lane 1,
W83; Lane 2, FLL92; Lane 3, FLL93
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Figure 3.6. Mass spectrometry analysis of TonB-receptor linked protein RagA
from FLL93 membrane vesicles.
Membrane vesicles isolated from cultures supernatants of P. gingivalis W83 and
FLL93 were separated by SDS-PAGE and stained with Simply Blue Safestain. A
band greater than 200kDa from FLL93 membrane vesicle was excised and analyzed
by mass spectrometry. A= stained protein gel, B= mass spectrometry data.
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D.6. Cell surface polysaccharide analysis

LPS from P. gingivalis strains W83, FLL92 and FLL93 were isolated, purified,
separated by SDS-PAGE and subjected to silver staining. As shown in figure 3.7, the
LPS bands for P. gingivalis FLL92 (Fig. 3.7A) and FLL93 (Fig. 3.7A) were similar, but
were truncated or of shorter length in comparison to the wild type strain. Analysis of the
polysaccharides from P. gingivalis after the removal of lipid A showed that vimAdefective mutant had polysaccharides (PS) of shorter length that the wild-type or FLL93
(Fig. 3.7B).
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Figure 3.7. LPS and PS profiles from P. gingivalis W83, FLL92 and FLL93
Lipopolysaccharides or polysaccharides isolated from P. gingivalis strains W83 and
isogenic mutants FLL92 and FLL93 from stationary phase were separated by SDS-PAGE
and silver stained. A= LPS, B= PS
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D.7. Glycosylation analysis

In P. gingivalis, post-translational modification of the gingipains by the covalent
attachment of sugars to the protein backbone has been shown to modulate the biological
properties of these enzymes and may influence their cell membrane association (10).
Because of an apparent defect in the maturation process of the gingipains in both the
vimA- and v/mis-defective mutants the glycosylation profile of the membrane and
extracellular proteins from these isogenic mutants were evaluated. Glycoprotein staining
of membrane and extracellular fractions (Fig. 3.8) from P. gingivalis W83, FLL92 and
FLL93 showed that the proteins in these mutants were being glycosylated or had
carbohydrate moeties. However, the pattern of glycosylated proteins in P. gingivalis
FLL93 appeared to be different than the wild type and P. gingivalis FLL92. Monoclonal
antibody 1B5 has been demonstrated to immunoreact with membrane associated Rgp
(mt-Rgp) and certain LPS modifications in P. gingivalis (9). Even though carbohydrates
were present on the membrane proteins, as shown in figure 3.9, there was no detectable
immunoreactivity in membrane preparations from P. gingivalis FLL92 or FLL93
compared to the wild-type.
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Figure 3.8. Membrane and extracellular proteins are glycosylated in P. gingivalis
FLL92 and FLL93.
Membranes or extracellular preparations of P. gingivalis strains W83, FLL92 and
FLL93 from stationary phase were separated by electrophoresis and oxidized
carbohydrates from the glycoproteins were stained. Lane 1, P. gingivalis FLL92; Lane
2, P. gingivalis FLL93; Lane 3, P. gingivalis W83. A= glycoprotein staining,
B=negative control (- oxidation step), C=total protein staining
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Figure 3.9. Immunoblot analysis of membrane using mAblBS
Membrane preparations from P. gingivalis W83 and isogenic mutants FLL92 and
FLL93 were separated by SDS-PAGE and analyzed for certain carbohydrate
modifications of mt-Rgps and/or LPS modifications of membrane proteins using
mAblBS. All lanes contained 20pg of protein.
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D.8. Activation of Rgp, but not Kgp, in extracellular fractions from P. gingivalis
FLL92 and FLL93

Purified RgpB was incubated with extracellular fractions from FLL92 or FLL93. In
figure 3.10, an increase in Rgp activity was observed in extracellular fractions from both
P. ginigvalis FLL92 (Fig. 3.10A) and FLL93 (Fig. 3.1 OB). There was however, no
detectable activation of Kgp in either the P. gingivalis FLL92 (Fig. 3.10C) or FLL93
(Fig. 3.10D) fraction incubated with the purified RgpB gingipain. Immunoblot analysis of
the activated fractions using antibodies against RgpB showed the disappearance of bands
representing the partially processed and unprocessed RgpB proenzyme (data not shown).
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Figure 3.10. Activation of inactive Rgps by purified RgpB
750 |ag of proteins from 37.5% extracellular acetone fractions containing the inactive
gingipains of P. gingivalis FLL92 (A and C) and FLL93 (B and D) were incubated with
2.5 units of RgpB for 1 hour at 37°C. A and B= Rgp activity, C and D= kgp activity.
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E. DISCUSSION

Multiple non-gingipain genes including the vimA, vimE,porR and gppX genes can
modulate proteolytic activity in P. gingivalis [(1, 13, 21, 23)].

Collectively, these

studies suggest that defects in post-translational modification of the gingipains can affect
their activation and distribution, which can also play a role in iron utilization and
virulence. The identification of the partially processed RgpB proenzyme in the vimAdefective mutant or immunoreactive bands representing this proenzyme species in the
v/mfi-defective mutant may indicate that both these genes are involved in the maturation
pathway(s) of the gingipains in P. gingivalis (19, 23). While these proenzyme species
have not yet been identified in the other P. gingivalis mutant strains, these observations
have raised the possibility of multiple mechanisms for protease maturation/activation in
P. gingivalis. Alternatively, although it is still unclear, these genes may be part of a
common pathway for gingipain activation.

We have further characterized the vz'wE-defective mutant that was previously
shown to exhibit reduced proteolytic activity. Similar to the v/wM-deficient mutant P.
gingivalis FLL92 previously reported (1), a 64 kDa band confirmed to be the partially
processed RgpB proenzyme was secreted in P. gingivalis FLL93, the v/mE-defective
mutant. Consistent with the lack of protease activation in this isogenic mutant, this
protein was present throughout the growth phases unlike the vzm^4-defective mutant that
demonstrated a late onset of proteolytic activity. In contrast to the wild-type and vimAdefective mutant, high molecular weight immunoreactive protein bands that could
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represent the unprocessed gingipains were also secreted in the P. gingivalis FLL93. The
high molecular weight protein band of 185 kDa was confirmed by mass spectrometry to
be the unprocessed proenzyme for RgpA. Also, The 80 kDa band that immunoreacted
with the RgpB proenzyme antibodies (data not shown) and RgpB antibodies may
represent the unprocessed, full length form of RgpB. In addition, the RgpB
immunoreactive bands between 80 and 48 kDa; may represent the intermediates or
partially processed RgpB species. Collectively, these data have confirmed a defect in the
maturation of the gingipains in P. gingivalis FLL93.

Membrane-associated RgpA, RgpB and Kgp were detected in P. gingivalis FLL93.
Based on the high molecular weight immunoreacting bands to antibodies against these
gingipains, the membrane-associated forms could represent the unprocessed or partially
processed proteases. Although cross reactivity can occur between RgpA, Kgp and
hemagglutanins using RgpA and Kgp antibodies, the lack of immunoreactivity to
antibodies against RgpA and Kgp in membrane fractions from P. gingivalis FLL92, the
vimA defective mutant, could suggest that those gingipains are not present on the cell
membrane in addition to the hemagglutanins. Alternatively, the antibodies may only be
immunoreactive with the modified forms of the gingipains, thus, the unmodified forms, if
present on the cell membrane of the vz>?M-defective mutant, may be undetectable. The
presence of Kgp and RgpA in extracellular fractions of P. gingivalis FLL92 has been
previously documented (19). In contrast to the absence of cell-associated RgpA and Kgp
in P. gingivalis FLL92, RgpB was detected in this fraction. This may suggest that there
are multiple mechanisms for post-translational modification of the gingipains that will
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enable cell-membrane association. This is consistent with emerging evidence that
polysaccharide biogenesis plays a significant role in cell-associated gingipains and the
difference in their distribution among P. gingivalis strains might be related to the degree
of production or maturation of cell surface polysaccharide. Recently, Rgp and Kgp were
shown to be produced, but not retained, on the cell surfaces of a P. gingivalis porR
mutant (21). The porR gene product is part of the polysaccharide biosynthetic pathway
that can affect gingipain biogenesis, its anchorage and possible distribution on the cell
surface (21).

There was no apparent defect in the production of membrane vesicles either in the
vimA or vimE isogenic mutants. Proteolytic activity was more readily released from
these vesicle fractions from P. gingivalis FLL92 in contrast to the wild-type. Western
blot analysis of the membrane vesicles from P. gingivalis FLL92 also showed less intense
immunoreactive bands for RgpA and Kgp when compared to the wild-type strain. These
observations are consistent with the mostly soluble gingipain activity previously reported
for P. gingivalis FLL92. It also raises questions on vesicle formation as a mechanism for
gingipain secretion in the vzw^4-defective mutant. Membrane vesicles contain components
of the cell membrane, including outer membrane proteins and lipopolysaccharides.
Formation of these vesicles is regulated by cell wall turnover and mechanical motion that
may shear the blebs, thus, facilitating their release into the culture medium (12, 22).
Consistent with the lack of proteolytic activity in the membrane fraction from the vimEdefective mutant, little gingipain activity was detected in the membrane vesicles.
Immunoblot analysis of vesicles however, showed only unique high molecular weight
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bands in P. gingivalis FLL93 in contrast to W83. Further, the unprocessed TonBdependent outer membrane receptor protein RagA was identified in this fraction from P.
gingivalis FLL93. It has been reported that RagA may be involved in virulence(5, 8) and
may be regulated by temperature. This unprocessed high molecular weight RagA protein
was not detected in P. gingivalis W83. The presence of this possible unprocessed RagA
protein may further suggest other factors involved in virulence (other than the gingipains)
are affected by the inactivation of vimE. Thus, it is possible that its maturation pathway
may require VimE, although we cannot rule out a role for the gingipains. Several reports
have documented a role for the gingipains in the maturation of cell membrane proteins (6,
22).

There was an alteration in the glycosylation profile of the vimA and vimEdefective isogenic mutants. While several proteins appeared to be glycosylated, the
gingipain-specific oligosaccharide moiety detectable by mAb 1B5 was missing in the
mutants. This data may suggest that the carbohydrate polymers or residues present in the
isogenic mutants may be altered which could affect the maturation of the gingipains.
Collectively, these data further support a role for glycosylation in the modulation of
gingipain activity in P. gingivalis. Glycosylation has been demonstrated to play a crucial
role in protein folding, its conformational stabilization, its activation and protection from
enzyme degradation (10). While oligosaccharides including Ara, Rha, Fuc, Man, Gal,
Glc, GalNAc, GlcNAc and NANA have been shown to be associated with the gingipains
in P. gingivalis (9), the specific alterations in the polysaccharide profile in the both the
vimA and v/wE-defective mutants is unclear. A possible explanation for the alteration
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could be the down-regulation of gene products, (such as glycosyltransferases), that play a
role in the glycosylation of proteins and synthesis of LPS. A preliminary microarray
analysis of the vz'myt-defective mutant has shown a down-regulation of several
glycosyltransferases and other genes involved in polysaccharide biogenesis (data not
shown). It has been shown that LPS modifications of the C-terminus of proteins are
needed for the stable interaction or attachment of the proteins to the cell surface (6, 21).
Analysis of the cell surface polysaccharides isolated from the parent strain W83 and
isogenic mutants grown under the same conditions showed that the LPS of FLL92 and
FLL93 were truncated compared to the wild-type. However, the removal of the lipid A
from the LPS resulted in polysaccharide fractions that had similar profiles for both the
parent strain and FLL93 compared to the polysaccharide profile of FLL92, which was of
shorter length, similar to that of the /zorK-defective mutant (21). The truncated
polysaccharides of P. gingivalis FLL92 may be correlated with the absence of RgpA and
Kgp on the membrane surface. These data may also suggest a difference or defect in the
lipid A species or structure in the isogenic mutants in comparison to the wild-type. A
possible mechanism for the role of the vimA and vimE gene products in this process is
under investigation in the laboratory.

Autoprocessing and/or the action of other proteolytic enzymes can generate active
enzymes, including cysteine proteases, from a larger polypeptide (16). In P. gingivalis
there is accumulating evidence that a multicomponent maturation pathway(s), including
an autolytic mechanism, may be involved in the production of Arg-X and Lys-specific
proteases in P. gingivalis (16, 18, 23). In this study, purified RgpB could only activate

179

Arg-specific gingipain activity. This is consistent with other observations that have
demonstrated a role for Rgp in the maturation of Arg-specific activity in P. gingivalis (4).
The lack of activation of Lys-specific activity in this study also confirms previous
observations that generation of this specific activity in P. gingivalis is independent of
Arg-gingipain activity in P. gingivalis (3). While it is clear that proteolytic processing of
the full-length gingipain precursors in P. gingivalis is required to produce the isoforms
detected, the presence of the partially processed or unprocessed proenzyme forms in the
vimA and vimE respectively, may suggest that the mechanism(s) of protease activation in
this organism require host specific factors. It is unclear whether factors including the
vimA and vimE gene products or products regulated by those genes, are involved in the
maturation process. It is also unclear if the vimA and vimE genes may affect the
phenotypic expression of other proteases in P. gingivalis. Further, it is also possible that
these gene products may interact with each other or other proteins to facilitate protease
activation. Preliminary studies in the laboratory have provided some evidence that both
the VimA and VimE proteins interact with the gingipains and other proteins that in other
organisms are involved in protease maturation and for virulence. The effects of these
proteins in gingipain maturation in P. gingivlis are being evaluated in the laboratory.

Finally, the data would support a hypothesis that inactivation of both the vimA and
vimE genes may affect a common pathway for protease biogenesis. The identification of
the unprocessed and partially processed gingipain proenzymes from the vz'm£-defective
mutant, may suggest that this gene product could act upstream of the VimA protein.
Unlike the v/mU-defective mutant, there was no growth-phase dependent activation of
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gingipain activity in the Wmis-defective mutant. This could implicate the vimE gene
product in the initiation process of gingipain biogenesis. We have presented evidence for
post-translational regulation of proteolytic activity in P. gingivalis. This model system
will facilitate a more careful evaluation of gingipain biogenesis in P. gingivalis.
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A. ABSTRACT

Regulation/activation of the Porphyromonas gingivalis gingipains is poorly
understood. A 1.2 kb open reading frame, a putative glycosyl transferase, downstream of
vimE, was cloned, insertionally inactivated using the ermF-ermAM antibiotic resistance
cassette and used to create a defective mutant by allelic exchange. In contrast to the wild
type W83 strain, this mutant designated P. gingivalis FLL95, when plated on Brucella
blood agar was non-pigmented and non-hemolytic. Arginine- and Lysine-specific
gingipain activities were reduced by approximately 97% and 96% respectively, relative to
that of the parent strain. These activities were unaffected by the growth phase in contrast
to the vzwyf-defective mutant P. gingivalis FLL92. Expression of the rgpA, rgpB and kgp
gingipain genes were unaffected in P. gingivalis FLL95 when compared to the wild-type
strain. In non-active gingipain extracellular protein fractions, multiple high molecular
weight proteins immunoreacted with gingipain specific antibodies. The specific
gingipain-associated sugar moiety recognized by monoclonal antibodies IBS was absent
in FLL95. Taken together, these results suggest that the vimE downstream gene,
designated vimE (virulence modulating gene F), which is a putative glycosyl transferase
group 1, is involved in the regulation of the major virulence factors of P. gingivalis.

188

B. INTRODUCTION

As a common theme, the expression of extracellular proteolytic activities is highly
regulated in both prokaryotic and eukaryotic systems [reviewed in (12, 53)]. This
regulation can occur at multiple levels including expression of the protease genes,
secretion, processing of an inactive secreted precursor to its active form and/or the
posttranslational glycosylation of the proteins (17, 50). The multiple layers of regulation
are vital to ensure that expression is tightly controlled in the appropriate temporal and
spatial patterns.
Porphyromonas gingivalis, a black-pigmented, Gram-negative anaerobe has been
implicated as an important etiological agent in adult periodontitis [reviewed in (27, 33,
49)]. While several virulence factors have been implicated in the pathogenicity of P.
gingivalis, the high proteolytic abilities of this organism is the focus of much attention as
it is considered to play the most significant role in virulence (35). The major proteases
called gingipains, are both extracellular and cell-associated. They consist of argininespecific proteases [Arg-gingipain, (Rgp)] and lysine-specific protease [Lys-gingipain,
(Kgp)] (35). Although glycosylation appears to be important for their activation
[reviewed in (17, 42)], there remains a gap in our knowledge on the regulation/activation
of the P. gingivalis gingipains.

Previously, we have reported that the recA locus can affect the phenotypic
expression and distribution of the gingipains in P. gingivalis (1, 2, 38). Using the cloned
vimA gene, which is downstream of the recA gene and part of the bcp-recA-vimA
transcriptional unit, a defective mutant was constructed by allelic exchange (1). The
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mutant strain, designated FLL92, was non-black-pigmented and showed increased
autoaggregration in addition to a significant reduction in proteolytic, hemolytic and
hemagglutinating activities (1). The rgpA, rgpB and kgp gingipain genes were expressed
in P. gingivalis FLL92 when compared to the wild-type strain (1). Furthermore, the
partially processed RgpB proenzyme was secreted in P. gingivalis, FLL92 (38). The
appearance of the gingipain proenzyme forms and the growth phase-dependent activation
of proteolytic (38) activity have raised the possibility of multiple mechanisms for
gingipain activation. In other studies we have also demonstrated that another gene
designated vimE, which is downstream of the vimA gene, is important in gingipain
activation in P. gingivalis. Inactivation of this gene resulted in a similar phenotype as the
vz'm^-defective mutant; however gingipain activities were unaffected by the growth
phase. Furthermore, in contrast to the

-defective mutant P. gingivalis FLL92, the

gingipains, although inactive, were membrane associated in the FLL93, the vimEdefective mutant (Vanterpool et al. in press ). It has been suggested that vimE is needed
for proper carbohydrate biogenesis (Vanterpool et al., In press). Collectively, these
observations suggest that multiple bacteria-specific factors in P. gingivalis are involved
in gingipain biogenesis.

Glycosylation, which is one of the important means in which protein maturation
and other cellular processes are regulated, may be important in gingipain biogenesis in P.
gingivalis. In this process, different glycosyl transferases catalyze the transfer of different
carbohydrate moieties from active donors to specific acceptors (including lipids, proteins
and nucleic acids) (10). Glycosyl transferases have been classified on the basis of the
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reaction catalyzed, substrate specificity and homology to other glycosyl transferases (9).
In eukaryotes, it has been established that glycosylation occurs in the endoplasmic
reticulum or golgi apparatus (17, 21). However, the localization or the mechanism of
glycosylation in prokaryotes has yet to be established. It has been shown in eukaryotes
that glycosylation of proteins play a role in protein folding, protein stablilization, and
protein conformation by sugar-sugar interaction or sugar-protein interactions (8, 17, 21).
In addition, it plays a regulatory role in the activation of protein precursors or zymogens,
resulting in active proteins. Only recently, the role of glycosylation and glycosyl
transferases in prokaryotes have been shown to be involved in the attachment of
membrane proteins to bacterial membrane, for fimbriae maturation, host-cell adhesion
and also maturation of bacterial proteins (5, 44, 50).

In this report we have investigated a 1.2 kb gene downstream of the vimE gene to
determine its role in protease activation in P. gingivalis. This gene, which shares
homology with glycosyl transferase 1 genes from several bacteria, was inactivated in P.
gingivalis by allelic exchange mutagenesis. The P. gingivalis isogenic mutant designated
FLL95 exhibited reduced Arg-X- and Lys-X-specific proteolytic activities that were not
affected by the phase of growth. The glycosylation of the gingipains was altered in this
mutant. These results suggest an important role for this putative glycosyl transferase
gene, now designated vimF, in protease maturation/activation in P. gingivalis and further
confirm the requirement of multiple specific host factors in this process.
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C. MATERIAL AND METHODS

C.l. Bacteria, growth conditions
Strains and plasmids used in this study are listed in Table 4.1. P. gingivalis strains
were grown in brain heart infusion (BHI) broth (Difco Laboratories, Detroit, MI.)
supplemented with hemin(5 pg/ml), vitamin K (0.5 pg/ml), and cysteine (0.1%).
Escherichia coli strains were grown in Luria-Bertani broth. Unless otherwise stated, all
cultures were incubated at 37°C. P. gingivalis strains were maintained in an anaerobic
chamber (Coy Manufacturing, Ann Arbor, MI.) in 10% LL, 10% CO2, 80% N2. Growth
rates for P. gingivalis and E. coli strains were determined spectrophotometrically (optical
density at 600 nm [OD6oo])- Antibiotics were used at the following concentrations:
clindamycin, 0.5 pg/ml; erythromycin, 300 pg/ml; and carbenicillin, 50-100 pg/ml.

C.l. Bioinformatic analysis of vimF

The protein sequence of vimF, obtained from the P. gingivalis genome
(www.oralgen.lanl.gov), was analyzed for any homology to other proteins or any
predicted class or functions using the analysis tool functions at that website. COG
searches, Pfam searches (with a cut off strategy of E-value of 1.0) and blast searches
were performed at the website.
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C.3. DNA isolation and analysis

P. gingivalis chromosomal DNA was prepared by the method of Marmur (32). For
plasmid DNA analysis, DNA extraction was performed by the alkaline lysis procedure of
Bimboim and Doly (6). For large-scale preparation, plasmids were purified using the
Qiagen (Santa Clarita, CA.) plasmid maxi kit.

C.4. Generation of vimF mutant P. gingivalis strain

A 2.5-kb fragment carrying the intact vimE and vimF downstream genes was
amplified by PCR using the PI and P6 oligonucleotide primers (Table 4.2). This
fragment was cloned into the pCR 2.1-Topo plasmid vector (Invitrogen, Carlsbad, CA)
and designated pFLLSO (Vanterpool et. al. in press). The 2.5-kb fragment was then
isolated from the EcoPl digested pFLLSO and then ligated to pUC19 linearized with
EcoK\. The new recombinant plasmid was designated pFLL86. Orientation was
confirmed by restriction analysis. The ermF-ermAM cassette which confers
erythromycin/clindamycin resistance in E. coli and P. gingivalis (16) was PCR amplified
from pVA2198 using Pfu turbo (Stratagene, La Jolla, CA) and inserted into the EcoRN
restriction site of the vimF gene. The resultant recombinant plasmid, pFLL87, was used
as a donor in electroporation of P. gingivalis W83 as previously reported (16).
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C.5. Hemagglutination studies

Hemagglutinin activity was determined as previously reported (18). Twenty-four
hour cultures of P. gingivalis W83, FLL93 and FLL95 cells were harvested by
centrifugation (10,000 x g, 15 minutes). Cells were washed twice in IX Phosphate
Buffered Saline (PBS; 0.147 m NaCl, 0.01 M sodium phosphate) and resuspended to a
final optical density (OD600) of 1.5. Sheep erythrocytes were washed twice with PBS and
resuspended to 1% in PBS. An aliquot (100-pl volumes) of the bacterial suspension was
serially diluted two-fold with PBS in round-bottom 96-well microtiter plates. An equal
volume (100 pi) of 1% sheep erythrocytes was mixed with each dilution and incubated at
4°C for 3 hours. Hemagglutination was visually assessed and the hemagglutination titer
was determined as the last dilution that showed complete hemagglutination.

C.6. Preparation of P. gingivalis extracellular fractions and protease assays

One-liter cultures of P. gingivalis strains FLL93, FLL95 and W83 were grown for
24 h in BHI supplemented with hemin, cysteine and yeast extract. Cells were harvested
by centrifugation 10,000xg for 30 minutes. The cell-free culture fluid was precipitated
with cold (-20°C) 37.5% acetone, and the protein pellet was resuspended in 7 ml of 100
mM Tris-HCl buffer (pH 7.4), dialyzed for 24 h against the same buffer, and then stored
on ice or at 0°C. The presence of Arg-X- and Lys-X-specific cysteine protease activities
was determined with a microplate reader (Bio-Rad Laboratories, Hercules, CA.) as
previously reported (45).
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C.7. Preparation of membrane fraction

One-liter cultures of P. gingivalis strains FLL93, FLL95 and W83 were grown to
ODeoo of 1.3-1.4. Cells were harvested by centrifugation 10,000 x g for 30 minutes.
Membrane fractions were prepared by using lysing the cells using French Pressure Cell
Press (American Instrument Company, Silver Spring, MD) for three cycles at 109 MPa.
The lysed cells were then centrifuged at 27,000 x g for 1 h. The supernatant was
subjected to ultracentrifugation at 100,000 x g for 1 h. The pellet, designated as the
membrane fraction, was resuspended in 100 mM Tris HC1 pH 7.4 containing ImM N-ap-tosyl-L-lysine chloro-methyl ketone (TLCK). The remaining supernatant was
considered the cytosolic fraction.

C.8. Protein concentration determination

Protein concentration was calculated spectrophotometrically using the Warburg formula
within the protein function of the Eppendorf Biophotometer (Brinkman. Westbury, NY).

C.9. SDS-PAGE and Immunoblot analysis

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed with a 4- 12% Bis-Tris separating gel in MOPS (morpholinepropanesulfonic
acid)-SDS running buffer (NuPAGENovex gels; Invitrogen, Carlsbad, CA.) according to
the manufacturer's instructions. Samples were prepared (65% sample, 25% 4x NuPAGE
EDS sample buffer, 10% NuPAGE reducing agent), heated at 72°C for 10 min, and then
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electrophoresed at 200 V for 65 min with the XCell SureLock Mini-Cell (Invitrogen,
Carlsbad, CA). The separated proteins were then transferred to nitrocellulose membranes
(Schleicher & Schuell, Keene, N.H.) and processed at 15 V for 25 min with a Semi-Dry
Trans-blot apparatus (Bio-Rad). The blots were probed with antibodies against specific
protease domains (41) or HagA specific antibodies (generously donated by the ProgulskeFox group). Immunoreactive proteins were detected by the procedure described in the
Western Lightning Chemiluminescence Reagent Plus kit (Perkin-Elmer Life Sciences,
Boston, MA.). The secondary antibody was immunoglobulin G (heavy plus light chains)horseradish peroxidase conjugate (Zymed Laboratories, Inc., South San Francisco, CA.).

C.10. Fibronectin cleavage using P. gingivalis

P. gingivalis W83 and isogenic mutants FLL92, FLL93 and FLL95 cells grown of
to early stationary phase (OD600 of 1.1), harvested washed and resuspended in PBS to a
final OD600 of 1.5. Fibronectin (75 pg), resuspended in PBS was incubated for 30 minutes
at 37°C with 50 pi of P. gingivalis strains. Reaction volume was 500 pi. After 30 minute
incubation, reaction samples were centrifuged at 10,000 x g for 5 minutes and cell-free
supernatant from samples were analyzed by SDS-PAGE and stained with Simply Blue
Safe Stain (Invitrogen, Calsbad, CA).
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C.ll. Analysis of P. gingivalis vimF mutant genes by RT-PCR

Total RNA was extracted from P. gingivalis strains grown to early stationary phase
(OD600 of 1.2 ) using RiboPure kit (Ambion, Austin TX). The primers used for reverse
transcription-PCR (RT-PCR) analysis were specific for the rgpA ,rgpB, kgp, vimE, vimA
and vimF, genes (Table 4.2) . The RT-PCR reaction (50 pi) contained 1 pg of template
RNA in the Superscript One-step RT-PCR reaction mix (Invitrogen, Carlsbad CA).
Negative controls were RT-PCR in the absence of reverse transcriptase.

C.12. LPS and polysaccharide isolation and silver staining

Overnight cultures of P. gingivalis W83 and FLL95 were grown to stationary phase.
LPS isolation was done according to the manufacturer’s protocol (Intron Biotechnology,
Korea). Polysaccharides (PS) were separated from lipid A by treating the LPS
preparations with 2% acetic acid for 2 h at 100°C. The soluble fraction containing the PS
was purified using the Superdex 75 column (Amersham Biosciences, Piscataway, NJ).
LPS were subjected to SDS-PAGE on 4-12% Bis Tris gel using the MOPS running
buffer. PS were subjected to SDS-PAGE on 4-12% Bis Tris gel using the MES running
buffer. LPS and PS were visualized using the SilverQuest Silver Staining Kit according
to manufacturer’s instructions (Invitrogen, Carlsbad, CA).
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Table 4.1. Plasmids and bacterial strains used
in this study
Plasmids
pCR-2.1 TOPO
pFLLSO
pFLL86
pFLL87
pVA2198

Phenotype/Description
Apr, Kmr
pCR 2.1-TOPO Pg0791.Pg0792
pUC 19: Pg0791:Pg0792
pUC 19: Pg0791:Pg0792:: ermF-ermAM
Spr, ermF-ermAM

Source
Invitrogen
(51)
This study
This study
(16)

Bacterial strains
Porphyromonas gingivalis
W83
FLL93
FLL95

Escherichia coli
DH5D

0)

Wild-type
wm£-defective
wmF-defective

(51)
This study

F'())80d/acZA Ml 5 A(/acZYA-argF) U169 recAl endA^
/7SC/R17(rk-, mk+) phoA supE44 X'thiA gy/A96 relA"!

Invitrogen

Top10
F" mcrA A (mrr-hsdRMS-mcrBC) ())80/acZA Ml5 A/acX74
Invitrogen
recAl are 139 A (ara-leu)7Q97 ga/U ga/K rpsL (StrR) encA1
nupG
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D. Results
D.l. Bioinformatic analysis of VimF

It has been demonstrated that vimA and vimE genes play important roles in gingipain
maturation/activation [(51), (Vanterpool et ah, In Press)]. It has also been reported that
vimE can be co-transcribed with vimF and vimA (51). In addition, it has been shown that
the vimA and vimE mutants display carbohydrate biogenesis defects, which may be
correlated with the altered gingipain maturation/activation (Vanterpool et ah, In press).
Thus, it is our hypothesis that inactivation of a glycosyl transferase needed for
modification of the gingipains, would result in a phenotype similar to what is seen in the
vimA and/or vimE defective mutants. The vimE downstream gene, vimF, may play a role
in gingipain maturation/activation. A Cluster of Orthologous Group (COG) search on the
gene sequence of vimF, (Fig. 4.1), from www.ncbi.nih.gov website revealed a COG of
glycosyl transferase type 1 (COG0438) of class M, which is involved in cell envelope
and outer membrane biogenesis. In addition, PSI or local blast searches from tool
analysis function on the www.oralgen.lanl.gov website, showed that vimF has homology
to other glycosyl transferases including from organisms Methanococcus sp. (26%
identity, 42% positives), Geobacter metallireducence (26% identity, 42% positives),
Haloarcula marismortui (24% identity, 44% positives), Bacillus cereus (24% identity,
42% positives), and Bacillus anthracis (24% identity, 41% positives) (PSI blast). Pfam
search of vimF showed a model and description of glycosyl transferase group 1 having a
significant E-value of less than 0.5.
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Figure 4.1. Diagram of the recA locus and the two downstream genes.
Diagram shows ORFs (taken from www.oralgen.lanl.gov.) of the recA locus and the two
downstream genes, vimE and vimF. ORFs are shown with given primer locations. Arrows
indicate gene orientation.
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D.2. Inactivation of the vimF gene in P. gingivalis W83 by allelic exchange
mutagenesis

Isogenic mutants of P. gingivalis W83 defective in the Pg0792 gene (designated
vimF) were constructed by allelic exchange mutagenesis. The circular recombinant
plasmid pFLL87, which carries the ermF-ermAM cassette in the unique EcoR Vrestriction
site (bp 909 of the open reading frame) of the vimF gene, was used as a donor in
electroporation of P. gingivalis W83 (Fig. 4.2A). Following electroporation and plating
on selective medium (BHI containing lOpg/ml erythromycin), we detected approximately
89 erythromycin-resistant colonies after a 5-day incubation period. To compare their
phenotypic properties with those of wild-type strain W83, twenty mutants were plated on
Brucella blood agar plates. In contrast to the wild-type strain, all selected mutants
displayed a non-black-pigmented, non-beta-hemolytic phenotype.

D.3. Confirmation of inactivation of vimF by PCR analysis

Chromosomal DNA from 2 randomly chosen clindamycin/erythromycin resistant
colonies and the wild-type W83 strain were analyzed by PCR to confirm the inactivation
in the vimF gene. If the vimF gene was interrupted by the ermF-ermAM cassette, a 3.1 kb
fragment was expected to be amplified using v/wT7 primers P4 and P5 (Table 4.2). In
addition, a 2.1 kb fragment should be amplified from the mutant using the ermF-ermAM
primers (Table 4.2). The expected 3.1 kb (using vzW7primers) and 2.1 kb (using
erythromycin primers) fragments were observed only in the erythromycin resistant strains
(Fig. 4.2B) in contrast to the wild-type (data not shown). The orientation of the ermFermAM cassette was also confirmed by restriction digest (data not shown). To further
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confirm the absence of the vimF transcript in the erythromycin resistant mutant, DNase
treated RNA for P. gingivalis FLL95 was subjected to RT-PCR. As shown in figure 4.2C,
no vimF transcript was detected from the mutant in comparison to the wild-type W83.
Using Agp-specific primers (Table 4.2) as a control, the expected 0.8 kb fragment was
amplified from all the P. gingivalis strains. There was no amplified fragment observed
from reactions in the absence of reverse transcriptase. Taken together these results
indicated the insertional inactivation of the chromosomal vimF gene with the 2.1 kb
antibiotic cassette was successful. One mutant designated P. gingivalis
FLL95 was randomly chosen for further study. In both the wild-type and the vimFdefective mutant a generation time of 3 hours was determined.
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Table 4.2. Primers used in this study

PI vimE forward
P2 vimE reverse
P3 vimE reverse (intragenic)
P4 vimE ( foward )
P5 vimE reverse (intragenic)
P6 vimE reverse
P7 vimA forward
P8 vimA reverse
P10 pro-kgp forward
Pll pro-kgp reverse
P12 pro-rgpA forward
P13 pro-rgpA reverse
PI4 pro-rgpB forward
P15 pro-rgpB reverse
PI6 erythromycin forward
PI7 erythromycin reverse

5’ATGAATACTGAAGTAATCCAC 3’
5’ TTGGTCGATGGCCGTTTCGTA 3’
5’ TCAGCACTTCCTTGCACAAC 3’
5’ ATTCTACAAAGAAGCGGGGA3’
5’ GCAGGATGGAGC GGGAGTATTC 3’
5’ TTCACGCGAAAAAGTGGAGAT 3’
5’ ATGCCCATCCCTCTATACCTG 3’
5’ TACCTGTTTTTGCTGACCGG 3’
5’ ATGAGGAAATTATTATTGCTGATCG 3’
5’ TTGAAGAGCTGTTTATAAGCTGTTT 3’
5’ ATGAAAAACTTGAACAAGTTTGTTTC 3’
5’ CCGGTGTGTAACGCCCTG3’
5’ CGACCGATGAAGACTTCG 3’
5’TGAAGACGCTCTTATAGATATCTT 3’
5’ TATTAGGCCTATAGCTTCCGCTATT 3’
5’ AATAGGCCTTAGTAACGTGTAACTTT 3’
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Figure 4.2. Construction and confirmation of the v/mF-defective mutant.
A. Construction of Mutant. pFLL87 contains the vimF gene interrupted by an ermFermAM cassette [the vimF gene with flanking sequences were amplified by PCR; the
ermF-ermAM cassette was purified from pVA2198]. The circular recombinant plasmid
pFLL87 was integrally introduced into P. gingivalis W83 by electroporation,
A
reciprocal recombination event between areas of homology on the chromosome and
regions flanking the ermAM-ermF cassette on pFLL87 replaced the intact vimF with an
inactivated copy. B. PCR analysis of allelic exchange mutants of P. gingivalis carrying
the vimF gene inactivated with the ermF-ermAM cassette. Oligonucleotide primers
specific for the vimF gene or erythromycin cassette were used to amplify that gene or
erythromycin from total chromosomal DNA from P. gingivalis. Lane 1, P. gingivalis
FLL95.1 (vimF::ermF-ermAM; vimF primers); lane 2, P. gingivalis FLL95.2
(vimF::ermF-ermAM; vimF primers); lane 3 P. gingivalis W83 (wild-type).lane 4, P.
gingivalis FLL95.1 (vimF::ermF-ermAM; erythromycin primers); lane 5, P. gingivalis
FLL95.2 (yimF::ermF-ermAM; erythromycin primers); lane 6, pVA2198 plasmid
(plasmid carrying the erythromycin cassette; erythromycin primers) as control.
C. Transcriptional profile of vzwA-defective mutant. Total RNA isolated from P.
gingivalis W83 and the vz'mA-defective mutant isolated from stationary phase (ODsoo of
1.4-1.5) was subjected to RT-PCR using primers for vimF and pro-kgp. No transcription
or vimF detected in P. gingivalis FLL95.
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D.4. vimE and vimA is transcribed in P. gingivalis FLL95

It has been shown that vimE and its downstream gene, vimF, can be co-transcribed
(51). To ensure that the inactivation of the vimE gene did not prevent the transcription of
vimE or vimA, DNase treated RNA from the P. gingivalis isogenic mutant and wild type,
was subjected to RT-PCR. As shown in figure 4.3, the vimA and vimE fragment was
amplified from the WmF-defective mutant in comparison and the wild-type W83. No
amplified fragments were observed for either the wild-type or the mutant when reverse
transcriptase was absent from the reaction mixture. Using 16s RNA specific primers as a
positive control, fragments of expected size was amplified from both the wild-type and
the isogenic mutant.
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Figure 4.3. vimE and vimA expression in v/TwF-defective mutant.
Total RNA isolated from P. gingivalis W83 and the vzmF-defective mutant was subjected
to RT-PCR using primers for vimE, vimA and 16s RNA as a control.
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D.5. Hemagglutinin activity in P. gingivalis FLL95

We assessed the hemagglutination potential of P. gingivalis FLL95 in comparison to
P. gingivalis W83 and P. gingivalis FLL93, the non-proteolytic v/mfF-defective mutant.
In contrast to the wild-type strain, there was a reduction in hemagglutinin activity in P.
gingivalis FLL95 (Fig. 4.4A). This level of activity was similar to P. gingivalis FLL93
and the negative control as previously reported (Vanterpool et ah, in press). Immunoblot
analysis of membrane and extracellular fractions using monoclonal antibodies raised
against HagA showed the presence of multiple high molecular weight immunoreactive
bands ranging between 45 kDa to >191 kDa in the vimE and v/mF-defective mutants
membrane fractions (Fig. 4.4B) and immunoreactive bands ranging between 25-185 kDa
in the extracellular fraction (Fig. 4.4B). However, lower immunoreactive bands ranging
between 19-64kDa were observed in the wild-type membrane and extracellular fractions
(Fig. 4.4B).
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Figure 4.4. Hemagglutinin analysis of the v/mF-defective mutant.
A. Hemagglutinin activities of P. gingivalis were performed on P. gingivalis W83,
FLL93 and FLL95 cells serially diluted and incubated with sheep erythrocytes at 4°C for
3 h in a round bottom microtiter plate. The titer was defined as the last dilution that
showed full agglutination. B. Membrane and extracellular fraction preparation were
performed as described for P. gingivalis W83, FLL93 and FLL95. Proteins were
analyzed by immunoblot analysis using monoclonal antibodies raised against
hemagglutinin protein HagA. Lane 1, P. gingivalis W83; Lane 2, P. gingivalis FLL93;
Lane 3, P. gingivalis FLL95
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D.6. Inactivation of the vimE gene affects proteolytic activity in P. gingivalis

We previously reported that the proteolytic activity of the non-black pigmented recA
defective mutant (P. gingivalis FLL32), vzmyt-defective mutant (P. gingivalis FLL92), or
the vz'mfs-defective mutant (FLL93) was reduced by more that 90% when compared to the
wild-type strain (1,2). In addition, a late onset of proteolytic activity was also reported
in the vimA mutant when compared to the wild-type strain (38). Because hemagglutinin
activities can be associated with gingipain activity in this organism (29, 46), P. gingivalis
FLL95 was assayed for proteolytic activity using -a-benzoyl-DL-arginine-p-nitroanilide
(BApNA) for Rgp activity and acetyl-lysine-p-nitroanilide (ALNA) for Kgp activity. In
late-exponential-growth-phase cultures, both Arg-X and Lys-X protease activity in
P. gingivalis FLL95 were very similar to P. gingivalis FLL93 (Vanterpool et al. in press)
which was reduced by approximately 94-96% compared to the wild-type strain (data not
shown). In stationary phase cultures of P. gingivalis FLL95, there was a slight increase in
Lys-X activity, relative to Rgp activity (Fig. 4.5), similar to that of FLL93 (Vanterpool et
al. in press). This is in contrast to the expected late onset of proteolytic activity that was
observed in P. gingivalis FLL92 (38). Taken together, these data suggest that under the
same physiological condition, the proteolytic profile for P. gingivalis FLL95 is
dramatically altered by inactivation of the vimF gene in P. gingivalis.
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Figure 4.5. Proteolytic activity of P. gingivalis v/mF-defective mutant.
P. gingivalis was grown stationary phase in BHI broth supplemented with hemin and
vitamin K. Activities against Rgp (A) and Kgp (B) were tested in whole-cell culture.
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D.7. Expression of the gingipain genes in the v/mF-defective mutant

The reduced proteolytic activity in P. gingivalis FLL95 strain could have been the
result of alteration in transcription of the gingipain genes. There is also the possibility
that the vimF gene may be involved in the posttranslational regulation of gingipain
expression. In previous reports of mutations in two genes (vimA and vimE) upstream of
the vimF gene, a reduction in gingipain activity was observed although the gingipains
were normally expressed (1, 2). Furthermore, the partially processed RgpB gingipain
proenzyme was identified in the

-defective mutant suggesting a defect in gingipain

biogenesis at the posttranslational level (38). To determine the presence of mRNA
transcripts for the gingipain genes (rgpB, rgpA and kgp), total RNA was isolated from the
wild-type W83 strain and P. gingivalis FLL93 grown to stationary phase. Specific
oligonucleotide primers as described in Table 4.2 for rgpB, rgpA, and kgp were used in
RT-PCR to amplify a predicted region of the transcripts. When the reverse transcriptase
was present in the reaction, amplified products of the predicted size (0.8 kb for rgpB and
0.9 kb for rgpA and kgp) were observed for all three gingipain gene transcripts in both
strains (Fig.4.6). This suggests that the gingipains were being expressed in P. gingivalis
FLL95 in comparison to the wild-type.
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Figure 4.6. Expression of the gingipains in the v/mF’-defective mutant.
DNase-treated Total RNA for P. gingivalis W83, FLL93 and FLL95 were grown to
stationary phase and subjected to reverse-transcriptase-PCR. A= Performed in the
presence of reverse transcriptase, B= Performed in the absence of reverse transcriptase.
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D.8. Extracellular proteins from P. gingivalis FLL95

Even though there was a dramatic reduction in proteolytic activity in P. gingivalis
FLL95, the gingipains appeared to be expressed. This may suggest a posttranscriptional
regulation of gingipain maturation/activation. To examine any changes in extracellular
proteins from P. gingivalis FLL95 in comparison to the wild-type W83 and vimEdefective mutant FLL93, extracellular fractions from stationary growth phase of all
three strains were analyzed by SDS-PAGE. As shown in figure 4.7A, there were multiple
high molecular weight protein bands in P. gingivalis FLL95 that were absent in the wildtype. Specific antibodies against RgpB, RgpA and Kgp were used to determine the
presence of the gingipain immunoreactive proteins in P. gingivalis FLL95. Similar to the
vzmE-defective mutant, the extracellular proteins from P. gingivalis FLL95 showed
multiple unique immunoreactive bands to RgpB (Fig.4.7B), RgpA (Fig.4.7C) and Kgp
(Fig.4.7D) in contrast to the wild-type strain. A 48 kDa band representing the catalytic
domain of RgpB was detected in the wild-type strain but was absent in P. gingivalis
FLL95 (Fig. 4.7B). It is noteworthy that other immunoreactive bands representing the
processed mature gingipains were absent in P. gingivalis FLL93 unlike the vimAdefective mutant. Similar to the vzmE-defective mutant, when probed with antibodies
against RgpA, high-molecular weight protein bands of were seen in the vz'mF-defective
mutant. A 185 kDa band was absent in the vimF mutant was present in the vimE mutant
(Fig. 4.7C). Also, immunoblot analysis using anti-RgpB antibodies showed an 80kDa
immunoreacting band consistent with the size of the RgpB proenzyme (Fig 4.7B).
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Figure 4.7. Extracellular protease profile of P. gingivalis FLL93 and FLL95 from
stationary phase.
Acetone precipitated proteins isolated from culture supernatants grown to an OD600
ODeoo 1.4-1.5 were analyzed by A) SDS-PAGE and stained with Simply Blue safe stain
or B) analyzed by immunoblot using gingipain specific antibodies. Approximately 20-25
pg of proteins were loaded in each lane. Lane 1 P. gingivalis W83; Lane 2 P. gingivalis
FLL93; Lane 3 P. gingivalis FLL95. Panel A=SimplyBlue stain, Panel B= rabbit antiRgpB, Panel C= chicken anti-RgpA, D= chicken anti-Kgp. Arrows indicate the
unprocessed and partially processed RgpB.
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D.9. Membrane protein profile of P. gingivalis FLL95

Gingipain-dependent protein processing is documented in P. gingivalis (23). Thus,
reduction in functional or active gingipains may result in unprocessed proteins on the
membrane of P. gingivalis. As shown in figure 4.8 A, SDS-PAGE analysis of membrane
preparations from P. gingivalis strains W83, FLL93 and FLL95 shows that there are
multiple high molecular weight protein bands that are present in the membrane
preparation of P. gingivalis FLL93 and FLL95 that are missing in the wild-type . To
determine the presence of the inactive cell-associated gingipain species in P. gingivalis
FLL95, membrane preparation of P. gingivalis W83, FLL93 and FLL95 were
immunoreacted with antibodies against RgpA, RgpB and Kgp. As shown in figure 8,
there were high molecular weight immunoreactive bands in the membrane preparations
from P. gingivalis FLL93 and FLL95 using antibodies against RgpB (Fig. 4.8B), RgpA
(Fig. 4.8C) or Kgp (Fig. 4.8D). It is noted that in contrast to the wild-type strain, there
were unique high-molecular-weight bands in P. gingivalis FLL95 that immunoreacted
with antibodies against RgpA, RgpB and Kgp. Taken together, these data may suggest
altered processing of the gingipains on the membrane of the vzm£'-defective mutant P.
gingivalis FLL93 or the WwF-defective mutant FLL95. In contrast to the wild-type, all
the gingipains, although inactive, were present in the membrane fraction of the vimEdefective mutant P. gingivalis FLL93 and vz'wF-defective mutant FLL95.
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Figure 4. 8. Membrane protease profile of P. gingivalis FLL93 and FLL95
Membrane preparations taken from P. gingivalis stains W83, FLL93 and FLL95 taken
from stationary phase were analyzed by SDS-PAGE and stained with Simply Blue Safe
stain or analyzed by immunoblot using gingipain specific antibodie. Approximately 2025 pg of protein was loaded in each lane. Lane 1 P. gingivalis W83; Lane 2 P. gingivalis
FLL93; Lane 3 P. gingivalis FLL95. Panel A=SimplyBlue stain, Panel B= rabbit antiRgpB, Panel C= chicken anti-RgpA, D= chicken anti-Kgp
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D.10. P. gingivalis FLL95 has reduced ability to cleave fibronectin

The gingipains of P. gingivalis have been shown to cleave extracellular matrix
components, such as fibronectin, in vitro (40). A defect in gingipain maturation should
abolish or reduced the potential of the organism to cleave fibronectin. To test this
hypothesis, 75 pg of fibronectin was incubated for 30 minutes at 37°C with P. gingivalis
W83, or isogenic mutants FLL92, FLL93 or FLL95 cells washed with and resuspended in
PBS. Incubation of fibronectin with the vzra/1-defective mutant of P. gingivalis
demonstrated no visible cleavage bands (Fig.4.9), however incubation with the vimEdefective resulted in a slight cleavage band at 50 kDa and incubation with the vimFdefective mutant demonstrated slight cleavage bands ranging between 39-52 kDa
(Fig.4.9). After incubation with P. gingivalis W83, the fibronectin was completely
degraded in contrast to the isogenic mutants of P. gingivalis (Fig.4.9).
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Figure 4.9. Reduced ability to cleave fibronectin in isogenic mutants of P. gingivalis.
Fibronectin was incubated for 30 minutes with P. gingivalis W83 and isogenic mutants
FLL92, FLL93 and FLL95 grown of to early stationary phase (OD600 of 1.1), harvested
washed and resuspended in 1XPBS to a final ODeoo of 1.5. Cell-free supernatant from
samples were analyzed by SDS-PAGE and stained with Simply Blue Safe Stain.
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D.ll. Immunoblot analysis using mAblBS
Monoclonal antibody 1B5 has been demonstrated to immunoreact with membrane
associated Rgp (mt-Rgp) and certain LPS modifications in P. gingivalis (14, 17). The
polysaccharide profile of the wild-type and the v/mF-defective mutant are similar (data
not shown). However, as shown in figure 4.10, there was no detectable immunoreactivity
in membrane preparations from P. gingivalis FLL93 or FLL95 compared to the wildtype.
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Membrane preparations

FLL93FLL95 W83

Figure 4.10. Immunoblot analysis of membrane using mAblBS
Membrane preparations from P. gingivalis W83 and isogenic mutants FLL93 and FLL95
were separated by SDS-PAGE and analyzed for certain carbohydrate modifications of
mt-Rgps and/or LPS modifications of membrane proteins using mAblBS. All lanes
contained 20pg of protein.
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E. DISCUSSION

We have used a genetic approach in this study to further assess the role of specific
host factors in protease regulation/activation. Several recent studies [(1, 20, 47),
reviewed in (35)] have identified non-gingipain genes that are involved in the modulation
of gingipain activity and other virulence factors in P. gingivalis. A comparison of several
of the P. gingivalis mutants from these studies has raised the possibility of multiple
mechanisms for gingipain activation. Mutation in the, vimE, vimA, porR or gppX gene
has shown delayed activation of proteolytic activity that is mostly soluble (1, 20, 47). A
mechanism of activation by these genes is currently not understood, furthermore, it is
unclear if they are part of a common pathway for gingipain activation. Although these
mutants had a similar proteolytic profile, inactivation of each gene did not affect the
expression of the others. This raises the possibility that regulation of virulence factors of
P. gingivalis W83 may occur through the function of gene products that may affect
carbohydrate biogenesis.

The vimF gene which is downstream of vimE, does appear to show similarity with
glycosyl transferase 1 genes from several organisms (www.oralgen.lanl.gov). P.
gingivalis FLL95, the isogenic mutant defective in this gene, showed reduced proteolytic
activity, and was non-black-pigmented. This is also similar to a mutant of P. gingivalis
that was defective in the glycosyl (rhamnosyl) transferase gene (11). Other glycosyl
transferases in P. gingivalis including NahA and GtfA have been identified (30, 31, 36).
They were demonstrated to be involved in the maturation of fimbriae and the attachment

222

of the bacteria to epithelial cells. While the effect of NahA on protease activation was
not evaluated(31), the

-defective mutant was pigmented which may suggest the

mutation had no effect on gingipain activity (36). Collectively, these observations would
support an important role for specific glycosyl transferases in the expression of gingipain
activity in P. gingivalis.

Because the posttranslational addition of carbohydrates to the gingipains are
highly variable, it may implicate a role for multiple genes in this process. In P. gingivalis
FLL95, the vz'mF-defective mutant, membrane-associated RgpA, RgpB and Kgp were
detected. Based on the high molecular weight immunoreacting bands to antibodies
against these gingipains, the membrane-associated forms could represent the unprocessed
or partially processed gingipains. Further, no immunoreactivity was detected using mAB
IBS, which is specific for carbohydrate modifications of membrane-associated Rgp and
LPS. While we cannot rule out an alteration in the carbohydrate composition of the LPS
in P. gingivalis FLL95, its mobility profile on SDS-PAGE appeared to be similar to the
wild-type strain. This may correlate with the anchorage of the gingipains in the
membrane of FLL95 and may suggest the ability of VimF to affect the gingipains more
directly. This is in contrast with a mutation in the porR locus, which is associated with
the synthesis of O-antigen side chains of the LPS (17, 47). In the />ori?-defective mutant
there was reduced membrane-associated gingipain activity and a late onset of protease
activity. The cell surface polysaccharide profile of this mutant was different from the
wild-type strain. This defective polysaccharide may have prevented the correct
distrubution and activation of the gingipain. If the inactive gingipains are cell-associated
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as observed in P. gingivalis FLL95, it could be possible that VimF could function
independent of PorR and is essential for gingipain activation. A specific mechanism for
the role of the vimF gene in protease activation is currently being investigated in the
laboratory.

The phenotype of P. gingivalis FLL95, could be related to the reduced gingipain
activity and, in particular, reduced membrane-associated activity. This would be similar
to P. gingivalis FLL32, a rec/t-defective mutant (2), P. gingivalis FLL92, a vimAdefective mutant (1) and vz'mP-defective mutant FLL93 (Vanterpool et. al, in press).
These results would also be consistent with other reports (15, 29, 39, 48) on the
involvement of gingipains, especially Kgp, with hemoglobin binding, absorption and
heme accumulation. Hemolysin activity could also be modulated by the vimF gene in P.
gingivalis. In this study, P. gingivalis FLL95, the vzmP-defective mutant, showed no
hemolytic activity when grown on blood plates. Because the gingipain Kgp has been
shown to have hemoglobinase activity (29) and plays a role in erythrocyte degradation
(45), our results are not surprising due to the reduced proteolytic activity in P. gingivalis
FLL95. In addition to the effect of proteolytic activity on the hemolysin potential,
several hemolysin-like genes have been identified from the P gingivalis genome project
[(www.oralgen.lanl.gov), (37)]. Furthermore, there is genetic evidence for the
involvement of two distinct hemolysins in the hemolysin activity of P. gingivalis (24).
Taken together, these observations may suggest regulation of those genes or gene
products by the vimF gene although we cannot rule out the effect of the gingipains on
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their expression. There is evidence that the gingipains are involved in the processing of
other proteins (23, 52).

The vimF gene in this study appears to also affect hemagglutination in P. gingivalis.
Hemagglutination of sheep erythrocytes was reduced in P. gingivalis FLL93, the vimEdefective mutant and the vzwF-deficient mutant FLL95. Again, these observations are
not unexpected due to the reduced proteolytic activity in P. gingivalis FLL95. The
gingipain RgpA and Kgp have hemagglutinating activity (46). Further a monoclonal
antibody (mAb 61BG1.3) that inhibited the hemagglutination and selectively prevented
the re-colonization of P. gingivalis in periodontal patients was found to recognize a
peptide within the adhesin domain encoded by rgpA, kgp and hagA (7, 25). In addition to
the association of the gingipains with hemagglutination in P. gingivalis, the presence of
several genetically distinct genes including hemagglutinin genes hagB, and hagC have
been reported (28, 43). In this study, the effects of the vimF gene product on
hemagglutination in P. gingivalis may also implicate the regulation of those genes or
gene products by this gene. The HagA protein appears to range in size from 210-283 kDa
[210 kDa (www.tigr.org), 233 kDa (www.oralgen.lanl.gov) or 283 kDa (19)]. Analysis of
the hemagglutanin protein, HagA, from the vimE and vimF defective mutants
demonstrated multiple high molecular weight bands in both the membrane and
extracellular fractions that were absent in the wild-type. The high molecular weight band
greater than 191kDa in the membrane of vimE and the vz^iF-defective mutants, which are
absent from the wild-type may represent the unprocessed or partially HagA protein. The
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other multiple immunoreactive bands that were present in the isogenic mutants may
represent the multiple intermediate HagA species. Collectively, these data suggest that
vimF is needed for the proper processing of the hemagglutinin protein HagA.

The formation of zymogens is an important strategy that organisms use to regulate
the activation of several enzymes. Thus the gingipain zymogen may be crucial in the
timely activation of the gingipains. Consistent with previous reports on two isogenic
mutants {P. gingivalis FLL92, a vzmT-defective mutant and P. gingivalis FLL93, a vimEdefective mutant) with reduced proteolytic activity, there was expression of the gingipain
genes in P. gingivalis FLL95. The gingipain RgpB was secreted in an inactive form in
the vimA and v/mF'-defective mutants suggesting a role of the vimA and vimE genes in the
post-translational regulation of protease activity in P. gingivalis (38). A comparison of
the extracellular proteins using the RgpB proenzyme-specific antibodies revealed a 64
kDa and a 80 kDa immunoreactive band in P. gingivalis FLL95, which is similar in size
to the RgpB proenzyme previously reported (38). Consistent with the lack of protease
activation in this isogenic mutant, this protein was present in stationary phase culture
media unlike the

-defective mutant that demonstrated a late onset of proteolytic

activity (1). In contrast to the wild-type, high-molecular-weight immunoreactive protein
bands that could represent the unprocessed gingipains were also secreted in the P.
gingivalis FLL95. In addition, there appeared to be RgpB immunoreactive bands between
80 and 54 kDa, which may represent an intermediate processed species. Furthermore, the
multiple immunoreactive bands to RgpA and Kgp may represent the gingipain precursors
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and other inactive gingipain intermediates. Collectively, these data have confirmed a
defect in the maturation of the gingipains in P. gingivalis FLL95.

Fibronectin play important roles in cellular signal transduction by its interaction
with the integrins (3). It has been documented that incubation of culture supernatants of
P. gingivalis with fibroblasts resulted in the disappearance of fibronectin and the integrin
subunits (4), however incubation with culture supernatants of the Rgp-deficient mutant
showed very little change in the adhesion molecules (4). In this study, incubation of P.
gingivalis W83 cells with fibronectin resulted in complete degradation of the fibronectin.
As expected, due to reduced gingipain activity in the vimA, vimE or vimF defective
mutants, there was a significant reduction in cleavage of the fibronectin when incubated
with these isogenic strains. The absence of fibronectin cleavage when incubated with the
-defective mutant could be explained by the absence of Kgp and RgpA on the
surface of the cell (Vanterpool et al, In press). The vimE and vimF -defective mutants
have low cell-associated gingipain activity. We cannot rule out the possibility that other
cell-associated protease(s) involved in fibronectin degradation might be present in the
vimE and vimF -defective mutants. This is under further investigation in the laboratory.

It is possible that a defect in the proper glycosylation of proteins, including the
gingipains, may contribute to the abnormal maturation of the gingipains. In the vimAdefective mutant FLL92, the RgpB 64kDa [(38), (Vanterpool et al., In Press)] may be
partially processed resulting in an inactive intermediate of the full length 80 kDa RgpB
proenzyme. The initial cleavage of the 80kDa RgpB and 185 kDa RgpA proenzyme is
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probably occurring at a normal rate. However, in the vimE and vimF mutants, the
presence of the 80kDa RgpB and/or the 185 kDa RgpA (Vanterpool et ah, In press) and
the 64kDa partially processed RgpB proenzyme intermediate (Vanterpool et ah, In press)
suggests that there may be a slow processing of the full length RgpB and RgpA, possibly
due to abberant modification of the proteins. VimA, VimE and/or VimF are possible
factors needed for carbohydrate biogenesis involved in the anchorage and/or activation of
the gingipains. In contrast, the absence of the 80 kDa RgpB in P. gingivalis FLL92
suggests that vimA may not be needed for the initial step of activation (Vanterpool et al.,
In press). Further, in the vimA mutant, the normal activation mechanism may be disrupted
resulting in a alternate pathway of activation, similar to that described by Salvesen et al
(34). Since RgpB has been shown to activate the inactivate the Rgps in vitro, but not Kgp
(Vanterpool et. al. In press), we can envision a scenario where in the vimA mutant, the
concentration of the secreted 64kDa RgpB reaches a high, critical concentration in
stationary phase where RgpB becomes activated by proximity-induced-like activation,
which subsequently activates RgpA. The activated Rgps may then be able to process
other proteins or factors needed for Kgp activation. In contrast to the wild-type, the vimE
and vimF mutants drastically reduced proteolytic activities may be a result of a defect in
the initial activations step of the RgpB proenzyme. Taken together, these data suggest
that the VimE and VimF proteins in P. gingivalis may be involved in protease activation
upstream of VimA.

The modulation of virulence in P. gingivalis may be coordinated via an ability to
modulate proteolytic activity [reviewed in (13, 22, 26, 40)]. Although not directly tested
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in this study, the vimF gene may be an important virulence gene. Because inactivation of
the vimF gene resulted in reduction in proteolytic activity and had a pleiotropic effect on
other important virulence factors, P. gingivalis FLL95 would be expected to have a
reduced pathogenic potential in contrast to the wild-type strain. This would be consistent
with the vz'm/1-defective mutant that had a similar phenotype as P. gingivalis FLL93 and
FLL95 and was dramatically less virulent that the wild-type strain in the mouse model
(1).
In summary, we have constructed an isogenic mutant of P. gingivalis that is
defective a putative glycosyl transferase gene. While this mutant had reduced
proteolytic activity, there was expression of the gingipain genes. Further, this mutant in
contrast to the wild-type strain, showed reduced hemolytic and hemagglutinating
activities. Because glycosyl transferases are important in carbohydrate biosynthesis and
posttranslational glycosylation, further study of this process in bacteria, in addition to its
ability to modulate virulence factors in pathogenic bacteria are of significance.
Identification of the vimF gene represents a potentially new mechanism for regulating
proteolytic activity and virulence in P. gingivalis and could possible be an important
therapeutic target.
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A. ABSTRACT

We have previously identified gingipain proenzyme proteins in the
Porphyromonas gingivalis vimE-defective mutant. These proenzyme species indicate a
post-translational regulation defect in this mutant and suggest an important role for vimE
in gingipain maturation/activation. It is unclear if the VimE protein interacts with the
gingipains and/or regulatory proteins involved in protease maturation/activation. To
further study a mechanism(s) for VimE-dependent protease activation, the vimE gene
product was further characterized. A 56 kDa protein consistent with the size of the
predicted VimE protein was purified. In protein-protein interaction studies using the
purified VimE protein, immunoblot analysis of the eluates with gingipain specific
antibodies showed that VimE interacts with gingipains RgpA, RgpB and Kgp. Using LCMS, other regulatory proteins were shown to interact with VimE. The purified VimE
protein was also immunoreactive with serum from periodontitis patients. Taken together,
these data may suggest interactions of the VimE protein with the gingipains. Its
recognition by the immune system of periodontitis patients may have implication for a
therapeutic strategy to prevent P. gwgzWz's-associated diseases.
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B. INTRODUCTION

A mechanism for temporal and spatial regulation of virulence factors is vital for a
successful pathogen. Porphyromonas gingivalis, a black-pigmented Gram-negative
anaerobic bacterium, is an important periodontal pathogen involved in chronic adult
peridontitis. In addition, it has been associated with other systemic diseases including
atherosclerosis [ Reviwed in (6,14,15,26)]. The proteases of P. gingivalis is shown to be
the most important virulence factor (8,12,29). The major proteases called gingipains, are
both extracellular and cell-associated, which includes the Arg-gingipain, Rgp and the
Lys-gingipain, Kgp. The gingipains are shown to play a role in the inactivation of
important components of the immune system and degradation of numerous proteins in the
host, leading to tissue destruction (22). While several reports have documented
posttranslational regulation of gingipains in P. gingivalis, there remains a gap in our
understanding of gingipain biogenesis.
We have previously shown that the vimE gene can modulate the activation of the
gingipains in P. gingivalis (27). The vimE gene, downstream of vimA, is co-transcribed
with either vimA or its downstream gene, vimE [(27)(Vanterpool et al. submitted data)].
The vzm£-defective mutant strain designated FLL93, was non-black pigmented and
showed significant reductions in proteolytic, hemolytic, and hemagglutinating activities
(27). While reductions in Arg-X- and Lys-X-specific proteolytic activities were observed
in the isogenic mutant FLL93, expression of the the gingipain genes were unaltered.
There was no late onset in proteolytic activity in P. gingivalis FLL93, the Wwfs-defective
mutant in contrast to the vzmyt-defective mutant was observed (27). The presence of
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inactive RgpB and RgpA species in the vimE isogenic mutant further suggest a role for
the vimE gene in gingipain maturation/activation (Vanterpool et. al. 2004, in press).
These observations have raised questions on the regulation of proteolytic activity in P.
gingivalis which may occur by multiple mechanisms. It is unclear if the vimE gene
product is part of a common pathway(s) for protease maturation/activation. To
understand the mechanism for VimE-dependent gingipain biogenesis, the vimE gene
product is further characterized.
In this study, we show that the purified recombinant VimE protein can interact
with the gingipains, in addition to other regulatory proteins in vitro. An immune response
to the VimE protein is also demonstrated in periodontitis patients. Collectively, these data
further confirm a role for VimE in gingipain maturation/activation and may have
implications for a new therapeutic strategy against P. gingivalis infections.
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C. MATERIAL AND METHODS

C.l. Cloning of vimE into an expression vector

Oligonucleotides primers specific for the open reading frame (vimE forward -5’
ATGAATACTGAAGTAATCCAC 3’, vimE reverse- 5’
TTGGTCGATGGCCGTTTCGTA 3’) of vimE gene were synthesized and used in PCR
amplification of the gene. The amplified vimE fragment was cloned into the expression
plasmid pTrcHis2-Topo (Invitrogen, Carlsbad CA) carrying a C-terminus His-tag. The
recombinant plasmid, designated pFLL135, was transformed into ToplOF’ competent E.
coli cells (Invitrogen, Carlsbad CA). The orientation of the insert fragment was
determined by restriction digest. The nucleotide sequence of the insert in pFLL135 was
confirmed as described elsewhere.

C.2. The expression and purification of rVimE

E. coli carrying pFLL135 was grown to exponential phase (OD 600 of 0.7) in Luria
Bertani broth in the presence of 50pg/ml of carbenicillin. ImM isopropyl-beta-Dthiogalactopyranoside (IPTG) was then added to the E. coli cells, which was allowed to
further incubate with shaking for 6 hours at 37°C. The cells were harvested by
centrifugation and lysed by sonciation. Cell membrane and debris were then harvested by
centrifugation. The supernatant and pellet were analyzed by SDS-PAGE for the rVimE
protein. rVimE was solubilized from the pellet by 8M urea (8M urea, 20 mM NaP04, 0.5
M NaCl). For large scale preparation, FPLC purification was performed using the HiTrap

244

Chelating Ni-NTA column (GE Healthcare, Piscataway, NJ). rVimE was eluted using
elution buffer (8M urea, 20 mM NaP04, 0.5 M NaCl, 0.5M Imidazole). Eluate fractions
were analyzed by SDS-PAGE for rVimE. Desired fractions were then pooled together
and dialyzed against protein binding buffer 20 mM NaP04, 0.5 M NaCl). For small scale
preparation, Ni-NTA magnetic bead and magnetic separator (Qiagen) was used to purify
the recombinant protein according to manufacturer’s recommendations.

C.3. His-Tag Stain.

The presence of the poly-histidine tag was confirmed by the GelCode 6xHis Protein Tag
(Pierce, Rockford, IT) kit according to manufacture’s instructions.

C.4. Protein interactions

About 75pg of purified recombinant VimE protein were incubated with Ni-NTA
magnetic beads (Qiagen). The beads were washed with wash/interaction buffers (50mM
NaH2PG4, 300mM NaCl, 50mM Imidazole and 0.005% Tween 20). Cells lysates of W83
grown to stationary phase was then incubated with the VimE attached magnetic beads. As
a negative control, the lysates were incubated with the magnetic beads without the
recombinant proteins. After incubation with cell lysates, unbound proteins were
eliminated with extensive washing in wash buffer. Proteins were eluted off the beads
under denaturing conditions (IX EDS sample buffer, heated to 90°C for 10 minutes). All
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W83 cell lysates was prepared in protein interation buffer (50mM Nat^PC^, 300 mM
Nacl, 50mM imidazole, ImM TLCK) by sonication.

C.5. Gel electrophoresis and immunoblot analysis

SDS-PAGE was performed with a 4 to 12% Bis-Tris separating gel in MOPS
(morpholinepropanesulfonic acid)-SDS running buffer according to the manufacturer's
instructions (NuPAGENovex gels; Invitrogen, Carlsbad, CA). Samples were prepared
(65% sample, 25% 4x NuPAGE EDS sample buffer, 10% NuPAGE reducing agent),
heated at 72°C for 10 min, and then electrophoresed at 200 V for 65 min in the XCell
SureLock Mini-Cell System (Invitrogen, Carlsbad, CA). The protein bands were
visualized by staining with Simply Blue Safe stain (Invitrogen, Carlsbad, CA). The
separated proteins were then transferred to BioTrace nitrocellulose membranes (Pall
Corporation, Ann Arbor, MI.) and processed at 15 V for 25 min with a Semi-Dry Trans
blot apparatus (Bio-Rad, Hercules, CA). The blots were probed with gingipain specific
antibodies as previously reported (23). Immunoreactive proteins were detected by the
procedure described in the Western Lightning Chemiluminescence Reagent Plus kit
(Perkin-Elmer Life Sciences. Boston, MA). The secondary antibody was immunoglobulin
G (heavy plus light chains)-horseradishperoxidase conjugate (Zymed Laboratories, Inc.,
South San Francisco, CA.).
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C.6. Identification of proteins interacting with rVimE

Eluates from the protein interaction studies were separated (SDS-PAGE) and
stained. Bands were excised using a gel cutter and dried in a speed vac for Ih. Dried gel
bands were then reduced with 20pl of 20mM TCEP at 56°C and the alkylated with 20pl
of 40mM iodacetamide for 30 minutes at 23°C. Alkylated samples were then washed
twice with lOOmM ammonium bicarbonate and dried using the speed vac for Ih. 15 pi of
digestion buffer (15 pi of 0.05 pg/pl trypsin stock diluted in 3% acetic acid) was added to
dried gel slice and incubated for 10 minutes on ice. Excess digestion buffer was removed
and 10 pi of lOOmM ammonium bicarbonate was added to cover the gel slice to prevent
drying. The gel slices were then incubated for 16 h at 30°C. After 16 h, an additional 10
pi of lOOmM ammonium bicarbonate was added to gel slices and then incubated for an
additional 30 minutes at 30°C. Proteins were then trapped, washed and eluted using
ZipTipcis according to manufacturer’s instructions (Millipore. Bedford, MD). Eluted
peptides were dried in the speed vac for 5-10 minutes and resuspended in 0.05 %
trifluoroacetic acid (TEA) in MS grade water. All buffers were prepared in lOOmM
ammonium bicarbonate. Tryptic peptides were separated and analyzed on a Picoview
Model PV-500 Nanospray ESI unit (New Objective, Wodburn, MA) coupled to an LCQ
Deca XP Ion Trap Mass Spectrometer (Thermo Electron, San Jose, CA) using a fourevent program consisting of a full MS scan followed by 3 MS/MS events for the most
intense ions on full MS. A 75p by 10 cm capillary column packed with 5p C-18 coated
silica was developed with a 40 minute gradient elution program of 2 to 90% acetonitrile
buffered with 0.5% acetic acid and 0.005% TEA at a flow rate of 300 nl/minute. Data
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was collected with the Xcalibur software (Thermo Electron) and screened using
Bioworks 3.1 Turbosequest software (Thermo Electron) against a pgin.fasta database
downloaded from the Los Alamos National Laboratory (www.oralgen.lanl.gov) website.
Peptide tandem mass spectra were screened to filter out low/poor quality spectra.
Individual peptide matches were also confirmed manually using the blast database at
www.oralgen.lanl.gov. Proteins were considered to be identified if at least two different
peptides were identical matches.
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D. RESULTS
D.l. Bioinformatic analysis of VimE

Blast and homology searches of VimE failed to yield matches to any known or
conserved proteins or enzymatic domains (www.oralgen.lanl.gov or
www.ncbi.nlm.nih.gov ) in the databases. In addition, no significant hydrophobic regions
or hydrophobic amino acids residues were detected as potential membrane regions
(www.tigr.org).

D.2. VimE codes for a protein

vimE was cloned into pTrcHis2-Topo expression vector as depicted in figure 5.1.
The plasmid carrying the gene without mutations was then transformed into Topi OF’
competent E. coli cell and induced for 6 hours with IPTG. Lysed E. coli cells carrying
the rVimE was purified was then analyzed by SDS-PAGE and stained for the presence of
the recombinant protein (data not shown). Uninduced samples were used for the controls.
As shown in figure 5.2, the vimE gene codes for the expected 56 kDa recombinant
protein.
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Figure 5.1. The cloning of vimE into pTrcHis2-TOPO. The vimE ORF was amplified
by PCR from chromosomal DNA of P. gingivalis W83 using the taq polymerase. This
fragment was then ligated into pTrcHis2-TOPO carrying a 6X His-tag and transformed
into Topi OF’ competent E. coli cells. To rule the occurrence of any mutations, the
nucleotide sequence of vimE fragment was determined
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Figure 5.2. vimE codes for a protein. E. coli cells with recombinant plasmids carrying
the vimE gene were induced with 1 mM IPTG. Cells were lysed by sonication and gene
products were purified using a Ni-NTA Ni-NTA magnetic beads.
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D.3. rVimE interact with the major gingipains of P. gingvalis W83

To determine if VimE can interact with the gingipains, purified recombinant
VimE protein, attached to Ni-NTA magnetic beads, were incubated with W83 cell
lysates. Negative controls were the W83 cell lysates incubated with the magnetic beads in
the absence of the recombinant protein. Eluates of the protein-protien interactions were
separated by SDS-PAGE and the presence of the gingipains were analyzed by western
blot using gingipain specific antibodies as probes. As shown in figure 5.3,
immunoreactive bands consistent with the catalytic and hemagglutantin domains for
RgpA and Kgp were observed . A 50 kDa immunoreactive band, representing the
catalytic domain of RgpB was shown to interact with rVimA (Fig. 5.3C)
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Figure 5.3. rVimE interacts with gingipains RgpA, RgpB and Kgp. Eluates of
protein-protein interaction were analyzed by immunoblot blots using gingipain specific
antibodies; RgpA (A), Kgp(B) or RgpB(C). Negative controls were cells lysates
incubated with the magnetic beads without the rVimE.
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D. 4. rVimE interacts with regulatory proteins.

To further identify other proteins that interacted with rVimE, protein bands
isolated from the eluates were analyzed by LC-MS. In addition to the homologues LepA
and ResD proteins, 2 other proteins of unknown function were identified (Table 5.1). The
gingipain RgpB was also confirmed to interact with rVimE.
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Table 5.1. Proteins that interact with Recombinant VimE

PG1097

LepA

GTP-binding protein
(translation)

PG0827

ResD

Two-component
response regulator
(transcription)

PG1305

Conserved hypothetical
protein

unknown

PG0404

Hypothetical protein

unknown

PG1605

Kgp

Lys-gingpain

PG1768

RgpA

Arg-gingipain

PG0461

RgpB

Arg-gingipain
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D.5. VimE is antigenic in a periodontitis patient.

Serum obtained from periodontitis patients were screened for immunoreactivity to
P. gingivalis (5). Of four periodontitis patients screened, two immunoreacted with P.
gingivalis cell lysates. Immunoreactivity against rVimE was also observed in these sera
(Fig. 5.4). This is in contrast to serum from normal healthy patients that only
immunoreacted to a 28 kDa molecular weight protein in P. gingivalis cell lysates. These
sera did not immunoreact with the rVimE protein.
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Figure 5.4. VimE is immunoreactive in a P. gingivalis infected patient. Serum
collected from a periodontitis patient and a normal patient (baseline) were used for
immuoblot analysis.
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E. DISCUSSION

It has been shown that the absence of the vimE gene product in P. gingivalis can
affect activation of the gingipains. In contrast to the

-defective mutant, there was no

late onset of proteolytic activity (1,27). Also, in the vimE mutant there were defects in
carbohydrate biogenesis which may be correlated to the drastically reduced proteolytic
activities observed (27). Reverse transcription showed that the gingipains were being
transcribed, suggesting the defect occurred on a translational level. The mechanism of
v/mfi-dependent gingipain activation has not been fully defined. Thus, identification of
interacting partners of VimE could help elucidate its role in regulation of the virulence
factors of P. gingivalis.

Since vimE was shown to be involved in gingipain activation/maturation, it would
be reasonable to suggest that VimE may be in a pathway needed for the maturation of the
gingipains. If VimE is in a maturation pathway, we would expect the gingipains to
interact with VimE, as well as other key players that are involved in regulating the
maturation of the virulence factors of P. gingivalis. Results from our studies have
demonstrated that rVimE can interact with the gingipains RgpA, Kgp and RgpB. This
further confirms the involvement of VimE with gingipain maturation. The nature of the
interaction is unclear and is the subject of further investigation.

The physical interaction of VimE with ResD may indicate the ability of the
VimE-dependent function to respond to environmental signals. ResD is a two-component
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response regulator. In Bacillus subtilis, ResD is part of an operon with resE. This twocomponent signal transduction system have been shown to be required for the induction
of anaerobic metabolism(19). Homologues in S. aureus have been demonstrated to have a
similar role in anaerobic metabolism in this organism. In addition, SrrAB can regulate the
expression of the virulence factors in S. aureus (3,24,28). ResD has not been evaluated
in P. gingivalis and its involvement in virulence regulation remains unclear. There are
reports that gingipains activity in P. gingivalis can be regulated by environmental
conditions (13,18,21). Our observations could support a hypothesis that could involve the
physical interaction of VimE and ResD. ResE sensor kinase may detect environmental
signals which will regulate ResD. The phosphorylation of ResD by ResE is known to
highly stimulate its transcriptional activity (9,11,19). ResD may be needed for survival
under environmental stress. In addition, it has been shown that the expression of the
virulence factors of P. gingivalis are influenced by environmental conditions, thus
regulating the virulence factors under environmental changes.

GTPase is depicted the molecular switch protein in many organsims (4). GTPases
become active by binding GTP and becoming hydrolysed resulting in conformational
changes of the GTP protein, causing it to become active (4). The active GTPase protein
then interacts with its target becoming the timed switch of the cell or organism. LepA, a
membrane GTPase, has been identified as an interacting protein of rVimE. lepA is
usually in an operon with lepB and/or rcn (16). In P. gingivalis, lepA is directly
downstream of a putative transcriptional regulator (www.oralgen.lanl.gov). It has been
suggested that membrane GTPases function in the regulation of membrane signaling
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pathways (17). Bijlsma et al demonstrated, a

-defective H. pylori mutant was

sensitive to low acidic pH (2). It was proposed that LepA can possibly detect changes in
the environmental pH and start the regulation of factors needed for P. gingivalis survival
in a low pH (2). In a similar manner, LepA in P. gingivalis may either work along with
ResD and/or the up-stream transcriptional regulator in detecting environmental changes.
LepA may regulate the virulence factors or other factors for its survival in the host. The
role of LepA in P. gingivalis has not been investigated.

The immunoreactivity of VimE with serum from periodontitis patients may
indicate that this protein is antigenic. This could have implication for for its development
as a therapeutic target. Several reports have documented the protection ability of animals
immunized with P. gingivalis virulence factor components against further infection.
Genco et al has demonstrated that immunization with RgpA hemmaglutanin domain or
RgpB catalytic domain provides protection against P. gingivalis diseases (7,10).
Reynolds group also demonstrated that immunization using the RgpA-Kgp complexed
could prevent the colonization of P. gingivalis and protect against different strains of P.
gingivalis (20,25). Because the VimE gene product can modulate activity of all the
gingipains and other virulence factors in P. gingivalis, targeting this protein could be of
greater significance. This is being further investigated in the lab.

A mechanism for VimE-dependent functions has been previously mentioned
(27).The presence of the vimE gene product may be necessary for the regulation of
proteins and factors involved in carbohydrate biogenesis (ie glycosyl transferases)
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(Vanterpool et al. 2004, in Press). The results from this study raise the possibility that
VimE could be involved in regulating the transcriptional and/or translational regulatory
proteins. These regulatory proteins may be needed for the maturation of the gingipains or
the other virulence factors of P. gingivalis. The mechanism(s) on how VimE function
will be further analyzed in our laboratory.
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A. ABSTRACT

Previous studies in our laboratory have provided the first evidence for posttranslational regulation of protease activity in P. gingivalis. We have shown the vimA
gene which is part of the bcp-recA-vimA operon plays an important role in protease
activation in this organism. Furthermore, the gingipain RgpB proenzyme is secreted in
the

-defective mutant P. gingivalis FLL92. These data suggest an important role for

the vimA gene in protease activation in P. gingivalis. An important question that is raised
is whether the vimA gene product directly interact with the proteases for their activation
or regulate a pathway responsible for protease activation. To further study the
mechanism(s) for VimA-dependent protease activation, the vimA gene product was
further characterized. A 39 kDa protein consistent with the size of the predicted VimA
protein was purified. In protein-protein interaction studies, the VimA protein was shown
to interact with gingipains RgpA, RgpB and Kgp. Immune sera from mice immunized
with P. gingivalis immunoreacted with the purified VimA protein. Taken together, these
data may suggest an interaction of VimA with the gingipains and further confirm the role
of this protein in their regulation or maturation. Its antigenic characteristics could have
therapeutic implications.
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B. INTRODUCTION

As a common theme, the expression of extracellular proteolytic activities is highly
regulated in both prokaryotic and eukaryotic systems. This regulation can occur at
multiple levels including expression of the protease genes, secretion, processing of an
inactive secreted precursor to its active form and/or the posttranslational glycosylation of
the proteins (3,8). The multiple layers of regulation are vital to ensure that expression is
tightly controlled in the appropriate temporal and spatial patterns. The mechanism of
virulence regulation in P. gingivalis is unclear.
Porphyromonas gingivalis, a black-pigmented Gram-negative anaerobic
bacterium, is an important etiological agent of chronic adult peridontitis and is associated
with other systemic diseases. While several virulence factors have been implicated in the
pathogenicity of P. gingivalis, the high proteolytic abilities of this organism have been
the focus of much attention, and appear to play an important role in virulence. The major
proteases called gingipains, are both extracellular and cell-associated. They consist of
arginine-specific protease [Arg-gingipain, (Rgp)] and lysine-specific protease [Lysgingipain, (Kgp)] (19). We have shown that the vimA gene can modulate the phenotypic
expression of the gingipains in P. gingivalis. The vimA gene is part of the bcp-recA-vimA
transcriptional unit. The defective isogenic mutant was constructed by allelic exchange
using the cloned vimA gene. The vimA -defective mutant strain designated P. gingivalis
FLL92 was non-black pigmented and showed significant reductions in proteolytic,
hemolytic, and hemagglutinating activities (1). While a reduction in Arg-X- and Lys-Xspecific proteolytic activities were observed in P. gingivalis FLL92, transcription of the
gingipain genes was unaltered in these mutants compared to that of the wild-type
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strain(l). A similar phenotype of the gingipain genes was also seen in P. gingivalis
FLL32, a rervl-defective and Wmis-defective isogenic mutants that had reduced Arg-Xand Lys-X-specific proteolytic activities(2,28). While there was a unique late onset of
Arg-X- and Lys-X-specific proteolytic activity in P. gingivalis FLL92, there were little or
no observed changes of proteolytic activity in stationary phase in the P. gingivalis
FLL93, the Wmis-defective mutant (28). Collectively, these observations have raised the
question that the regulation of proteolytic activity in P. gingivalis may occur by multiple
mechanisms. Further, it is unclear if the vimA gene product can physically interact with
the gingipains or regulate a pathway for protease maturation/activation. To understand
the mechanism for VimA-dependent gingipain biogenesis, the vimA and gene product is
further characterized. VimA-linked Ni-NTA beads incubated with cell lysates showed
that VimA interacted with the gingipains and other proteins, including one known to
function in protease maturation. The purified RgpB did not demonstrate any direct
interaction with rVimA. Immunoblot analysis using sera from P. gingivalis challenged
ApoE mice showed immunoreactivity to the VimA protein. Taken together, these data
demonstrate an interaction of VimA protein with the gingipains, which may suggest a
possible role of this protein in their regulation.
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C. MATERIAL AND METHODS

C.l. Cloning of vimA into an expression vector

Oligonucleotides primers specific for the open reading frames of the vimA gene was
synthesized (yimA forward- 5’ ATGCCCATCCCTCTATACCTG 3’, vimA reverse- 5’
TACCTGTTTTTGCTGACCGG 3’) and used for PCR amplification of the vimA gene.
The fragment carrying the vimA gene was cloned into pCRT7/CT-TOPO expression
plasmid carrying a C-terminus His-tag. The recombinant plasmid, designated pFLL131,
was transformed into BL21(DE3)pLysS competent E. coli cells. The orientation was
determined by endonuclease restriction digest. The nucleotide sequence of the insert of
pFLL131 was confirmed to rule out the possibilities of any mutations.

C.2. The expression and purification of rVimA

E. coli cells carrying pFLL131 was grown to exponential phase (OD 600 of 0.7) in
Luria Bertani broth in the presence of 50pg/ml of carbenicillin and 24 pg/ml of
chloramphenicol. Isopropyl-beta-D-thiogalactopyranoside (IPTG) was added to the log
phase E. coli and allowed to incubate at 37°C with shaking for 6 hours. Cells were
harvested by centrifugation and lysed by sonciation. Cell membrane and debris were then
harvested by centrifugation and supernatant and pellet were analyzed for the rVimA
protein by SDS-PAGE. The insoluble rVimA was solubilized from the pellet by 6M
guanidine (6M guanidine, 20mM NaP04, 0.5mM NaCl). For large scale preparation,
rVimA was purified by FPLC purification using the HiTrap Chelating Ni-NTA column
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(GE Healthcare, Piscataway, NJ). The recombinant protein (rVimA) was eluted using
guanidine elution buffer (6M guanidine, 20mM NaP04, 0.5mM NaCl, 0.5M Imidazole).
Eluate fractions were analyzed for rVimA by SDS-PAGE. Desired fractions were then
pooled together and dialyzed against an 8M Urea buffer (8M urea, 20mM NaP04, 0.5mM
NaCl) followed by a protein binding buffer (20mM NaP04, 0.5mM NaCl, 0.5.M LArginine). For small scale preparation, Ni-NTA magnetic bead and magnetic separator
(Qiagen) was used to purify the recombinant protein according to manufacturer’s
recommendations.

C.3. His-Tag Stain
The presence of the poly-histidine tag was confirmed by the GelCode 6xHis Protein
Tag (Peirce, Rockford, IL) kit according to manufacture’s instructions

C.4. Preparation of extracellular fractions of P. gingivalis

P. gingivalis W83 was grown from actively growing cells. Cells were harvested by
centrifugation at 10,000 x g for 30 minutes. The cell-free culture fluid was precipitated
with 37.5% or 60% acetone (-20°C), and the protein pellet was resuspended in 7 ml of
100 mM Tris-HCl buffer (pH 7.4) in the presence of ImM TLCK, dialyzed for 24 h
against the same buffer, and then stored on ice or at 0°C.
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C.5. Protein-protein interactions

About 75 |ag of purified recombinant VimA protein were incubated with Ni-NTA
magnetic beads. Beads were washed with wash/interaction buffers (50mM NaH2P04,
300mM NaCl, 50mM Imidazole and 0.005% Tween 20) and the cells lysates of W83,
FLL92 or extracellular fractions were then incubated with the recombinant proteins on
the magnetic beads. As a negative control, the lysates were incubated with the magnetic
beads without the recombinant proteins. After incubation with cell lysates, unbound
proteins were eliminated with repeated washing in wash/interaction buffer. Proteins were
eluted off the beads under denaturing conditions.

C.6. Gel electrophoresis and immunoblot analysis

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed with a 4 to 12% Bis-Tris separating gel in MOPS (morpholinepropanesulfonic
acid)-SDS running buffer according to the manufacturer's instructions (NuPAGENovex
gels; Invitrogen, Carlsbad, CA). Samples were prepared (65% sample, 25% 4x NuPAGE
EDS sample buffer, 10% NuPAGE reducing agent), heated at 72°C for 10 min, and then
electrophoresed at 200 V for 65 min in the XCell SureLock Mini-Cell System
(Invitrogen, Carlsbad, CA). The protein bands were visualized by staining with Simply
Blue Safe stain (Invitrogen, Carlsbad, CA). The separated proteins were then transferred
to BioTrace nitrocellulose membranes (Pall Corporation, Ann Arbor, MI.) and processed
at 15 V for 25 min with a Semi-Dry Trans-blot apparatus (Bio-Rad, Hercules, CA). The
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blots were probed with gingipain specific antibodies(25). Immunoreactive proteins were
detected by the procedure described in the Western Lightning Chemiluminescence
Reagent Plus kit (Perkin-Elmer Life Sciences. Boston, MA). The secondary antibody was
immunoglobulin G (heavy plus light chains)-horseradishperoxidase conjugate (Zymed
Laboratories, Inc., South San Francisco, CA.).

C.7. Identification of protein that can physically interact with rVimA

Eluates from the protein-protein interaction studies were separated (SDS-PAGE) and
stained. Bands were excised using a gel cutter and dried in a speed vac for Ih. Dried gel
bands were then reduced with 20pl of 20mM TCEP at 56°C and the alkylated with 20pl
of 40mM iodacetamide for 30 minutes at 23°C. Alkylated samples were then washed
twice with lOOmM ammonium bicarbonate and dried using the speed vac for Ih. 15 pi of
digestion buffer (15 pi of 0.05 pg/pl trypsin stock diluted in 3% acetic acid) was added to
dried gel slice and incubated for 10 minutes on ice. Excess digestion buffer was removed
and 10 pi of 1 OOmM ammonium bicarbonate was added to cover the gel slice to prevent
drying. The gel slices were then incubated for 16 h at 30°C. After 16 h, an additional 10
pi of lOOmM ammonium bicarbonate was added to gel slices and then incubated for an
additional 30 minutes at 30°C. Proteins were then trapped, washed and eluted using
ZipTipcis according to manufacturer’s instructions (Millipore. Bedford, MD). Eluted
peptides were dried in the speed vac for 5-10 minutes and resuspended in 0.05 %
trifluoroacetic acid (TFA) in MS grade water. All buffers were prepared in 1 OOmM
ammonium bicarbonate. Tryptic peptides were separated and analyzed on a Picoview
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Model PV-500 Nanospray ESI unit (New Objective, Wodburn, MA) coupled to an LCQ
Deca XP Ion Trap Mass Spectrometer (Thermo Electron, San Jose, CA) using a fourevent program consisting of a full MS scan followed by 3 MS/MS events for the most
intense ions on full MS. A 75p by 10 cm capillary column packed with 5p C-18 coated
silica was developed with a 40 minute gradient elution program of 2 to 90% acetonitrile
buffered with 0.5% acetic acid and 0.005% TEA at a flow rate of 300 nl/minute. Data
was collected with the Xcalibur software (Thermo Electron) and screened using
Bioworks 3.1 Turbosequest software (Thermo Electron) against a pgin.fasta database
downloaded from the Los Alamos National Laboratory (www.oralgen.lanl.gov) website.
Peptide tandem mass spectra were screened to filter out low/poor quality spectra.
Individual peptide matches were also confirmed manually using the blast database at
www.oralgen.lanl.gov. Proteins were considered to be identified if at least two different
peptides were identical matches.

C.8. Antibody production towards rVimA

Approximately 12 mg of rVimA was expressed and purified using the Ni-NTA
column. Purified samples were separated by SDS-PAGE (25 pg/lane). The 39 kD band
representing the rVimA was excised using a gel cutter. A total of approximately 12 mg of
the rVimA protein was excised from preparative gels, placed in PBS and stored at -80°C.
The frozen gel slices were sent to Zymed Laboratories Inc.( South San Francisco, CA) for
the production of polyclonal rabbit rVimA antibodies using the manufacture's standard
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protocol. Dilutions and efficiency of the antibodies were tested in laboratory using the
purified rVimA.

C.9. Purification of VimA antibodies by CNBr-Activated sepharose 4B

For preparation of FLL92 cell lysate as coupling proteins/ligand, FLL92 was grown
to (OD600 of 0.8) and lysed by French press. After removing the unbroken and cell debris,
the supernatant was centrifuged at 39K rpm for 60 minutes. The supernatant of this spin
containing 1.759mg/ml was used as coupling with the resins. For preparation of the gel,
0.5 g of CNBr-Activated Sepharose 4B (Amersham Biosciences, Uppsala Sweden), was
suspended in ImM HC1 to swell (100 ml added in 10 aliquotes). The gel was washed to
remove lactose by suction Pasture pipet between successive additions. The gel was
loaded to a Pasteur pipet and washed with distilled water (10 column volumes were used)
and then it was further washed with 0.1 M NaHCOS coupling buffer containing 0.5 M
NaCl, pH 8.3-8.5. The gel was transferred to a 15 ml Falcon tube and immediately 5mls
of coupling ligand FLL92 lysate, (1.759mg/ml) were mixed with the above gels and left
for overnight at 4°C using end-to-end mixer. The gel was loaded to a new Pasture pipet
column and washed away unreacted ligand using NaHCOs/NaCl coupling buffer. The
unreacted groups of the resins were blocked by passing 0.2M glycine, pH 8.0 for 2 hours
at room temperature. The column was then washed extensively five times to remove the
blocking solution; first with the basic coupling buffer at pH 8.5 and then with acetate
buffer (0.1M, pH 4.0) containing NaCl (0.5M). Two mis of VimA antisera (from maxbleed) was repeatedly (5X) loaded to the column at 4°C. The fifth effluate was considered
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to be pure as far as the VimA antisera was concerned and was judged by the western
blots using pre-immune antisera as control.

C.9. Immunization of ApoE mice with P. gingivalis

Mating pairs of the C57BLK mice (male ApoE-/-) was purchased from Jackson
Laboratories (Bar Harbor, ME). Breeding of ApoE (+/-) mice was performed at Loma
Linda University, Animal Care Facility. Male and female mice were pair-housed
(monogamous pairing: one male and one female). The litters were separated when they
weaned between 21-28 days. Oral infection was performed by randomly separating the
male and female and divided into groups. Each group had 5 animals. At 10 weeks,
experimental group was inoculated once with Porphyromonous gingivalis W83 and other
group with FLL92. lOOpl inoculum with 109 cfu was used. At the completion of 14 and
24 weeks, the animals were sacrificed. The blood was collected through cardiac puncture
and spun to isolate the serum. The serum was collected and stored at -80 C. Similarly, the
sera of baseline animals were collected and stored at -80C.
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D. RESULTS

D.l. Bioinformatic analysis of VimA

Blast and homology searches of VimA failed to yield matches to any known or
conserved proteins or enzymatic domains (www.oralgen.lanl.gov or
www.ncbi.nlm.nih.gov ) in the databases. However, hydrophobicity scaling of the VimA
proteins shows approximately 20 amino acid residues located at the N-terminus to be
hydrophobic. A score of 1.16 identified this protein to be a certain membrane protein.

D.2. VimA code for a protein

The vimA ORF was isolated from P. gingivalis W83 chromosomal DNA and cloned
in CT/T7 TOPO expression vector as depicted in figure 1A. E.coli carrying pFLL131 was
expressed and purified. Lysed E. coli cell proteins were purified by FPLC then analyzed
by SDS-PAGE and stained for the 6x His-tag or Simply Blue safe stain (Fig. 6.IB and
6.1C, respectively). Uninduced samples were used for the controls. As shown in figure
6.2, the vimA codes for the expected 39 kDa recombinant protein.
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Figure 6.1. Expression of rVimA.
The vimA ORF was amplified by PCR from chromosomal DNA of P. gingivalis W83
using the taq polymerase. This fragment was then ligated into CT/T7 TOPO carrying a
6X His-tag and transformed into BL21(DE3)pLysS competent E. coli cells. E. coli cells
carrying pFLL131 was analyzed for expression and the presence of the poly His-tag.
Cells were grown to lag phase and induced with ImM IPTG. Samples were analyzed
every hour. Lane 1, uninduced; Lane 2, 1 h; Lane 3, 2 h; Lane 4, 3 hr; Lane 5, 4h; Lane 6,
5h. A=Simply Blue Safe Stain, B= his-tag stain
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Figure 6.2. vimA codes for protein.
E. coli cells with pFLL131 carrying the vimA or gene was induced with ImM IPTG.
Cells were lysed by sonication and gene products were purified using a Ni-NTA column.
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D.3. rVimA interacts with the major gingipains of P. gingvalis W83

To determine if VimA can interact with the gingipains, purified recombinant
VimA protein attached to Ni-NTA magnetic beads were incubated with W83 cell lysates
or P. gingivalis FLL92 cell lysates. As a negative control, the lysates were incubated with
the magnetic beads without the recombinant proteins. As shown in figure 6.4,
immunoreactive bands consistent with the catalytic and hemagglutinin domains of RgpA
and Kgp (Fig. 6.3A and 6.3B) were observed. In addition, 50 kDa and 70-90 kDa
immunoreacting bands representing the catalytic RgpB and mt-RgpB, respectively, were
observed (Fig 6.3C).

D.4.VimA does not interact with RgpB directly

rVimA was incubated with purified RgpB to determine if it could directly interact
with the mature processed gingipain. As shown in figure 6.4, a 50kDa band, consistent
with the size of RgpB was observed only when VimA was incubated in the presence of
the extracellular fraction from P. gingivalis. These results suggest that rVimA does not
interact with the purified mature gingipain directly, possible through a complex.
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Figure 6.3. rVimA interacts with gingipains RgpA, RgpB and Kgp.
Eluates were analyzed by immunoblot blots using gingipain specific antibodies; RgpA
(A) or Kgp (B), RgpB (C). Negative controls were cells lysates incubated with the
magnetic beads only. The lysates were prepared from cells grown the late exponential
phase.
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Figure 6.4. RgpB does not directly interact with rVimA.
Purified RgpB and extracellular proteins of P. gingivalis W83 were incubated with with
Ni-NTA beads in the presence or absence of rVimA. Eluates of the protein interaction
were separated by SDS-PAGE and for immunoblot analysis, RgpB specific antibodies
were used as probes. Lane l=Purified RgpB in the presence of VimA, Lane 2= Purified
RgpB in the absence of VimA, Lane 3= P. gingivalis W83 extracellular proteins in the
presence of VimA, Lane 3= P. gingivalis W83 extracellular proteins in the absence of
VimA
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D.5. rVimA interacts with possible regulatory proteins

To further identify other proteins that interact with rVimA, protein bands from the
eluates were analyzed by LC-MS. In addition to sugar metabolism proteins (3-lactamase
and a putative sialidase, two hypothetical proteins, a translational protein and the HtrA
homologue were also identified (Table 6.1).

D.6. Identification of possible protein tagging by rVimA

LC-MS analysis of interacting partners of rVimA interestingly demonstrated a
unique 27 peptide residue present on the hypothetical protein Pgl833 and also the
periplasmic serine protease HtrA. The 27 peptide residue is located towards the Cterminus of the VimA proteins demonstrated in figure 6.5
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Table 6.1. Proteins that interact with Recombinant
VimA
Gene ID

Gene Name

Description

PG1101

Alanyl-tRNA synthase

Translation

PG0535

HtrA

serine periplasmic protein

PG1833

Conserved hypothetical
protein

unknown

PG1337

Hypothetical protein

unknown

PG0324

Conserved hypothetical
protein (putative sialidase)

unknown

PG1768

RgpA

Arg-gingipain

PG0461

RgpB

Arg-gingipain

PG1605

Kgp

Lys-gingpain

PG0010

Beta-lactamase

Energy/Sugar metabolism
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A
MPIPLYLQDWWLDAVCGFDEWMAFVLEEEGTVSGVMPCYMPVPGHISMP
PFTQFLGSYSFIGINEDSTTSFRAHRRVHDMLRSMLPPHKSFMVQYSKDFT
DWLPYYWQGYSQTTRYTYRIDLSPGIDWRMAIRPDAMKKIRKAERDGLR
CTSATVDDLLRLCRISMSRQEAKGFAAETLQRLAEVAIERHAGEIVGCED
SEGRLLAAVFLAHDHNTAYTlASGQIREGQGRNAGAFVLYEAlVr RACEME
G1HTFDFEGSMLEGIEGFFR*SFGGIQTPYFRLSKGRIGLYGRLRRKWRAF
HDTGQQKQV

B

N-terminus
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t
Possible
membrane
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Putative binding
domain

Schematic diagram of VimA with putative binding domain and
membrane anchor region

Figure 6.5. Amino acid sequence of VimA.
LC-MS analysis of VimA interacting proteins identifies a unique 27 amino acid residue
of VimA that is present on proteins HtrA and Pgl833. The unique sequenced if in bold.
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D.7. Antibody production towards rVimA

The purified rVimA protein was used for the production of rabbit polyclonal
antibodies. The antibodies were purified by the protocol described. 1:2000 dilutions of
the antibodies were observed to be efficient for western blotting (Fig.6.6).

D.8. VimA in antigenic in an ApoE mouse model

Western blotting revealed sera from animals immunized with P. gingivalis W83
exhibited immunoreactivity with rVimA (Fig. 6.7). In contrast, sera from animals not
immunized with P. gingivalis or immunized with FLL92, a vwl4-defective mutant
exhibited no immunoreactivity with the rVimA protein. Taken together, these results
suggest that the vimA gene product is immunogenic in the ApoE mice.
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Figure 6.6. Antibody production towards rVimA.
Immunoreactivity of the rVimA proteins using rVimA antibodies as a probe. A 1:2000
dilution was the desired dilution
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Figure 6.7. VimA is antigenic in a mouse model.
Serum was drawn from the P. gingivalis challenged ApoE mice after immunization. Sera
from challenged mice were then used as primary antibodies against the purified rVimA
protein.
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E. DISCUSSION

According to bioinformatic analysis (www.tigr.org), VimA is a unique putative
membrane protein that has been shown to play a role in virulence regulation in P.
gingivalis. Inactivation of vimA resulted in reduced virulence in a mouse model and also
defects in gingipain maturation resulting in a late onset of proteolytic activity (1). The
absence of vimA also showed carbohydrate biogenesis defects which may contribute to
the absence of the gingipains onto the surface of P. gingivalis and the delayed gingipain
maturation observed (Vanterpool er al. 2004, In press). The involvement of vimA in
gingipain maturation has been demonstrated and the hypothetical mechanism through
carbohydrate biogenesis has been suggested, however, the mechanism on how VimA
functions has not been identified. One method of defining a mechanism of proteins is
determining the proteins interacting partners. Protein-protein interactions were done
using purified recombinant VimA expressed in E. coli.

It has been shown that vimA plays a role in the maturation of the gingipains
[(1,21)(Vanterpool et al. In press)]. If vimA is in a pathway or regulate pathways involved
in the maturation and activation of the gingipains, then VimA should interact with the
gingipain directly or indirectly. Interestingly, interaction studies demonstrate the
interaction of rVimA with the gingipains of P. gingivalis. Protein-protein interaction
using purified RgpB suggests this interaction may be indirect. Data from this study
further confirms the involvement of VimA in the maturation pathway of the gingipains.
Other proteins identified that interact with VimA may also be regulatory proteins or
possible virulence factors of P. gingivalis.
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The rVimA protein has also shown to interact with p-lactamase, a protein
involved in sugar metabolism and antibiotic resistance in many organisms (11). Recently,
it has also been correlated with cell adhesion (26). P-lactamase strains of bacteria,
including P. gingivalis, are more pathogenic, due to drug resistance (4,11). Thus, Plactamase may be considered a virulence factor of P. gingivalis. The interaction of
rVimA with p-lactamase may suggest, in addition to regulating the gingipains, VimA
may also be important in regulating sugar metabolism proteins as well. These findings are
consistent with the carbohydrate defects observed in the vz'7?l4-defective mutant
(Vanterpool et al. In press). It has been suggested that VimA may regulate factors
involved in carbohydrate biogenesis (Vanterpool et al. In press). Another sugar
metabolism protein that was shown to interact with rVimA is a putative sialidase protein.

Sialidases cleaves a-ketosidic linkages between sialic residues and glycoproteins.
Sialidase from bacteria E. rhusiopathiae was shown to play a role in infection and tissue
destruction (17,18). Also, proteolytic bacteria can use the sialidases to remove glycan
moeties leaving glycoproteins of the host vulnerable to cleavage by proteases. Sialidases
has also been shown to modulate the hosts ability to respond to bacterial infections.
Previously it was reported that strains of the oral pathogen, Tannerella forsythensis that
possesses sialidase activity are more pathogenic and those that lack sialidase activity
(12,27). This raises an important question if this putative sialidase in P. gingivalis play
any role in its pathogenicity or regulation of virulence factors, since it has been shown
that P. gingivalis has sialidase activity. The sialidase of P. gingivalis is probably released
into the environment, along with the gingipains, on membrane vesicles. The sialidase
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may then cleave selected sugar moieties from tissues, leaving them susceptible to
cleavage by proteolytic enzymes, such as the gingipains. The physical interaction of the
sialidase with VimA further suggests a role that VimA plays in not only regulating the
virulence factor of this organism, but also help in the coordination of its pathogenesis.
The role of this sialidase gene in P. gingivalis has not been evaluated and will be
evaluated in laboratory.

Another interacting partner of rVimA includes the serine periplasmic protein HtrA.
HtrA is a heat shock induced serine protease which plays a crutial role in many bacteria.
HtrA have been shown to degrade misfolded proteins (23); posses a chaperone function
at low temperatures and proteolytic activity at high temperature in organism T. maritima
(13); provides oxidative stress resistance and regulates growth at high temperature in S.
pneumonia (22); degrades misfolded or aggregated proteins and is involved in the
maturation of cysteine protease SpeB in S. pyogenes (16); can process proteins in L. lactis
(7,24), able to degrade misfolded proteins in the periplasm and the folding of secreted
proteins of E. coli (15,23) and oligomerization and the export of virulence factors in K.
pneumonia. (5) In addition, the absence of HtrA also results in attenuated virulence in
several organisms (5,16). The regulatory role(s) of HtrA in P. gingivalis is currently
being investigated in the laboratory. Preliminary results show that HtrA can regulate the
gingipains under stressful environmental conditions (data not shown). In addition,
preliminary results from our laboratory also demonstrate a regulatory role that the
hypothetical protein Pgl833 has in regulating the gingipains under environmental stress
(data not shown). The interaction of VimA with HtrA and Pgl833 further confirms a
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regulatory role of VimA in P. gingivalis. Also, a unique VimA protein residue sequence
was present in mass spectrometry data from the HtrA and Pgl833 proteins. This type of
protein-tagging has not been identified in P. gingivalis.

Protein-tagging has been a mechanism used by organisms to regulate or determine
the fate of a protein (14,29). The SsrA system in B. subtilis has been shown to tag
proteins. This system have been suggested to be involved in monitoring the amount of
certain proteins suggesting a regulatory role of this system (14,29). The identification of
the 27 amino acid residue of VimA on selected proteins may suggest that VimA could
function as regulatory protein in P. gingivalis. This tagging may regulate the function of
selective proteins. It is also a possibly that VimA could also function as an “adaptor”
protein or a unique protein involved in carbohydrate biogenesis.

Studies on VimA in our lab may demonstrate a potential candidate for vaccine
development or therapeutic target in the prevention of periodontal disease and/or
systemic infections caused by periodontal infections (ie. cardiovascular, stroke, preterm
births). It has been reported that immunization of animals using the virulence factors of
P. gingivalis can provide protection against P. gingivalis diseases (6,9,10,20). Since
VimA is shown to modulate the virulence factors of P. gingivalis, it is reasonable to think
that this protein may be a potential therapeutic target. In this study, the sera from the P.
gingivalis W83 challenged mice were shown to immunoreact to the purified rVimA. The
recognition of VimA by the immune system of P. gingivalis challenged mice, suggests
that VimA would be an ideal candidate for developing a vaccine. Data from this and
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other studies confirms that VimA may be apart of a common regulatory pathway in P.
gingivalis. The mechanism of VimA will continue to be evaluated in our laboratory.
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A. ABSTRACT

In several microorganisms, HtrA, a serine periplasmic protease, is considered an
important virulence factor that plays a regulatory role in oxidative and temperature stress.
Previously in the laboratory, we have shown that the vimA gene product is an important
virulence regulator in P. gingivalis. Further, the purified recombinant VimA physically
interacted with the major gingipains and the HtrA from P. gingivalis. To further evaluate
a role for HtrA in the pathogenicity of this organism, a 1.5 kb fragment containing the
htrA gene was PCR-amplified from the chromosomal DNA of P. gingivalis W83. This
gene was insertionally inactivated using the ermF-ermAM antibiotic cassette and used to
create an

-deficient mutant by allelic exchange. In one randomly chosen isogenic

mutant, designated P. gingivalis FLL203, there was increased sensitivity to hydrogen
peroxide. Growth of this mutant at an elevated temperature was more inhibited compared
to the wild-type. Further, in contrast to the wild-type after heat shock, there was a
significant decrease in Arg-gingipain activity in FLL203. The gingipain activity in this
mutant however returned to normal levels after a further 30 minute incubation period at
room temperature. The purified recombinant HtrA protein was shown to physically
interact with the gingipains RgpA, RgpB, Kgp and hemagglutanin protein HagA.
Collectively, these data may suggest that HtrA interacts with the gingipains in P.
gingivlis and may play similar role in oxidative and temperature stress as observed in
other organisms.
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B. INTRODUCTION

Porphyromonas gingivalis, a black-pigmented Gram-negative anaerobic bacterium,
has been implicated as a major etiological agent in the development of chronic adult
periodontitis [Reviewed in (7,8,10,33)], a destructive inflammatory disease of the
supporting tissues of the teeth. This organism is also associated other systemic diseases,
including atherosclerosis [Reviewed in (16,26,32)]. The high-level of proteolytic
activities of this organism have been the focus of much attention and appear to play an
important role in its virulence (7,12,24). The major proteases called gingipains are
extracellular and/or cell-associated. The Arg-specific gingipains, RgpA and RgpB are
encoded by the rgpA and rgpB gene respectively. The Lys-specific protease (Kgp) is
encoded by the kgp gene (25). There is a gap in our understanding of the regulation and
processing of the gingipains. We have reported the posttranslational regulation of the
gingipains in the

-defective mutant P. gingivalis FLL92 (1). The vimA gene is a part

of bcp-recA-vimA operon. Further, protein-protein interaction studies using the purified
rVimA showed that this protein interacts with the gingipains and the HtrA homologue in
P. gingivalis (unpublished data). A role for HtrA in gingipain regulation and virulence in
P. gingivalis is unclear.
Protein quality control is essential for bacterial survival in a hostile environment.
This quality control is regulated by chaperones and proteases (9,19). HtrA (high
temperature requirement A) is a perisplasmic heat-shock serine protease that functions as
a molecular chaperone at low temperatures and has proteolytic activity at elevated
temperatures (15). In several organisms, including bacteria, yeast, plant and humans,
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HtrA is considered an important factor that is involved in protein folding and maturation
as well as in the degradation of proteins that are misfolded (30). Inactivation of the htrA
gene has been shown to affect the sensitivity of many organisms to thermal and oxidative
stress (18,28). Here we report that HtrA physically interacts with the gingipains RgpA,
RgpB and Kgp. HtrA is involved in resistance to thermal and oxidative stress in P.
gingivalis.
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C. MATERIALS AND METHOD

C.l. Bacterial strains and growth conditions.

Strains and plasmids used in this study are listed in Table 1. P. gingivalis strains
were grown in brain heart infusion (BHI) broth (Difco Laboratories, Detroit, Mich.)
supplemented with hemin(5 pg/ml), vitamin K (0.5 pg/ml), and cysteine (0.1%).
Experiments with hydrogen peroxide were performed in BHI without cysteine.
Escherichia coli strains were grown in Luria-Bertani broth. Unless otherwise stated, all
cultures were incubated at 37°C. P. gingivalis strains were maintained in an anaerobic
chamber (Coy Manufacturing, Ann Arbor, Mich.) in 10% Hi-10% CO2-80% Ni. Growth
rates for P. gingivalis and E. coli strains were determined spectrophotometrically (optical
density at 600 nm [OD6oo])- Antibiotics were used at the following concentrations:
clindamycin, 0.5 pg/ml; erythromycin, 300 pg/ml; and carbenicillin, 100 pg/ml.

C.2. DNA isolation and analysis

P. gingivalis chromosomal DNA as previously reported (34). For plasmid DNA
analysis, DNA extraction was performed by the alkaline lysis procedure of Birnboim and
Doly. For large-scale preparation, plasmids were purified using the Qiagen (Santa Clarita,
CA.) plasmid maxi kit.
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C.3. Generation of A/M-defective mutant P. gingivalis strain

A 1.5-kb fragment carrying the intact htrA open reading frame (gene number Pg0535,
WAVw.oralgen.lanl.gov) was amplified by PCR using the PI and P2 oligonucleotide
primers (Table 1). This fragment was cloned into the pCR 2.1-Topo plasmid vector
(Invitrogen, Carlsbad, CA) and designated pFLL200. The 1.5-kb fragment was then
isolated from pFLL200 digested with BamHl and A&a 1 and ligated to pUC19 linearized
with the same enzymes. The new recombinant plasmid was designated FLL201.
Orientation was confirmed by restriction analysis. The ermF-ermAM cassette which
confers erythromycin/clindamycin resistance in E. coli and P. gingivalis was PCR
amplified from pVA2198 using Pfu turbo (Stratagene, La Jolla, CA) with primers P5 and
P6 (Table 1). The amplified fragment was inserted into the Ms'cT restriction site of the
htrA gene. The resultant recombinant plasmid, pFLL202, was used as a donor in
electroporation of P. gingivalis W83 as previously reported (34).

C.4. Preparation of P. gingivalis extracellular fractions and protease assays

One-liter cultures of P. gingivalis strains FLL203 and W83 were grown from
actively growing cells. Cells were harvested by centrifugation at 10,000xg for 30
minutes. The cell-free culture fluid was precipitated with cold (-20°C) 37.5 or 60%
acetone, and the protein pellet was resuspended in 7 ml of 100 mM Tris-HCl buffer (pH
7.4), dialyzed for 24 h against the same buffer, and then stored on ice or at 0°C. The
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presence of Arg-X- and Lys-X-specific cysteine protease activities was determined with a
microplate reader (Bio-Rad Laboratories, Hercules, CA.) as previously reported (31).

C.5. Protein concentration determination

Protein concentration was calculated spectrophotometrically using the Warburg formula
within the protein function of the Eppendorf Biophotometer (Brinkman. Westbury, NY).

C.6. SDS-PAGE and Immunoblot analysis

SDS-PAGE was performed with a 4-12% Bis-Tris separating gel in MOPS
(morpholinepropanesulfonic acid)-SDS running buffer (NuPAGENovex gels; Invitrogen,
Carlsbad, CA.) according to the manufacturer's instructions. Samples were prepared (65%
sample, 25% 4x NuPAGELDS sample buffer, 10% NuPAGE reducing agent), heated at
72°C for 10 min, and then electrophoresed at 200 V for 65 min with the XCell SureLock
Mini-Cell (Invitrogen, Carlsbad, CA). The separated proteins were then transferred to
nitrocellulose membranes (Schleicher & Schuell, Keene, N.H.) and processed at 15 V for
25 min with a Semi-Dry Trans-blot apparatus (Bio-Rad). The blots were probed with
antibodies against specific protease domains (27) or HagA (generously donated by
Progulske-Fox). Immunoreactive proteins were detected by using the Western Lightning
Chemiluminescence Reagent Plus kit (Perkin-Elmer Life Sciences, Boston, MA.). The
secondary antibody was immunoglobulin G (heavy plus light chains)-horseradish
peroxidase conjugate (Zymed Laboratories, Inc., South San Francisco, CA.).
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C.7. Analysis of P. gingivalis toA-defective mutant genes by RT-PCR

Total RNA was extracted from P. gingivalis strains grown to early stationary phase
(OD600 of 1.2 ) using RiboPure kit (Ambion, Austin TX). The primers used for reverse
transcription-PCR (RT-PCR) analysis were specific for the kgp (primers P3 and P4) and
htrA (PI and P2), genes (Table?. 1). The RT-PCR reaction (50 pi) contained 1 pg of
template RNA in the Superscript One-step RT-PCR reaction mix (Invitrogen, Carlsbad
CA). Negative controls were RT-PCR in the absence of reverse transcriptase.

C.8. Cell fraction preparation

One-liter cultures of P. gingivalis strains FLL203 and W83 were grown from
actively growing cells. Preparations of whole-cell culture, cell-free medium, cell
suspension, vesicles, and vesicle-free medium were made as previously reported (34).
The whole-cell culture (WC) fraction is a sample of the culture after the bacterium has
been grown to a specific growth phase. This sample has the bacterial cells suspended in
the growth medium, and the enzyme activity includes the gingipains that are attached to
the bacterial cell surface plus those that are secreted in the culture medium. After
centrifugation, the cell pellet was resuspended, and the enzyme activity in this sample
(the cell suspension fraction, CS) represents the gingipains that are attached to the
bacterial cell surface; While the enzyme activity in the supernatant (the cell-free medium
fraction, CF) includes the gingipains that are secreted in the culture medium. Secreted
gingipains can either be associated with vesicles or soluble in the culture medium; thus,
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ultracentrifugation of the cell-free fractions will yield a vesicle pellet (V) and a
supernatant of soluble gingipains (VF).

C.9. Effect of heat shock on gingipain activity and recovery

24 hour cultures of P. gingivalis strains FLL203 and W83 were grown from actively
growing cell cultures. Cells were incubated for 10 minutes at 55°C and proteolytic
activities were analyzed immediately and at 30 minutes after heat shock treatment.

C.10. Growth analysis under elevated temperatures and oxidative stress conditions

100 ml cultures of P. gingivalis strains FLL203 and W83 were grown from actively
growing cell cultures. For adaptation of P. gingivalis strains to elevated temperatures,
cells were incubated at 42°C under anaerobic conditions for 28 hours. Growth was
determined as described above at intervals at 0, 4, 8, 24 and 28 hours. For adaptation
under oxidative stress conditions, /z/tG-defective mutant and the wild-type were grown in
BHI without cysteine in the presence of 0.25mM H2O2. Controls were grown in the
absence of H2O2.

C.ll. Cloning and expression of rHtrA
Oligonucleotides primers specific for the open reading frame (PI and P2) of the htrA
gene was synthesized and used for PCR amplification of the gene. This amplified
fragment carrying the htrA open reading frame, was cloned into pTrcHis2-TOPO
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expression plasmid (Invitrogen, Carlsbad CA) carrying a C-terminus His-tag. The
recombinant plasmid (designated pFLL137) was then transformed into Topi OF’
competent E. coli cells (Invitrogen, Carlsbad CA). Orientation of the htrA was
determined by endonuclease restriction digest. The nucleotide sequence of the insert was
determined to rule out the occurrence of mutations. E. coli carrying the htrA open reading
frame was grown in Luria Bertani broth to exponential phase (OD 600 of 0.7) in the
presence of SOpg/ml of carbenicillin. ImM isopropyl-beta-D-thiogalactopyranoside
(IPTG) was added to the log phase E. coli and allowed to incubate at 37°C with shaking
for 6 hours. Cells were harvested by centrifugation and lysed by sonciation. Cell
membrane and debris were then harvested by centrifugation and supernatant and pellet
were analyzed for the presence of the rHtrA protein. The presence of the poly-histidine
tag was confirmed by the GelCode 6xHis Protein Tag (Pierce, Rockford, IT) kit
according to manufacture’s instructions.

C.12. Protein-Protein interactions

The E. coli carrying the expressed rHtrA was purified using Ni-NTA magnetic
beads. The purified rHtrA protein was then incubated for 30 minutes with magnetic beads
covered with Ni-NTA (Qiagen). Beads were washed four times with wash/interaction
buffers (50mM Na^PCN, 300mM NaCl, 50mM Imidazole and 0.005% Tween 20). Cells
lysates from W83 grown to stationary phase was then incubated for 30 minutes with the
recombinant proteins on the magnetic beads. As a negative control, the lysates were
incubated with the magnetic beads without the recombinant proteins. After incubation
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with cell lysates, unbound proteins were eliminated with extensive washing in wash
buffer. Proteins were eluted off the beads under denaturing conditions (IX LDS sample
buffer, heated to 90°C for 10 minutes). Eluates were then analyzed by SDS-PAGE and
immunoblot analysis.
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D. RESULTS

D.l. Inactivation of the htrA gene in P. gingivalis W83 by allelic exchange
mutagenesis

Isogenic mutants of P. gingivalis W83 defective in the htrA gene were constructed
by allelic exchange mutagenesis. The circular recombinant plasmid pFLL202, which
carries the ermF-ermAM cassette in the unique Ms^l restriction site of the htrA gene, was
used as a donor in electroporation of P. gingivalis W83 (Fig.7.1). Because the plasmid
was unable to replicate in P. gingivalis, we predicted that two double-crossover events
between the regions flanking the erm marker and the wild-type gene on the chromosome
would result in replacement of a segment of the wild-type gene with a fragment
conferring erythromycin resistance. Following electroporation and plating on selective
medium (BHI containing lOpg/ml erythromycin), we detected approximately 51
erythromycin-resistant colonies after a 7-day incubation period. To compare their
phenotypic properties with those of wild-type strain W83, all mutants were plated on
Brucella blood agar plates. Similar to the wild-type strain, all mutants displayed a blackpigmented, beta-hemolytic phenotype.
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The htrA ORF was amplified using specific^
oligonucleotides and cloned into an pCR-2.1 Topo
cloning vector

htrA was isolated using BamHI and Xba1 and
ligated to the BamHI and Xba1 linearized pUC19
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htrA was digested with Msc\ and blunted
erythromycin resistant cassette was ligated to
the Msd site

The recombinant plasmid carrying the
inactivated htrA was designated pFLL202
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1
P. gingivalis FLL203

Figure 7.1. Generation of a /ifM-defective mutant by allelic exchange mutagenesis.
pFLL202 contains the htrA gene interrupted by the ermF-ermAM cassette isolated from
pVA2198. The circular recombinant plasmid, FLL202 was introduced into P. gingivalis
W83 by electroporation.
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D.2. Confirmation of inactivation of htrA by PCR analysis

Chromosomal DNA from 6 randomly chosen clindamycin/erythromycin resistant
colonies and the wild-type W83 strain were analyzed by PCR to confirm the inactivation
in the htrA gene. If the htrA gene was interrupted by the ermF-ermAM cassette, a 3.5 kb
fragment was expected to be amplified using htrA primers PI and P2. In addition, a 2.1
kb fragment should be amplified from the mutant using the ermF-ermAM

The

expected 3.5 kb (using htrA primers) and 2.1 kb (using erythromycin primers) fragments
were observed only in the erythromycin resistant strains in contrast to the wild-type (Fig.
7.2A). To further confirm the absence of the htrA transcript in the erythromycin resistant
mutant, DNase treated RNA for P. gingivalis FLL203 and the wild-type was subjected to
RT-PCR. As shown in figure 7.2B, no htrA transcript was detected from the mutant in
contrast to the wild-type W83. Using Agp-specific primers (Table 7.2) as a control, the
expected 0.8 kb fragment was amplified from all the P. gingivalis strains. There was no
amplified fragment observed from similar reactions in the absence of reverse
transcriptase. Taken together these results indicated the insertional inactivation of the
chromosomal htrA gene with the 2.1 kb ermF-ermAM antibiotic cassette was successful.
One mutant designated P. gingivalis FLL203 was randomly chosen for further study. In
both the wild-type and the

-defective mutant FLL203, a generation time of 3 hours

was determined (data not shown). Both the Zz/rU-defective mutant and the wild-type were
black pigmented and hemolytic. Since it has been predicted that the htrA gene may be in
a transcriptional unit with its downstream gene -70 sigma factor. The presence of this
downstream gene was analyzed in the

-defective mutant using primers P7 and P8
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(see Table 7.1). The transcription of the htrA downstream gene was not prevented by the
htrA inactivation (Fig. 7.3.).
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Table 7.1. Primers used in this study

P1
P2
P3
P4
P5
P6
P7
F8

htrA forward
htrA reverse
pro-kgp forward
pro-kgp reverse
erythromycin forward
erythromycin reverse
rpo-70 forward
rpo-70 reverse

5'
5’
5’
5'
5’
5’
5’
5’

ATGAACAAAGTGTGGAAATAC3’
TAGTTCTACTTCGAAGGTCCG3’
ATGAGGAAATTATTATTGCTGATCG 3’
TTGAAGAGCTGTTTATAAGCTGTTT 3’
TATTAGGCCTATAGCTTCCGCTATT 3'
AATAGGCCTTAGTAACGTGTAACTTT 3’
ATGAGGCAACTTAAAATTTCC 3’
TTAGCCGAGATAACCTTTCAG 3’
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Table 7.2. Plasmids and bacterial strains used in this
study

Plasmids
pCR-2.1 TORO
pUC19
PFLL200
PFLL201
PFLL202
PVA2198

Phenotype/Description
Apr, Km'
Apr
pCR 2.1-TORO: htrA
pUC19:ttrA
pUC19: htrA:: ermF-ermAM
Sp', ermF-ermAM

Source
Invitrogen
Invitrogen
This study
This study
This study
(34)

Bacterial strains
Porphyromonas gingivalis
W83
FLL203

This study

Wild-type
MrA-defective mutant

This study

Escherichia coii
DH5a
Top10

F' <t>80d/acZA M15 A(/acZYA-argF) U169 recA1 endAI hsdRI 7(rk-, mk+)
phoA supEAA X' thiA gyrA96 re/AI

Invitrogen

F mcrA A (mrr-hsdRMS-mcrBC) <\>80lacZA Ml5 AlacXJA recAl ara 139 A
(ara-/eu)7697 ga/U ga/K rpsL (StrR) endA'l nupG

Invitrogen
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Figure 7.2. Confirmation of inactivation by PCR and RT-PCR analysis.
A. Primers specific for the htrA gene (PI and P2; Table 7.2) were used to amplify that gene
from total cellular DNA from P. gingivalis. Lane 1, P. gingivalis FLL203.1 (htrA:\ermFermAM); lane 2, P. gingivalis FLL203.2 (htrA:\ermF-ermAM)’, lane 3, P. gingivalis
FLL203.3 (htrAwermF-ermAM). Primers specific for the ermF-ermAM cassette (P5 and P6)
were used to amplify the 2.1 cassette; Lane 4, P. gingivalis FLL203.1 (htrA::ermF-ermAAP);
lane 5, P. gingivalis FLL203.2 (htrA::ermF-ermAM); lane 6, P. gingivalis FLL203.3
(htrA:\ermF-ermAM)-, and lane 6, P. gingivalis W83 (wild-type) using htrA primers. B. Total
RNA isolated from P. gingivalis W83 and the /z/rT-defective mutant isolated from stationary
phase (OD600 of 1.4-1.5) was subjected to RT-PCR using primers for htrA and pro-kgp. No
transcription or htrA detected in P. gingivalis FLL203.1 and in the negative controls without
reverse transcriptase.
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sigma

+RT
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Figure 7.3. The -70 sigma factor transcription is unaffected in the A/M-defective
mutant. Approximately 1 pg DNase treated RNA from P. gingivalis W83 and FLL203
were subjected to RT-PCR using primers specific for the htrA or the -70 sigma factor
ORFs. Amplification products were observed by gel electrophoresis, stained with
ethidium bromide and visualized using ultraviolet wavelengths. Negative controls were
reactions performed in the absence of reverse transcriptase.
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D.3. P. gingivalis FLL203 is more sensitive to oxidative stress than the P. gingivalis
W83

P. gingivalis W83 and the /z/M-defective mutant FLL203 were evaluated for
oxidative stress resistance by its ability to grow in the presence of hydrogen peroxide. In
contrast to the parent strain (Fig. 7.4A), FLL203 demonstrated increased sensitivity to
hydrogen peroxide at a final concentration of 0.25 mM (Fig. 7.4B).

D.4. Growth and Rgp activity of P. gingivalis FLL203 at elevated temperatures are
affected

P. gingivalis FLL203, the /zfrvt-defective mutant, was found to grow at a similar rate
to that of the wild-type at 37°C (data not shown). However, the mutant grew more slowly
than the W83 wild-type at 42°C (Fig. 7.5C) and under the same experimental conditions
as the wild-type did not grow over the optical density of 0.9. In cells grown at 42°C for 8
hours or 28 hours, Rgp activity was increased by approximately 20% and 10%
respectively in the mutant compared to the wild-type strain (Fig. 7.5A and B). The ability
of the P. gingivalis FLL203 to recover from heat shock was also evaluated. After a 10
minute incubation at 55°C, both the wild-type and the mutant strains were further
incubated for 24 hrs at 37°C. There was a slightly longer lag phase observed in the htrAdefective mutant in comparison to the wild-type (data not shown).
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Figure 7.4. /r/M-defective mutant is more sensitive to hydrogen peroxide than the
wild-type.
Actively growing P. gingivalis W83 and FLL203 were incubated with 0.25mM
hydrogen peroxide in the absence of cysteine. Sensitivities to hydrogen peroxide were
determined by optical density 600nm over time. A=P. gingivalis W83, B= P. gingivalis
FLL203.H = treated, ♦ =untreated controls.
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Figure 7.5. Growth and Rgp activity of P. gingivalis FLL203 at elevated
temperatures are affected.
Cultures of P. gingivalis W83 and FLL203 were grown at 42°C for 28 hours under
anaerobic conditions. Growth was analyzed by optical density 600nm over time. Rgp
activity was determined at exponential phase and stationary phase of growth. A= Rgp
activity at exponential phase, B= Rgp activity at stationary phase, C= growth analysis at
42°C. ■= P. gingivalis FLL203, ♦=F>. gingivalis W83
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D.S.Gingipain activity is altered under temperature stressful conditions

To determine if the gingipains are affected by elevated temperatures in the htrAdefective mutant, P. gingivalis W83 and FLL203 were incubated at 55°C for 10 minutes.
At 37°C, there was no significant difference in Rgp activity (data not shown) in the
mutant compared to the wild-type. However, immediately after heat treatment, Rgp
activity in the wild-type was elevated by 7% in comparison to the untreated control
(Fig.7.6). Interestingly, the Rgp activity in the /z/>vf-defective mutant was decreased by
13% in comparison to the untreated control (Fig. 7.6). Rgp activities determined 30
minutes after heat treatment, had similar Rgp activities for both the wild-type and
FLL203 (data not shown).

D.6.Gingipain profiles and distribution are altered under temperature stress

The distribution of gingipains in the wild-type (Fig. 7.7A) and the /zfrvf-defective
(Fig. 7.7B) mutants were very similar under normal growth conditions. However, the
distribution of the Rgps appeared to be slightly altered by incubations at temperatures at
42°C. There appeared to be approximately 30% less cell associated Rgp activity in the
/z/tvI-defective (Fig.7.7D) mutant in comparison to the wild-type (Fig. 1.1C). Very little
alteration in Kgp activity was observed (data not shown). Immunoblot analysis of
extracellular fractions demonstrated the absence of selective RgpA and RgpB
immunoreactive bands in the /z/ryf-defective mutant as seen in figure 7.8.
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Figure 7.6. Gingipain activity is altered under short incubations at elevated
temperatures.
P. gingivalis FLL203 and W83 were incubated at 55°C for 10 minutes. Rgp activity was
determined by BApNA hydrolysis in comparison to the untreated P. gingivalis FLL203
or W83.
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Figure 7.7. Distribution of Rgp activity is altered in the Zi//c4-defective mutant
P. gingivalis FLL203 or W83 were grown at either 37°C or 42°C. Activities against
BApNA were tested in whole cell culture (WC), cell free media (CF), cell suspension
(CS), vesicles (V) and vesicle free (VF) of the P. gingivalis strains. A=W83 grown at
37°C, B=FLL203 grown at 37°C, C= W83 grown at 42°C, D=FLL203 grown at 42°C.
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Figure 7.8. Gingipain profiles are altered under elevated temperatures
P. gingivalis FLL203 and W83 cells incubated at 37°C or 42°C for 28 hours were
fractionated into extracellular. Extracellular proteins were separated by SDS-PAGE and
gingipains were analyzed by immunoblot analysis. Arrows indicates missing
immunoreactive bands in the /zfrvf-defective mutant.
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D.7. rHtrA codes for a 60kDa protein and can interact with the virulence factors in
vitro
To determine if HtrA can physically interact with and possibly regulate the
gingipains , the htrA open reading frame was isolated, cloned into an expression vector
and expressed in E. coli. The htrA gene was shown to encode for the predicted 60kDa
protein (Fig. 1.9A). Immunoblot analysis of interacting proteins of HtrA using gingipain
specific antibodies and monoclonal HagA antibodies demonstrated that HtrA interacts
with gingipains RgpA, RgpB , Kgp and hemagglutanin protein HagA (Fig.7.9B).
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Figure 7.9. rHtrA interacts with gingipains RgpA, RgpB and Kgp and
hemagglutinin protein HagA.
The htrA ORF was amplified by PCR from chromosomal DNA of P. gingivalis W83,
cloned into pTrcHis2-TOPO, sequenced and E. coli cells with recombinant plasmids
carrying the htrA gene were induced with ImM IPTG. The rHtrA protein was analyzed
by SDS-PAGE (A). Cells were lysed by sonication and gene products were attached to
Ni-NTA magnetic beads. The rHtrA protein was then incubated with W83 cell lysates
grown to exponential phase. Eluates of protein interactions with rHtrA were analyzed by
immunoblot blots using gingipain specific antibodies; RgpA, Kgp, RgpB or HagA
antibodies (B). Negative controls were cells lysates incubated with the magnetic beads
only.
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E. DISCUSSION

In many organisms, HtrA is shown to play a regulatory role under environmental
stress (4,6,30). HtrA is a periplasmic serine protease which plays a crutial role in many
organisms, which includes protection against oxidative stress, survival at elevated
temperatures and/or biogenesis of bacterial virulence factors [Reviewed in
(11,18,20,28,30)]. In addition, it has also been reported that the absence of HtrA in
several bacterial species also results in attenuated virulence in an animal model(3).

The role of HtrA in P. gingivalis was evaluated in this study. The periodontal
pocket during an infection is a very hostile environment (2,14,37). P. gingivalis possesses
strategies to survive by regulating its virulence factors. Our data suggest that HtrA may
play a role in P. gingivalis survival in the periodontal pocket during an infection. We
have demonstrated that the /z/rH-defective mutant is more sensitive to elevated
temperature than the wild-type. This could have implications for growth in the
periodontal pocket where there is usually increased temperature due to inflammation. The
growth of the mutant at 42°C was altered compared to the wild-type. In addition to the
compromised growth of the /z^rJ-defective mutant, there was significantly more Rgp-X
activity in comparison to the wild-type. These results suggest that HtrA is needed for
proper Rgp regulation under elevated temperatures.

It has been reported that P. gingivalis responds to elevated temperatures by
decreasing the expression of their virulence factors (22,29). Prolonged growth at
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temperatures above 37°C results in a significant decrease in gingipain activity. The
decrease in proteolytic activity could be correlated with a down-regulation of the
gingipain gene transcript, which were observed in P. gingivalis cells grown at elevated
temperatures (23,29). Distribution of the gingipains also appeared to be more cellassociated when incubated at elevated temperatures (23). A reduction in hemagglutanin
activity was also observed from cells grown at increased temperatures (29). In our study,
the distribution of the gingipains in /zfrvt-defective mutant showed less cell-associated
Arg-gingipain activity than that of the wild-type grown under the same conditions. There
was approximately double the activity of gingipains in the culture supernatant of the
mutant to that of the parent strain grown under the same conditions. The presence of htrA
in P. gingivalis may act as a stress sensor for environmental changes, in addition to its
chaperone and proteolytic functions.

It has been shown that members of the bacterial HtrA family, including DegS and
DegP, are stress sensors in the bacterial periplasm (17,18,35,36). In the bacterial stress
response, signals passes through the bacterial membrane causing transcription by release
of the sigma factor (17,18,35,36). It has been suggested that the HtrA proteins are the
actual stress sensors (35). Some HtrA proteins have a portion of the protein which is
anchored to the membrane on the periplasmic side (36). The PDZ switch domain of the
HtrA proteins enables it to regulate its proteolytic activity (17,35). Consitent with these
reports, bioinformatic analysis demonstrates that the P. gingivalis HtrA have a PDZ
domain and also a N-terminal hydrophobic region, indicating membrane association
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(www.tigr.org). Futhermore, htrA has been predicted to be in an operon with a RNA
polymerase -70 sigma factor and several ribosomal protein subunits (www.tigr.org).

The detection of elevated temperatures by HtrA may cue P. gingivalis to downregulate the gingipains. This down-regulation of the gingipain genes that normally occurs
in P. gingivalis was hypothesized to promote their invasion and colonization in the host
and also to prevent a massive inflammatory response (23). We can envision a scenario
in P. gingivalis, when there is an elevation in temperatures, the HtrA protein detects the
change and signals proteins to release the sigma factor. This will lead to transcription of
proteins and factors that will protect the organism. In addition, the virulence factors,
including the gingipains will be down-regulated. The reduction in the ability of the htrAdefective mutant to completely regulate the Arg-gingipains to that of the wild-type levels
may indicate that importance of HtrA in regulating the virulence factors. In a host, this
mutant may not invade and colonize very well. It may also cause more of an
inflammatory response due to levels of Rgp activity. This will have to be further
evaluated.

HtrA may directly regulate the gingipains. The ability of the gingipain activity to
decrease after a short heat shock treatment, where the wild-type had increased Rgp
activity, further suggest the direct involvement of HtrA with the Rgps. During heat shock
in the

-defective mutant, the Rgp catalytic domains could have been denatured

resulting in the decreased Rgp activity observed. htrA may be needed for protection of
the gingipains under these conditions. Withing 30 minutes of treatment, the wild-type and
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/zfryl-defect mutant Rgp activity were similar. We cannot rule out the possibility of other
heat shock proteins were possibly up-regulated to return the organism to homeostasis.
Protein-protein interaction experiments using rHtrA also demonstrates that HtrA could be
directly involved with the regulation of the gingipains though its interaction. These data
further confirms the direct involvement of HtrA with the gingipains.

It has been demonstrated that HtrA was needed for the maturation of the
staphopain SpeB (20). The data in this study may suggest that HtrA may not be essential
for the maturation/activation of the gingipains under normal conditions, but may be
necessary for their fate under elevated temperatures. However, we cannot rule out the
possibility that other factors or proteins could be up-regulated to compensate for the
defect. There may be alternative pathways and/or proteins in P. gingivalis that can be upregulated to compensate for the HtrA deficiency. It has been documented that other
chaperones can also regulate the sigma factor, like the HtrA protein. P. gingivalis has
many heat shock proteins (HSPs) (9,21). These HSPs acts as chaperones that aids in the
assembly and folding of proteins. It is imperative that P. gingivalis have these very
important proteins. P. gingivalis has several HSPs including GroES, GroEL, DnaK, HtpG
and HtrA (9,21). In the absence of HtrA, anyone of these heat shock proteins can be upregulated.

In addition to elevated temperatures, the periodontal pocket during an infection can
have reactive oxygen species and oxidative radicals (2,14). These ROS and oxidative
radicals can contribute to oxidative stress against P. gingivalis, a strict anaerobe. Our data

333

suggest that the

-defective mutant in more susceptible to hydrogen peroxide than that

of the wild-type. As mentioned previously, HtrA acts as an environmental stress sensor.
In an oxidative stressful condition, HtrA possibly signal the up-regulation of antioxidant
enzymes, such as AhpC (5,13). The inability of this mutant to combat high oxygen
species may suggest that in the periodontal pocket, the /z^-defective mutant may not
survive.

Collectively, these data demonstrates an important regulatory protein, HtrA, in the
regulation of P. gingivalis under elevated temperature and oxidative stressful conditions.
We have not perform virulence experiments in this study, but the inability of the htrAdefective mutant to properly modulate the growth, gingipain activity and defense against
oxidative stress in this organism may suggest that the /z/zvl-defective mutant may not be
able to invade or survive in a host. Data from this study and VimA studies demonstrates a
possible regulatory function of HtrA for the gingipains in P. gingivalis.
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A. ABSTRACT

It has been shown previously in our laboratory that purified recombinant VimA
can interact with the major gingipains of P. gingivalis. In addition, rVimA was shown to
interact with a hypothetical protein Pgl833. The role of this protein in P. gingivalis has
not been evaluated. To further evaluate the role(s) Pgl833 play in P. gingivalis, the
predicted open reading frame was PCR amplified from P. gingivalis W83 and
insertionally inactivated using the ermF-ermAM antibiotic resistant cassette. The Pgl833defective mutant was created by allelic exchange. One randomly chosen mutant,
designated FLL205 was used for characterization. Under normal conditions, the Arg-X
and Lys-X gingipain activities were reduced by approximately 35% and 21%,
respectively, in comparison to the wild-type. However, prolonged growth under elevated
temperatures, the Arg-X activities were over 40% more in comparison to the wild-type
under the same conditions. Further, the Pg/#33-defective mutant growth was shown to
be more resistant to oxidative stress when treated with 0.25mM hydrogen peroxide than
the wild-type. Taken together these results suggest that the Pgl833 gene, designated regT
(regulator or gingipain activity under elevated temperatures), may be involved in
regulating gingipain activity under elevated temperatures.
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B. INTRODUCTION

Many pathogenic organisms posses mechanisms or strategies that enables them to
regulate factors needed for invasion, establishment and survival in the host (5,7). These
strategies ensure the regulation of important virulence factors of these pathogens.
Porphyromonas gingivalis, a Gram negative, anaerobic bacteria, have been shown to be
associated with periodontal disease (2,12,30). It has also been associated with many
systemic diseases, including cardiovascular disease (8,18,19). The major virulence factor
of P. gingivalis includes the Rgp-X and Lys-X gingipains. The gingipains are both
membrane-associated and extracellular proteases (7).

Regulation, maturation and activation of the gingipains have been the focus of
study (1,13,21,27,29,33). There have been many speculations and hypothesis on how the
gingipains are regulated and activates, but only recently there evidence is pointing to a
unique regulatory mechanism or mechanism(s) that P. gingivalis utilizes for the
regulation, maturation and activation of the gingipains. Several genes, including vimA,
vimE, vimF, gppX and porR, have been shown to play regulatory roles in gingipain
activation and/or maturation [(1,13,29,33), (Vanterpool et al In Press), (Vanterpool et al,
submitted)]. Previously in our laboratory, a late onset of proteolytic activity and altered
gingipain distribution was observed in this mutant, FLL92 (1). In addition, the 64kDa
partially process RgpB was secreted from the

-defective mutant (24). These data

suggest vimA may regulate the gingipains through an unidentified pathway. In vitro
protein interaction studies using Recombinant VimA identifies the hypothetical protein
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Pgl833 as an interacting partner of VimA (Unpublished data). The role of Pg 1833
(RegT) in P. gingivalis is the focus of this study.

To determine the role, if any, that RegT play in gingipain regulation, we have
created and characterized the P. gingivalis isogenic mutant FLL205, defective in the
gene, now designated as regT. While there was a reduction in gingipain activity under
normal conditions, it appears that this gene may play a regulatory role for the gingipains
under elevated temperatures. Immunoblot analysis shows altered extracellular gingipain
profde, but unaltered cell associated gingipain profile, suggesting a role for regT with the
extracellular proteases. In addition, the regT-defective mutant appeared to be more
resistant to oxidative stress than the wild-type. These results suggest an important
regulatory role that regT plays in regulating the gingipains under elevated temperatures.
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C. MATERIAL AND METHODS

C.l. Bacterial strains and growth conditions

Strains and plasmids used in this study are listed in Table 1. P. gingivalis strains
were grown in brain heart infusion (BHI) broth (Difco Laboratories, Detroit, Mich.)
supplemented with hemin(5 pg/ml), vitamin K (0.5 pg/ml), and cysteine (0.1%).
Experiments with hydrogen peroxide were performed in BHI without cysteine.
Escherichia coli strains were grown in Luria-Bertani broth. Unless otherwise stated, all
cultures were incubated at 37°C. P. gingivalis strains were maintained in an anaerobic
chamber (Coy Manufacturing, Ann Arbor, Mich.) in 10% H2-10% CO2-80% N2. Growth
rates for P. gingivalis and E. coli strains were determined spectrophotometrically (optical
density at 600 nm [OD6oo])- Antibiotics were used at the following concentrations:
clindamycin, 0.5 pg/ml; erythromycin, 300 pg/ml; and carbenicillin, 100 pg/ml.

C. 2. DNA isolation and analysis

P. gingivalis chromosomal DNA was prepared as previously described. For plasmid
DNA analysis, DNA extraction was performed by the alkaline lysis as previously
performed (33). For large-scale preparation, plasmids were purified using the Qiagen
(Santa Clarita, CA.) plasmid maxi kit.

346

C. 3. Generation of

555-defective mutant P. gingivalis strain

A 4.7 kb fragment carrying the intact Pgl833 open reading frame was amplified by
PCR using the PI and P2 oligonucleotide primers (Table 8.2). This fragment was cloned
into the pCR 2.1-Topo plasmid vector (Invitrogen, Carlsbad, CA) and designated
pFLL99. Pgl 833 was digested with Hindi, which removes 3.1 kb of the gene. The ermFermAM cassette which confers erythromycin/clindamycin resistance in E. coli and
P. gingivalis was PCR amplified from pVA2198 using Pfu turbo (Stratagene, La Jolla,
CA) and inserted into the Hindi site. Orientation of the erythromycin cassette was
determined by restriction analysis. The resultant recombinant plasmid, pFLL204, was
used as a donor in electroporation of P. gingivalis W83 as previously reported (10).

C. 4. Growth analysis under elevated temperatures and oxidative stress conditions

100 ml cultures of P. gingivalis strains FLL205 and W83 were grown from actively
growing cell cultures. For adaptation of P. gingivalis strains to elevated temperatures,
cells were incubated at 42°C under anaerobic conditions for 28 hours. Growth was
determined by optical density (OD 600nm) reading at 0, 4, 8, 24 and 28 hours. For
adaptation under oxidative stress conditions, PgT#33-defective mutant and the wild-type
were grown in BHI without cysteine in the presence of 0.25mM H2O2. Controls were
grown in the absence of H2O2. The growth was determined by optical density readings at
0, 2, 4, 6, 24 and 28 hours.
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C. 5. Protease activity under environmental stress conditions

For analysis of gingipain activity of P. gingivalis strains under elevated
temperatures, cells were incubated at 42°C under anaerobic conditions for 28 hours.
Protease activity was determined as previously reported for cells grown to exponential
phase (ODeoo of 0.8) and stationary phase (ODeoo of 1.2).

C. 6. SDS-PAGE and immunoblot analysis

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was
performed with a 4 to 12% Bis-Tris separating gel in MOPS (morpholinepropanesulfonic
acid)-SDS running buffer according to the manufacturer's instructions (NuPAGENovex
gels; Invitrogen, Carlsbad, CA). Samples were prepared (65% sample, 25% 4x NuPAGE
EDS sample buffer, 10% NuPAGE reducing agent), heated at 72°C for 10 min, and then
electrophoresed at 200 V for 65 min in the XCell SureLock Mini-Cell System
(Invitrogen, Carlsbad, CA). The protein bands were visualized by staining with Simply
Blue Safe stain (Invitrogen, Carlsbad, CA). The separated proteins were then transferred
to BioTrace nitrocellulose membranes (Pall Corporation, Ann Arbor, MI.) and processed
at 15 V for 25 min with a Semi-Dry Trans-blot apparatus (Bio-Rad, Hercules, CA). The
blots were probed with gingipain specific antibodies (26). Immunoreactive proteins were
detected by the procedure described in the Western Lightning Chemiluminescence
Reagent Plus kit (Perkin-Elmer Life Sciences. Boston, MA). The secondary antibody was
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immunoglobulin G (heavy plus light chains)-horseradish peroxidase conjugate (Zymed
Laboratories, Inc., South San Francisco, CA.).
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Table 8.1 Plasmids and bacterial strains used in this
study

Plasmids
pCR-2.1 TORO

Phenotype/Description

Source
Invitrogen

pFLL99

Apr, Kmr
pCR 2.1-TORO: Pg1833

This study

PFLL205

pCR 2.1-TORO: Pg1833:: ermF-ermAM

This study

PVA2198

Spr, ermF-ermAM

(D

Bacterial strains
Porphyromonas gingivalis
W83
FLL205

Escherichia coli
DH5a

Wild-type
regT-defective mutant

F" (j)80d/acZA M15 A(/acZYA-argF) U169 recA1 endA'l
/isdR17(rk-, mk+) phoA supEAA- X ' thi-'\ gyrAQG re/A1
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This study
This study

Invitrogen

Table 8.2 Primers used in this study

P 1 Pgl833 forward
P 2 PgJ833 reverse
P 3 erythromycin forward
P 4 erythromycin reverse

5’ ATGGGTCGTATCAAGCAACGT3’

5’ TCGCTTT GTCGGAATGATATS ’
5’ TATTAGGCCTATAGCTTCCGCTATT S’
5’ AATAGGCCTTAGTAACGTGTAACTTT S’
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D.RESULTS

D.l. Inactivation of the regT gene in P. gingivalis W83 by allelic exchange
mutagenesis

Isogenic mutants of P. gingivalis W83 defective in the Pgl833 gene (designated
regT) was constructed by allelic exchange mutagenesis. The circular recombinant
plasmid pFLL204, which carries the ermF-ermAM cassette in the Hindi restriction site
(bp 0.8kb of the open reading frame) of the regT gene, was used as a donor in
electroporation of P. gingivalis W83 (Fig. 8.1). Following electroporation and plating on
selective medium (BHI containing lOpg/ml erythromycin), we detected approximately 70
erythromycin-resistant colonies after a 6-day incubation period. To compare their
phenotypic properties with those of wild-type strain W83, all mutants were plated on
Brucella blood agar plates. Similar to the wild-type strain, all mutants were blackpigmented and beta-hemolytic phenotype.
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Pg1833

*5

he Pg1833 gene was amplified using specific oligonucleotides
nd cloned into an pCR-2.1 Topo cloning vector

Hindi
Hindi
,...1....................... . .

Hindi
::

1

■

...

______________

*

->

Pg1833 was digested with Hindi and blunted
erythromycin resistant cassette was ligated to the Hindi
site

Xv................

5S ermF-ermAM
yy.'..

V

i

_

The recombinant plasmid carrying the
inactivated Pg^833 was designated pFLL205

The defective copy of Pg1833 replaced the
wild-type copy by allelic exchange

P. gingivalis FLL205

Figure 8.1. Generation of a r^J-defective mutant by allelic exchange mutagenesis.
pFLL204 containing the regT gene interrupted by the ermF-ermAM cassette isolated
from pVA2198. The circular recombinant plasmid, FLL204 was introduced into P.
gingivalis W83 by electroporation.
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D.2. Confirmation of inactivation of regT by PCR analysis

Chromosomal DNA from 2 randomly chosen erythromycin resistant colonies and
the wild-type W83 strain were analysed by PCR to confirm the inactivation in the
Pgl833 gene. If the Pgl833 gene was interrupted by the ermF-ermAM cassette, a 3.7 kb
fragment was expected to be amplified using primers PI and P2 (table 8.2). The
expected 3.7 kb and 4.7 kb fragments were observed in the 2 erythromycin resistant
strains and the wild-type W83 respectively (Fig. 8.2A). Using erythromycin primers
should amplify the 2,1 kb ermF-ermAMcassette from the Pgl833 defective mutants.
PCR analysis using erm cassette primers yielded a 2.1 kb fragment amplified (Fig. 8.2B).
Taken together these results indicated the insertional inactivation of the chromosomal
Pgl833 gene with the 2.1 kb ermF-ermAM antibiotic cassette was successful. One
mutant designated P. gingivalis FLL205 was randomly chosen for further study.
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1

2

W83

4.7kb
3.7kb

Pg1833
primers

1

2

Erm
control
erythromycin
primers

2.1 kb

Figure 8.2. Confirmation of inactivation by PCR analysis. A. Primers specific for the
Pgl833 gene (PI and P2; Table 2) were used to amplify that gene from total cellular
DNA from P. gingivalis. Lane 1, P. gingivalis FLL205.1 (Pgl833:\ermF-ermAM); lane
2, P. gingivalis FLL205.2 (Pgl833::ermF-ermAM); lane 3, P. gingivalis W83 (wild-type)
using Pgl833 primers. B. Using primers specific for the ermF-ermAM cassette (P3 and
P4) were used to amplify the 2.1 cassette; Lane 1, P. gingivalis FLL205.1
(Pgl833::ermF-ermAM); lane 2, P. gingivalis FLL205.2 (Pgl833::ermF-ermAM); lane 6,
pVA2198.
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D.3. Growth analysis under stressful conditions

To determine if Pgl833 (regT) played a role in regulating P. gingivalis growth under
oxidative stressful conditions or growth under elevated temperatures, P. gingivalis regTdefective mutant and W83 strains were grown either at 42°C or in the presence of 0.25
mM H2O2. In the presence of 0.25mM H2O2, the regT-defective mutant appeared to be
more resistant to 0.25mM H2O2 in comparison to the wild-type (Fig. 8.3). To determine if
regT played a role in growth of P. gingivalis at elevated temperatures, P. gingivalis W83
and FLL205 were incubated at 42°C under anaerobic conditions for 28 hours. There was
no significant difference in the growth in the regT-defective mutant (Fig. 8.4B) and the
wild-type when grown at 42°C (Fig.8.4C).
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Figure 8.3. Growth of P. gingivalis FLL205 at elevated temperatures are not
affected. Cultures of P. gingivalis W83 and FLL205 were grown at 42°C for 28 hours
under anaerobic conditions. Growth was analyzed by optical density 600nm over time.
■= P. gingivalis FLL205, ♦=P. gingivalis W83.
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Figure 8.4. The r^J-defective mutant is more resistant to hydrogen peroxide than
the wild-type. Actively growing P. gingivalis W83 and FLL205 were incubated with
0.25mM hydrogen peroxide in the absence of cysteine. Sensitivities to hydrogen peroxide
were determined by optical density 600nm over time. A=P. gingivalis W83, B= P.
gingivalis FLL205. ■= treated, ♦untreated controls.
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D.4. Protease activity under normal and elevated temperature conditions

To determine if regT can affect proteolytic activity, P. gingivalis regT-defective
mutant and the wild-type were grown at 37°C under anaerobic conditions. At stationary
phase, the proteolytic activity was analyzed. In stationary phase, there was approximately
a 35% decrease in Arg-X activity (Fig. 8.5A) and a 21% decrease in Kgp activity (Fig.8.
5B). The ability of regT to regulate the gingipain activity when grown at elevated
temperatures were evaluated. P. gingivalis regT-defective mutant and the wild-type were
grown at 42°C for 28 hours under anaerobic conditions. At exponential phase, there was
35% more Arg-gingipain activity (Fig. 8.6A) in comparison to the wild-type grown under
similar conditions. There was a 40% more Kgp activity in the rcgT-defective (Fig. 8.6B)
mutant than the wild-type. At stationary phase, there was only 18% more Arg-gingipains
activity (Fig. 8.6C) than the wild-type, however, there remained 41% more Kgp activity
in the regT-defective mutant (Fig.8.6D) than the wild-type. Immunoblot analysis using
RgpA and RgpB specific antibodies of extracellular fractions after growth at 42°C,
showed differences in the immunoreactive bands between the wild-type and the mutant
(Fig.8.7). Immunoblot analysis of cellular fractions after growth under elevated
temperatures showed no significant differences between the immunoreactive bands
between the wild-type of the mutant (data not shown).
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Figure 8.5. Inactivation of regT resulted in altered proteolytic activity of P.
gingivalis. P. gingivalis was grown to stationary phase [(OD600) of 1.4] in BHI broth
supplemented with yeast extract, hemin and vitamin K. Activities against Rgp (A) and
Kgp (B) were tested in whole-cell culture
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Figure 8.6. Gingipain activity of P. gingivalis FLL205 at elevated temperatures are
affected. Cultures of P. gingivalis W83 and FLL205 were grown at 42°C for 28 hours
under anaerobic conditions. Gingipain activity was analyzed by BApNA or ALNA
hydrolysis. Rgp and Kgp activity was evaluated at exponential phase and stationary phase
of growth. A=Rgp activity at exponential phase, B= Kgp activity at exponential phase C=
Rgp activity at stationary phase, D= Kgp activity at stationary phase
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Figure 8.7. Gingipain profiles are altered under elevated temperatures. P. gingivalis
FLL205 and W83 cells incubated at 42°C for 28 hours and extracellular proteins were
precipitated with 60% acetone. Proteins were separated by SDS-PAGE and gingipains
were analyzed by immunoblot analysis. Arrows indicates missing immunoreactive bands
in the rcgE-defective mutant.
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E. DISCUSSION

In the oral cavity under normal conditions or during an infection, the environmental
conditions can be very hostile towards periodontal pathogens (11,22,34). Conditions of
the periodontal cavity include elevated temperatures and also an environment of constant
oxidative stress and oxygen tension (6,16). It is imperative that periodontal pathogens
must posses ways of combating these harsh conditions. It is also imperative that these
organisms posses strategies to regulate their virulence factors to ensure their invasion and
survival.

We have previously showed that vimA gene can play a role in modulating the
virulence factors of P. gingivalis [(l,24)(Vanterpool et al. In Press)]. Furthermore,
protein-protein interaction studies using purified rVimA show that, in addition to the
gingipains and HtrA, the hypothetical protein Pgl833 (RegT) was identified as an
interacting protein of rVimA (unpublished data). This may suggest that this protein may
also regulate the gingipains of this organism. Bioinformatic analysis of RegT failed to
show any homology to any known proteins or conserved enzymatic domains and is
shown to be a putative membrane protein (www.oralgen.lanl.gov. and
www.ncbi.nlm.nih.gov). In this study, we have identified a gingipain stress regulator.

P. gingivalis has several heat-shock proteins/chaperones that can help regulate P.
gingivalis growth, survival and virulence in the host. It has been reported that the average
temperature in a healthy oral cavity is 36.8°C and can range up to two degrees higher in

363

the periodontal pocket (22). Forng et al also demonstrated that the gingival can have a
constant temperature range of 30-38°C (11). Studies on the temperature response in P.
gingivalis have been performed at temperatures ranging from 39°C to 43°C. Amano et al.
demonstrated temperature stress on P. gingivalis occurred at temperatures above 39°C
(3,4). In this study, we have used 42°C. In this study, the regF-defective mutant growth
was not altered under elevated temperatures in comparison to the wild-type. This
suggests that regT may not play a role in survival of the organism under temperature
stress in vitro. The role of regT in vivo may be different than the wild-type. This will
have to be evaluated.

Protection against oxidative stress is an important survival strategy of P.
gingivalis. P. gingivalis uses many antioxidant enzymes and endonuceleases to ensure its
survival (32). Several antioxidant enzymes includes, superoxide dismutase (SOD),
rubrerythrin (Rbr) and alkyl hyrdroperoxide peroxidase (AhpC), among others, have be
shown to be key players in the protection against oxidative stress in vitro (9,14,28,31). It
has been reported that the ahpC and sod-defective mutants are more sensitive to
hydrogen peroxide in comparison to the parent strain. Although these mutants
demonstrated increased sensitivities in vitro, the virulence potential of the o/zpC-defective
mutant and the survival of the sod-defective mutant in neutrophils were similar to the
wild-type (14,20). Interestingly, in this study, the rogT-defective mutant was shown to
be more resistant to oxidative stressful conditions in relation to the parent strain. These
findings are similar to what was observed in the vz'm/1-defective mutant, FLL92 (15). We
cannot rule out the possibility that in the vzm^-defective mutant, the function of the regT
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gene product could be altered, which would result in the increased resistance to oxidative
stress observed in P. gingivalis FLL92 (15). This may suggest that in the regT-defective
mutant, an up-regulation of antioxidant enzymes may be occurring to protect the
organism under oxidative stress. It has also been suggested that the increased resistance
in P. gingivalis FLL92 may require more DNA damage repair activity to repair DNA
damage due to oxidative stress (15). A similar mechanism may be occurring in the regT
defective mutant. This has not been evaluated.

We have also provided evidence that the absence of regT causes altered regulation
of the gingipains under normal or elevated temperatures. The increased amount of
gingipain activity in comparison to the wild-type grown under stressful conditions
suggests that regT may play a role in gingipain regulation. In exponential phase there was
approximately 40% more Rgp activity that was decreased to 18% in stationary phase.
Interestingly, Kgp activity remained approximately 41% more than the wild-type through
out the growth phase. These findings suggest that abnormal regulation of the gingipains
are occurring in the rcgT-defective mutant. Normally, P. gingivalis can down regulate
their virulence factors to ensure their invasion and survival in the host (3,4,11,17,23,25).
However, this abnormal regulation may prevent the colonization and survival in the host
(23). In addition, immunoblot analysis demonstrates that the extracellular Rgps are
affected, but not cell-associated Rgps. This may suggest RegT functions on regulating the
extracellular Rgps of P. gingivalis. Collectively, we have identified a new gingipain
stress regulator of P. gingivalis, RegT, which is shown to modulate gingipain activity
under normal 37°C and 42°C temperatures.
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CHAPTER NINE

CONCLUSION AND FUTURE STUDIES

The study of virulence regulation in any bacteria is challenging. Each pathogen
possesses unique strategies to ensure its invasion and survival in the host. As a common
theme, the expression of extracellular proteolytic activities is highly regulated in both
prokaryotic and eukaryotic systems. This regulation usually occurs at the level of
expression of the protease genes, secretion and/or processing of an inactive secreted
precursor to its active form. Since it has been shown that P. gingivalis posses several
virulence factors that are important in periodontitis and complications of periodontitis
(2,14,20), it is imperative to determine mechanisms involved in regulating virulence of
this pathogen. We have investigated and developed putative models involved in
virulence regulation and gingipain activation.

We have shown that the vimA and it newly identified downstream gene, vimE,
can modulate the phenotypic expression of the gingipains in P. gingivalis. While the vimA
gene is part of the bcp-recA-vimA transcriptional unit, the downstream vimE can either be
co-transcribed with vimA or can be independently expressed (39). The vimA and vimEdefective mutant strains designated P. gingivalis FLL92 and FLL93, respectively, were
non-black pigmented and showed significant reductions in proteolytic, hemolytic, and
hemagglutinating activities (1,39). While reductions in Arg-X- and Lys-X-specific
proteolytic activities were observed in P. gingivalis FLL92 and FLL93, the gingipain
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genes were being transcribed, similar to the wild-type (39). The 64 kDa RgpB partially
processed proenzyme was secreted in both P. gingivalis, FLL92 and FLL93 (29,39). The
distribution of the proteolytic activity in P. gingivalis FLL93 was similar to the wild-type
strain in contrast to P. gingivalis FLL92, the

-defective mutant (1,39).

While there was a unique late onset of Arg-X- and Lys-X-specific proteolytic
activity in P. gingivalis FLL92, there were little or no observed changes of proteolytic
activity in stationary phase in the P. gingivalis FLL93, the vzmA-defective mutant
(1,29,39). These observations have raised the question that the regulation of proteolytic
activity in P. gingivalis may occur by multiple mechanisms. Further, it is unclear if the
vimA and vimE gene products are part of a common pathway for protease
maturation/activation.

Since the gingipains were being transcribed in the vimA and vz'mfs-defective
mutants of P. gingivalis, indicates posttranslational regulation. Consistent with the lack
of protease activation in the vimE- defective mutant, the 64 kDa RgpB protein was
present throughout the growth phases unlike the vzzzz^4-defective mutant that demonstrated
a late onset of proteolytic activity and the disappearance of the 64 kDa RgpB proenzyme
(Vanterpool et al, In press). A high molecular weight protein band of 185 kDa was
confirmed by mass spectrometry to be the unprocessed proenzyme for RgpA (Vanterpool
et al, In press). Also, The 80 kDa band that immunoreacted with the RgpB proenzyme
antibodies and RgpB antibodies may represent the unprocessed, full length form of RgpB
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(Vanterpool et al, In press). Collectively, these data have confirmed a defect in the
maturation of the gingipains in P. gingivalis FLL93.

Membrane-associated RgpA, RgpB and Kgp were detected in P. gingivalis FLL93 in
contrast to the

-defective mutant. Based on the high molecular weight

immunoreacting bands to antibodies against these gingipains, the membrane-associated
forms could represent the unprocessed or partially processed proteases (Vanterpool et al,
In press). Although cross reactivity can occur between RgpA, Kgp and hemagglutanins
using RgpA and Kgp antibodies, the lack of immunoreactivity to antibodies against
RgpA and Kgp in membrane fractions from P. gingivalis FLL92, the vimA defective
mutant, could suggest that those gingipains and hemagglutanins are not present on the
cell membrane. Alternatively, the antibodies may only be immunoreactive with the
modified forms of the gingipains, thus, the unmodified forms, if present on the cell
membrane of the vz'myf-defective mutant, may be undetectable. The presence of Kgp and
RgpA in extracellular fractions of P. gingivalis FLL92 has been previously
documented(29). In contrast to the absence of cell-associated RgpA and Kgp in P.
gingivalis FLL92, RgpB was detected in this fraction (Vanterpool et al, In press). This
may suggest that there are multiple mechanisms for post-translational modification of the
gingipains that will enable cell-membrane association. This is consistent with emerging
evidence that polysaccharide biogenesis plays a significant role in cell-associated
gingipains and the difference in their distribution among P. gingivalis strains might be
related to the degree of production or maturation of cell surface polysaccharide (See
Figure 1 A). Recently, Rgp and Kgp were shown to be produced, but not retained, on the
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cell surfaces of a P. gingivalis porR mutant (37). The porR gene product is part of the
polysaccharide biosynthetic pathway that can affect gingipain biogenesis, its anchorage
and possible distribution on the cell surface.

Figure 9.1 A. Putative LPS-gingipain anchorage model of P. gingivalis

Figure 9.1B. Putative LPS-defective gingipain attachment model of P. gingivalis
v/mA-defective mutant
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There was no apparent defect in the production of membrane vesicles either in the
vimA or vimE isogenic mutants (Vanterpool et al, In press). Proteolytic activity was
more readily released from these vesicle fractions from P. gingivalis FLL92 in contrast to
the wild-type. Western blot analysis of the membrane vesicles from P. gingivalis FLL92
also showed less intense immunoreactive bands for RgpA and Kgp when compared to the
wild-type strain (Vanterpool et al, In press). These observations are consistent with the
mostly soluble gingipain activity previously reported for P. gingivalis FLL92. It also
raises questions on vesicle formation as a mechanism for gingipain secretion in the vimAdefective mutant. Consistent with the lack of proteolytic activity in the membrane
fraction from the vzmfs-defective mutant, little gingipain activity was detected in the
membrane vesicles. Immunoblot analysis of vesicles however, showed only unique high
molecular weight bands in P. gingivalis FLL93 in contrast to W83. Thus, it is possible
that its maturation pathway may require VimE, although we cannot rule out a role for the
gingipains. Several reports have documented a role for the gingipains in the maturation
of cell membrane proteins.
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Putative model of gingipain glycosylation in
Newly translated gin<^c?n?irf?-lle^penp?^ri?^pa^^)e^^)^Pg1^osylated by the role of

1)
different glycosyl transferases. Once at the surface, the final modification needed to
complete the glycosylation will promote the proper folding and activation of the
gingipains.
The glycosyl transferases, which are involved with the cell surface polysaccharide
biosynthesis, helps to synthesize the proper cell surface polysaccharides and promotes
the anchorage of the gingipains to the surface of the organism.
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Figure 9.2 A. Glycosylation in P. gingivalis

Alterations in the glycosylation profile of the vimA and v/mfs-defective isogenic
mutants were observed (Vanterpool et al, In press). While several proteins appeared to
be glycosylated, the gingipain-specific oligosaccharide moiety detectable by mAb 1B5
was missing in the mutants membrane fractions. This data may suggest that the
carbohydrate polymers or residues present in the isogenic mutants may be altered which
could affect the maturation of the gingipains. Collectively, these data further support a
role for glycosylation in the modulation of gingipain activity in P. gingivalis. It has been
demonstrated that the gingipains are glycoproteins, however the specific alteration in the
polysaccharide profile in the both the vimA and vz'm£-defective mutants are unclear. A
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possible explanation for the alteration could be the down-regulation of gene products,
(such as glycosyl transferases), that play a role in the glycosylation of proteins and
synthesis of LPS. A preliminary microarray analysis of the

-defective mutant has

shown a down-regulation of several glycosyl transferases and other genes involved in
polysaccharide biogenesis. It has been shown that LPS modifications of the C-terminus
of proteins are needed for the stable interaction or attachment of the proteins to the cell
surface. Analysis of the cell surface polysaccharides isolated from the parent strain W83
and isogenic mutants grown under the same conditions showed that the LPS of FLL92
and FLL93 were truncated compared to the wild-type. However, the removal of the lipid
A from the LPS resulted in polysaccharide fractions that had similar profiles for both the
parent strain and FLL93 compared to the polysaccharide profile of FLL92, which was of
shorter length, similar to that of the />orR-defective mutant. The truncated
polysaccharides of P. gingivalis FLL92 may be correlated with the absence of RgpA and
Kgp on the membrane surface. Currently, there are no good models for prokaryotes or for
P. gingivalis depicting the importance of glycosyl transferases and glycosylation in
protein anchorage and maturation. With information from this study and others, a model
for glycosylation in P. gingivalis has been proposed (See Model 2A).
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Alteration in carbohydrate biogenesis in the
vimA defective mutant
1) Glycosylation of gingipains are altered by possibly defects of specific glycosyl transferases,
which may prevent the gingipains from folding correctly preventing the timely activation of the
gingipains.
2) Glycosyl transferases involved in synthesis of the cell surface polysaccharides may also be
affected preventing the anchorage of the gingipains onto the surface of the organism.
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Figure 9.2B. Glycosylation in P. gingivalis FLL92, the v/m/l-defective mutant

To determine if carbohydrate biogenesis plays a role in gingipain
maturation/activation, we investigated a 1.2 kb gene downstream of the vimE gene to
determine its role in protease activation in P. gingivalis. This gene, which shares
homology with glycosyl transferase 1 genes from other bacteria including Geobacter
metallireducens, Methanococcus sp. and Treponema denticola (www.oralgen.lanl.gov),
was inactivated in P. gingivalis by allelic exchange mutagenesis. The P. gingivalis
isogenic mutant designated FLL95 exhibited reduced Arg-X- and Lys-X-specific
proteolytic activities that were not affected by the phase of growth. The glycosylation of
the gingipains was altered in this mutant. These results suggest an important role for the
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putative glycosyl transferase gene, vimF, in protease maturation/activation in P.
gingivalis and further confirm the requirement of multiple specific host factors in this
process.

Altered glycosylation in the v/m&
and vimF defective mutants

1)Glycosylation of gingipains are altered by possibly defects of specific glycosyl transferases,
which may also prevent the gingipains from folding correctly preventing the timely activation of
the gingipains.
2)Glycosyl transferases involved in synthesis of the cell surface polysaccharides are not
affected therefore the anchorage of the gingipains onto the surface of the organism are not
prevented.
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Figure 9.2C. Glycosylation in vimE and v/Vw^-defective mutants

Consistent with the lack of protease activation in this vzmF-defective isogenic
mutant, this protein was present in stationary phase culture media unlike the vimAdefective mutant that demonstrated a late onset of proteolytic activity [(l,29)(Vanterpool
et al, submitted data)]. In contrast to the wild-type, high-molecular-weight
immunoreactive protein bands that could represent the unprocessed gingipains were also
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secreted in the P. gingivalis FLL95. In addition, there appeared to be RgpB
immunoreactive bands between 80 and 54 kDa, which may represent an intermediate
processed species. Collectively, these data have confirmed a defect in the maturation of
the gingipains in P. gingivalis FLL95, suggesting the importance of proper glycosylation
in gingipain maturation/activation.

One method of defining a mechanism of proteins is determining the proteins
interacting partners. According to bioinformatic analysis, VimA is a unique putative
membrane protein. The involvement of vimA in gingipain maturation has been elucidated
and the hypothetical mechanism through carbohydrate biogenesis has been suggested,
however, the mechanism on how VimA functions has not been identified. Protein
interactions were done using purified recombinant VimA expressed in E. coli (See Figure
3).
The rVimA protein has also shown to interact with p-lactamase, a protein
involved in sugar metabolism and antibiotic resistance in many organisms (13). Recently,
it has also been correlated with cell adhesion (36). P-lactamase strains of bacteria,
including P. gingivalis, are more pathogenic, due to drug resistance (5,13). Thus, Plactamase may be considered a virulence factor of P. gingivalis. The interaction of
rVimA with P-lactamase may suggest, in addition to regulating the gingipains, VimA
may also be important in regulating sugar metabolism proteins as well. These findings are
consistent with the carbohydrate defects observed in the

-defective mutant

(Vanterpool et al. In press). It has been suggested that VimA may regulate factors
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involved in carbohydrate biogenesis (Vanterpool et al. In press). Another sugar
metabolism protein that was shown to interact with rVimA is a putative sialidase protein.

Sialidases cleaves a-ketosidic linkages between sialic residues and glycoproteins.
Sialidase from bacteria E. rhusiopathiae was shown to play a role in infection and tissue
destruction (26,27). Also, proteolytic bacteria can use the sialidases to remove glycan
moeties leaving glycoproteins of the host vulnerable to cleavage by proteases. Sialidases
has also been shown to modulate the hosts ability to respond to bacterial infections.
Previously it was reported that strains of the oral pathogen, Tannerella forsythensis that
possesses sialidase activity are more pathogenic and those that lack sialidase activity
(15,38). This raises an important question if this putative sialidase in P. gingivalis play
any role in its pathogenicity or regulation of virulence factors, since it has been shown
that P. gingivalis has sialidase activity. The sialidase of P. gingivalis is probably released
into the environment, along with the gingipains, on membrane vesicles. The sialidase
may then cleave selected sugar moieties from tissues, leaving them susceptible to
cleavage by proteolytic enzymes, such as the gingipains. The physical interaction of the
sialidase with VimA further suggests a role that VimA plays in not only regulating the
virulence factor of this organism, but also help in the coordination of its pathogenesis.
The role of this sialidase gene in P. gingivalis has not been evaluated and will be
evaluated in laboratory.

Another interacting partner of rVimA includes the serine periplasmic protein
HtrA. HtrA is a heat shock induced serine protease which plays a crutial role in many
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bacteria. HtrA have been shown to degrade misfolded proteins (31); posses a chaperone
function at low temperatures and proteolytic activity at high temperature in organism T.
maritima (17); provides oxidative stress resistance and regulates growth at high
temperature in S. pneumonia (30); degrades misfolded or aggregated proteins and is
involved in the maturation of cysteine protease SpeB in S. pyogenes (22); can process
proteins in L. lactis (8,33), able to degrade misfolded proteins in the periplasm and the
folding of secreted proteins of E. coli (21,31) and oligomerization and the export of
virulence factors in K. pneumonia. (7) In addition, the absence of HtrA also results in
attenuated virulence in several organisms (7,22).

Since HtrA and Pgl 833 were shown to interact directly with Vim A due to the
presence of the unique VimA sequence, the role that these genes play in P. gingivalis was
evaluated. By insertional inactivation using the erythromycin cassette and allelic
exchange, these mutants were generated. The

-defective mutant was shown to be

more sensitivity to hydrogen peroxide than the wild-type. Growth of this mutant at an
elevated temperature was more inhibited compared to the wild-type. Further, in contrast
to the wild-type after heat shock, there was a significant decrease in Arg-gingipain
activity. The gingipain activity in this mutant however returned to normal levels after a
further 30 minute incubation period at room temperature. The purified recombinant HtrA
protein was shown to physically interact with the gingipains RgpA, RgpB, Kgp and
hemagglutanin protein HagA. Collectively, these data may suggest that HtrA interacts
with the gingipains in P. gingivlis and may play similar role in oxidative and temperature
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stress as observed in other organisms. HtrA may directly regulate the gingipains under
stressful conditions.

To evaluate the role Pgl833 (RegT) play in P. gingivalis, we characterized the
Pgl833-defective mutant was generated by allelic exchange. Under normal conditions,
the Arg-X and Lys-X gingipain activities were reduced by approximately 35% and 21%,
respectively, in comparison to the wild-type. However under prolonged growth under
elevated temperatures, the Arg-X activities were increased by 40% in comparison to the
wild-type. Further, the regT-defective mutant growth was shown to be more resistant to
oxidative stress when treated with hydrogen peroxide than the wild-type. Taken together
these results suggest that the regT gene may be involved in regulating Arg-X activity
under elevated temperatures. The interaction of VimA with HtrA and Pgl 833 (RegT)
further confirms a regulatory role of VimA in P. gingivalis.

Also, protein-protein interaction shows a unique VimA protein residue sequence
was present in mass spectrometry data from the HtrA and Pgl 833 proteins. This type of
protein-tagging has not been identified in P. gingivalis. Protein-tagging has been a
mechanism used by organisms to regulate or determine the fate of a protein (18,40). The
SsrA system in B. subtilis has been shown to tag proteins. This system have been
suggested to be involved in monitoring the amount of certain proteins suggesting a
regulatory role of this system (18,40). The identification of the 27 amino acid residue of
VimA on selected proteins may suggest that VimA could function as regulatory protein
in P. gingivalis. This tagging may regulate the function of selective proteins. It is also a
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possibly that VimA could also function as an “adaptor” protein or a unique protein
involved in carbohydrate biogenesis.
It has been shown that the absence of the vimE gene product in P. gingivalis can
affect activation of the gingipains. In contrast to the

-defective mutant, there was no

late onset of proteolytic activity (1,39). Also, in the vimE mutant there were defects in
carbohydrate biogenesis which may be correlated to the drastically reduced proteolytic
activities observed (39). Reverse transcription showed that the gingipains were being
transcribed, suggesting the defect occurred on a translational level. The mechanism of
v/w£-dependent gingipain activation has not been fully defined. Thus, identification of
interacting partners of VimE could help elucidate its role in regulation of the virulence
factors of P. gingivalis.

Since vimE was shown to be involved in gingipain activation/maturation, it would
be reasonable to suggest that VimE may be in a pathway needed for the maturation of the
gingipains. If VimE is in a maturation pathway, we would expect the gingipains to
interact with VimE, as well as other key players that are involved in regulating the
maturation of the virulence factors of P. gingivalis. Results from our studies have
demonstrated that rVimE can interact with the gingipains RgpA, Kgp and RgpB. This
further confirms the involvement of VimE with gingipain maturation. The nature of the
interaction is unclear and is the subject of further investigation.

The physical interaction of VimE with ResD may indicate the ability of the
VimE-dependent function to respond to environmental signals. ResD is a two-component
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response regulator. In Bacillus subtilis, ResD is part of an operon with resE. This twocomponent signal transduction system have been shown to be required for the induction
of anaerobic metabolism(25). Homologues in S. aureus have been demonstrated to have a
similar role in anaerobic metabolism in this organism. In addition, SrrAB can regulate the
expression of the virulence factors in S. aureus (4,34,41). ResD has not been evaluated
in P. gingivalis and its involvement in virulence regulation remains unclear. There are
reports that gingipains activity in P. gingivalis can be regulated by environmental
conditions (16,24,32). Our observations could support a hypothesis that could involve the
physical interaction of VimE and ResD. ResE sensor kinase may detect environmental
signals which will regulate ResD. The phosphorylation of ResD by ResE is known to
highly stimulate its transcriptional activity (10,12,25). ResD may be needed for survival
under environmental stress. In addition, it has been shown that the expression of the
virulence factors of P. gingivalis are influenced by environmental conditions, thus
regulating the virulence factors under environmental changes.

GTPase is depicted the molecular switch protein in many organsims (6). GTPases
become active by binding GTP and becoming hydrolysed resulting in conformational
changes of the GTP protein, causing it to become active (6). The active GTPase protein
then interacts with its target becoming the timed switch of the cell or organism. LepA, a
membrane GTPase, has been identified as an interacting protein of rVimE. lepA is
usually in an operon with lepB and/or rcn (19). In P. gingivalis, lepA is directly
downstream of a putative transcriptional regulator (www.oralgen.lanl.gov). It has been
suggested that membrane GTPases function in the regulation of membrane signaling
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pathways (23). Bijlsma et al demonstrated, a

-defective H. pylori mutant was

sensitive to low acidic pH (3). It was proposed that LepA can possibly detect changes in
the environmental pH and start the regulation of factors needed for P. gingivalis survival
in a low pH (3). In a similar manner, LepA in P. gingivalis may either work along with
ResD and/or the up-stream transcriptional regulator in detecting environmental changes.
LepA may regulate the virulence factors or other factors for its survival in the host. The
role of LepA in P. gingivalis has not been investigated.

Since vimE was shown to be involved in gingipain activation/maturation, it would
be reasonable to suggest that VimE may be in a pathway needed for the maturation of the
gingipains. If VimE is in a maturation pathway, we would expect the gingipains to
interact with VimE, as well as other key players that are involved in regulating the
maturation of the virulence factors of P. gingivalis. Results from our studies have
demonstrated that rVimE can interact with the gingipains RgpA, Kgp and RgpB. This
further confirms the involvement of VimE with gingipain maturation. The nature of the
interaction is unclear and is the subject of further investigation.

The immunoreactivity of VimE with serum from periodontitis patients may
indicate that this protein is antigenic. This could have implication for its development as
a therapeutic target. Several reports have documented the protection of animals
immunized with P. gingivalis virulence factor components against further infection.
Genco et al has demonstrated that immunization with RgpA hemmaglutanin domain or
RgpB catalytic domain provides protection against P. gingivalis diseases (9,11).
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Reynolds group also demonstrated that immunization using the RgpA-Kgp complexed
could prevent the colonization of P. gingivalis and protect against different strains of P.
gingivalis (28,35). Because the VimE gene product can modulate activity of all the
gingipains and other virulence factors in P. gingivalis, targeting this protein could be of
greater significance. This is being further investigated in the lab.

In addition to VimE, studies on VimA in our lab may demonstrate a potential
candidate for vaccine development or therapeutic target in the prevention of periodontal
disease and/or systemic infections caused by periodontal infections (ie. cardiovascular,
stroke, preterm births). Since VimA is shown to modulate the virulence factors of P.
gingivalis, it is reasonable to think that this protein may be a potential therapeutic target.
In this study, the sera from the P. gingivalis W83 challenged mice were shown to
immunoreact to the purified rVimA. The recognition of VimA by the immune system of
P. gingivalis challenged mice, suggests that VimA would be an ideal candidate for
developing a vaccine. Data from this and other studies confirms that VimA may be apart
of a common regulatory pathway in P. gingivalis. The mechanism of VimA will continue
to be evaluated in our laboratory.
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Figure 9.3. VimA and interacting partners

The actual mechanism of how VimE functions has only been speculated.
According to previous findings, the presence of vimE seems to be necessary for the
regulation of proteins and factors involved in carbohydrate biogenesis (ie glycosyl
transferases) to perform their full function. The data received from these interaction
studies indicate that VimE may involved in regulating the transcriptional and
translational regulatory proteins. These regulatory proteins may be needed for the
maturation of the gingipains or the other virulence factors of P. gingivalis. The
mechanism(s) on how VimE functions will be further analyzed in our laboratory.
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As previously mentioned, VimA may act as an “adaptor” protein for many different
proteins involved in many different pathways of P. gingivalis, including gingipain
activation. In the absence of VimA, the gingipains may become activated by a “default”
mechanism depicted in Figure 4A. The secreted and unattached gingipains will be
released into the culture supernantant, where it reaches a high critical concentration,
stimulating pro-RgpB activation by the RgpB auto-proccessing model or the induced
proximity model for caspases. This putative default mechanism may account for the late
onset of proteolytic activity observed in the

-defective mutant. Since most of the

gingipains are anchored to the membrane of the vimE and v/wF-defective mutants, the
accumulation of secreted pro-RgpB does not reach a critical high concentration to
become activated by the “default” mechanism of activation as seen in Figure 4B. Thus, a
late onset of proteolytic activity is not observed in either the vimE or vimF mutants.
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Exponential Phase

During exponential phase,
the gingipains are secreted.
Although secreted, the
concentration of the
gingipain Pro-RgpB is not
high enough to become
activated by autoprocessing
or molecular interactions in
relation to concentration
described by Salvesen et al.

Stationary Phase

During stationary phase, the
accumulation of secreted
and unattached Pro-RgpB
reaches a high critical
concentration, which starts
the activation of RgpB to that
described by Salvesen et al.
RgpB activation model or the
induced proximity model
described for caspase
activation.

After RgpB becomes
activated, it can
subsequently activate
RgpA and with the
assistance of a host factor,
the activation of Kgp

Figure 9.4. Putative default-activation model of P. gingivalis FLL92
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Stationary Phase

In stationary phase, most of the gingipains remains cell associated. This will
prevent the concentration of the secreted Pro-RgpB from becoming critical for
the proposed default activation mechanism

Figure 9.4B. No activation of gingipains in vimE and vi>wF-defective mutants

Below, we have postulated a tentative model which may be part of the mechanism
for P. gingivalis gingipain and protein maturation.

a. Genes for virulence factors are transcribed and translated in the cell of
Porphyromonas gingivalis. As the proteins are translated, they are transported across the
cytoplasmic membrane by the SEC translocon and released into the periplasmic space
and interacts with periplasmic chaperones (such as HtrA). Chaperones help stabilize and
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partially fold the proteins that are destined to be membrane or secreted proteins. The
presence of VimA and VimF, starts the modification and maturation process of a number
of proteins with. VimE may also work in the periplasmic space to help modify or mature
proteins. The proteins are then transported across the outer membrane to the surface.
Once at the surface, the pro-domain and C-terminus domain of LPS-RgpB are autoprocessed to enable folding to complete and full activity to be obtained. On the surface,
LPS-RgpA and Kgp may be proteolytically processed at the N- and C- terminus of each
domain by possibly by VimA or proteins that interact with VimA, PG1833 and a
carboxypeptidase. After, the released domains complete their processes. EPS
modifications and attachment may occur either in the periplasmic space or on the surface
of the cell.

b.

It is possible that a defect in the proper glycosylation of proteins, including the

gingipains, may contribute to the abnormal maturation of the gingipains. In the vimAdefective mutant FLL92, the RgpB 64kDa may be partially processed resulting in an
inactive intermediate of the full length 80 kDa RgpB proenzyme. The initial cleavage of
the 80kDa RgpB and RgpA poenzyme is probably occurring at a normal rate. However,
in the vimE mutant, the presence of the 80kDa full length RgpB, 185 kDa RgpA and the
64kDa partially processed RgpB proenzyme intermediate suggests that there maybe is a
slow processing of the full length RgpB possibly due to abberant modification of the
proteins. VimE is maybe needed for or involved with factors for carbohydrate biogenesis,
which is important for the activation process of the gingipains. In contrast, the absence of
the 80kDa RgpB in P. gingivalis FLL92 suggests that vimA may not be needed for the
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initial step of activation. Further, in the vimA mutant, the normal activation mechanism
may be disrupted resulting in a default pathway of activation, similarly to that described
by Salvesen et al. We can envision a scenario where in the vimA mutant, the
concentration of the 64kDa RgpB reaches a high, critical concentration in stationary
phase where RgpB becomes activated by proximity-induced activation, which
subsequently activates RgpA. The activated Rgps may then be able to process other
proteins or factors that may be needed for Kgp activation. In contrast, in the vimE mutant,
the drastically reduced proteolytic activity may be a result of a defect in the initial
activations step of the RgpB proenzyme. Taken together, these data suggest that the
VimE protein in P. gingivalis may be involved in protease activation upstream of VimA.

In this report, we have identified several genes involved in regulating the virulence
factors of P. gingivalis. The identification of the production of inactive gingipains from
these isogenic mutants suggests gingipain maturation may be dependent upon proper
carbohydrate biogenesis. Through a proteomic approach, we have identified interacting
partners of VimA and VimE to help establish the mechanism that these proteins may play
in P. gingivalis. We have provided evidence that VimA and VimE proteins are in
pathway(s) needed for gingipain regulation. Additional regulatory proteins were also
identified in P. gingivalis. In our reports, we have contributed to the scientific pool
important information on regulating virulence in P. gingivalis. We have identified
excellent candidates for a therapeutic approach against this periodontal pathogen. With
knowledge from this study and others, we can make great strides in the prevention and
treatment of periodontal disease and its complications.
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